id	sid	tid	token	lemma	pos
fnp-3866	1	1	neurodegeneration	neurodegeneration	NOUN
fnp-3866	1	2	:	:	PUNCT
fnp-3866	1	3	2022	2022	NUM
fnp-3866	1	4	update	update	NOUN
fnp-3866	1	5	feel	feel	VERB
fnp-3866	1	6	free	free	ADJ
fnp-3866	1	7	to	to	PART
fnp-3866	1	8	add	add	VERB
fnp-3866	1	9	comments	comment	NOUN
fnp-3866	1	10	by	by	ADP
fnp-3866	1	11	clicking	click	VERB
fnp-3866	1	12	these	these	DET
fnp-3866	1	13	icons	icon	NOUN
fnp-3866	1	14	on	on	ADP
fnp-3866	1	15	the	the	DET
fnp-3866	1	16	sidebar	sidebar	NOUN
fnp-3866	1	17	free	free	ADJ
fnp-3866	1	18	neuropathology	neuropathology	NOUN
fnp-3866	1	19	3:13	3:13	NUM
fnp-3866	1	20	(	(	PUNCT
fnp-3866	1	21	2022	2022	NUM
fnp-3866	1	22	)	)	PUNCT
fnp-3866	1	23	review	review	NOUN
fnp-3866	1	24	neurodegeneration	neurodegeneration	NOUN
fnp-3866	1	25	:	:	PUNCT
fnp-3866	1	26	2022	2022	NUM
fnp-3866	1	27	update	update	NOUN
fnp-3866	1	28	john	john	PROPN
fnp-3866	1	29	f.	f.	PROPN
fnp-3866	1	30	crary	crary	PROPN
fnp-3866	1	31	neuropathology	neuropathology	PROPN
fnp-3866	1	32	brain	brain	PROPN
fnp-3866	1	33	bank	bank	PROPN
fnp-3866	1	34	&	&	CCONJ
fnp-3866	1	35	research	research	PROPN
fnp-3866	1	36	core	core	NOUN
fnp-3866	1	37	,	,	PUNCT
fnp-3866	1	38	department	department	NOUN
fnp-3866	1	39	of	of	ADP
fnp-3866	1	40	pathology	pathology	PROPN
fnp-3866	1	41	,	,	PUNCT
fnp-3866	1	42	nash	nash	PROPN
fnp-3866	1	43	family	family	PROPN
fnp-3866	1	44	department	department	PROPN
fnp-3866	1	45	of	of	ADP
fnp-3866	1	46	neuroscience	neuroscience	NOUN
fnp-3866	1	47	,	,	PUNCT
fnp-3866	1	48	department	department	NOUN
fnp-3866	1	49	of	of	ADP
fnp-3866	1	50	artificial	artificial	ADJ
fnp-3866	1	51	intelligence	intelligence	PROPN
fnp-3866	1	52	&	&	CCONJ
fnp-3866	1	53	human	human	PROPN
fnp-3866	1	54	health	health	PROPN
fnp-3866	1	55	,	,	PUNCT
fnp-3866	1	56	ronald	ronald	PROPN
fnp-3866	1	57	m.	m.	PROPN
fnp-3866	1	58	loeb	loeb	PROPN
fnp-3866	1	59	center	center	PROPN
fnp-3866	1	60	for	for	ADP
fnp-3866	1	61	alzheimer	alzheimer	PROPN
fnp-3866	1	62	's	's	PART
fnp-3866	1	63	disease	disease	NOUN
fnp-3866	1	64	,	,	PUNCT
fnp-3866	1	65	friedman	friedman	PROPN
fnp-3866	1	66	brain	brain	PROPN
fnp-3866	1	67	institute	institute	PROPN
fnp-3866	1	68	,	,	PUNCT
fnp-3866	1	69	icahn	icahn	PROPN
fnp-3866	1	70	school	school	PROPN
fnp-3866	1	71	of	of	ADP
fnp-3866	1	72	medicine	medicine	NOUN
fnp-3866	1	73	at	at	ADP
fnp-3866	1	74	mount	mount	PROPN
fnp-3866	1	75	sinai	sinai	PROPN
fnp-3866	1	76	,	,	PUNCT
fnp-3866	1	77	new	new	PROPN
fnp-3866	1	78	york	york	PROPN
fnp-3866	1	79	,	,	PUNCT
fnp-3866	1	80	ny	ny	PROPN
fnp-3866	1	81	,	,	PUNCT
fnp-3866	1	82	usa	usa	PROPN
fnp-3866	1	83	corresponding	corresponding	PROPN
fnp-3866	1	84	author	author	NOUN
fnp-3866	1	85	:	:	PUNCT
fnp-3866	1	86	john	john	PROPN
fnp-3866	1	87	f.	f.	PROPN
fnp-3866	1	88	crary	crary	PROPN
fnp-3866	1	89	,	,	PUNCT
fnp-3866	1	90	md	md	PROPN
fnp-3866	1	91	-	-	PUNCT
fnp-3866	1	92	phd	phd	NOUN
fnp-3866	1	93	·	·	PUNCT
fnp-3866	1	94	friedman	friedman	PROPN
fnp-3866	1	95	brain	brain	PROPN
fnp-3866	1	96	institute	institute	PROPN
fnp-3866	1	97	·	·	PUNCT
fnp-3866	1	98	ronald	ronald	PROPN
fnp-3866	1	99	m.	m.	PROPN
fnp-3866	1	100	loeb	loeb	PROPN
fnp-3866	1	101	center	center	PROPN
fnp-3866	1	102	for	for	ADP
fnp-3866	1	103	alzheimer	alzheimer	PROPN
fnp-3866	1	104	’s	’s	PART
fnp-3866	1	105	disease	disease	NOUN
fnp-3866	1	106	·	·	PUNCT
fnp-3866	1	107	icahn	icahn	PROPN
fnp-3866	1	108	school	school	NOUN
fnp-3866	1	109	of	of	ADP
fnp-3866	1	110	medicine	medicine	NOUN
fnp-3866	1	111	at	at	ADP
fnp-3866	1	112	mountsinai	mountsinai	NOUN
fnp-3866	1	113	·	·	PUNCT
fnp-3866	1	114	1	1	NUM
fnp-3866	1	115	gustave	gustave	X
fnp-3866	1	116	l.	l.	PROPN
fnp-3866	1	117	levy	levy	PROPN
fnp-3866	1	118	place	place	PROPN
fnp-3866	1	119	box	box	PROPN
fnp-3866	1	120	1194	1194	NUM
fnp-3866	1	121	·	·	PUNCT
fnp-3866	1	122	new	new	PROPN
fnp-3866	1	123	york	york	PROPN
fnp-3866	1	124	,	,	PUNCT
fnp-3866	1	125	ny	ny	PROPN
fnp-3866	1	126	10029	10029	NUM
fnp-3866	1	127	·	·	PUNCT
fnp-3866	2	1	usa	usa	PROPN
fnp-3866	2	2	john.crary@mountsinai.org	john.crary@mountsinai.org	PROPN
fnp-3866	2	3	submitted	submit	VERB
fnp-3866	2	4	:	:	PUNCT
fnp-3866	2	5	18	18	NUM
fnp-3866	2	6	april	april	PROPN
fnp-3866	2	7	2022	2022	NUM
fnp-3866	2	8	accepted	accept	VERB
fnp-3866	2	9	:	:	PUNCT
fnp-3866	2	10	05	05	NUM
fnp-3866	2	11	may	may	AUX
fnp-3866	2	12	2022	2022	NUM
fnp-3866	2	13	copyedited	copyedit	VERB
fnp-3866	2	14	by	by	ADP
fnp-3866	2	15	:	:	PUNCT
fnp-3866	2	16	georg	georg	NOUN
fnp-3866	2	17	haase	haase	NOUN
fnp-3866	2	18	published	publish	VERB
fnp-3866	2	19	:	:	PUNCT
fnp-3866	2	20	10	10	NUM
fnp-3866	2	21	may	may	AUX
fnp-3866	2	22	2022	2022	NUM
fnp-3866	2	23	https://doi.org/10.17879/freeneuropathology-2022-3866	https://doi.org/10.17879/freeneuropathology-2022-3866	PROPN
fnp-3866	2	24	keywords	keyword	VERB
fnp-3866	2	25	:	:	PUNCT
fnp-3866	2	26	neurodegeneration	neurodegeneration	NOUN
fnp-3866	2	27	,	,	PUNCT
fnp-3866	2	28	neuropathology	neuropathology	NOUN
fnp-3866	2	29	,	,	PUNCT
fnp-3866	2	30	aging	aging	NOUN
fnp-3866	2	31	,	,	PUNCT
fnp-3866	2	32	microglia	microglia	ADJ
fnp-3866	2	33	,	,	PUNCT
fnp-3866	2	34	alzheimer	alzheimer	NOUN
fnp-3866	2	35	disease	disease	NOUN
fnp-3866	2	36	,	,	PUNCT
fnp-3866	2	37	tauopathy	tauopathy	NOUN
fnp-3866	2	38	,	,	PUNCT
fnp-3866	2	39	huntington	huntington	PROPN
fnp-3866	2	40	’s	’s	PART
fnp-3866	2	41	disease	disease	NOUN
fnp-3866	2	42	,	,	PUNCT
fnp-3866	2	43	α	α	NOUN
fnp-3866	2	44	-	-	PUNCT
fnp-3866	2	45	synucleinopathy	synucleinopathy	ADJ
fnp-3866	2	46	,	,	PUNCT
fnp-3866	2	47	tdp-43	tdp-43	NOUN
fnp-3866	2	48	proteinopathy	proteinopathy	ADJ
fnp-3866	2	49	,	,	PUNCT
fnp-3866	2	50	traumatic	traumatic	ADJ
fnp-3866	2	51	brain	brain	NOUN
fnp-3866	2	52	injury	injury	NOUN
fnp-3866	2	53	abstract	abstract	NOUN
fnp-3866	2	54	here	here	ADV
fnp-3866	2	55	,	,	PUNCT
fnp-3866	2	56	we	we	PRON
fnp-3866	2	57	review	review	VERB
fnp-3866	2	58	a	a	DET
fnp-3866	2	59	collection	collection	NOUN
fnp-3866	2	60	of	of	ADP
fnp-3866	2	61	recent	recent	ADJ
fnp-3866	2	62	manuscripts	manuscript	NOUN
fnp-3866	2	63	and	and	CCONJ
fnp-3866	2	64	research	research	NOUN
fnp-3866	2	65	trends	trend	NOUN
fnp-3866	2	66	on	on	ADP
fnp-3866	2	67	the	the	DET
fnp-3866	2	68	neuropathology	neuropathology	NOUN
fnp-3866	2	69	of	of	ADP
fnp-3866	2	70	neurodegeneration	neurodegeneration	NOUN
fnp-3866	2	71	that	that	PRON
fnp-3866	2	72	are	be	AUX
fnp-3866	2	73	considered	consider	VERB
fnp-3866	2	74	by	by	ADP
fnp-3866	2	75	the	the	DET
fnp-3866	2	76	author	author	NOUN
fnp-3866	2	77	to	to	PART
fnp-3866	2	78	be	be	AUX
fnp-3866	2	79	among	among	ADP
fnp-3866	2	80	the	the	DET
fnp-3866	2	81	potentially	potentially	ADV
fnp-3866	2	82	most	most	ADV
fnp-3866	2	83	impactful	impactful	ADJ
fnp-3866	2	84	.	.	PUNCT
fnp-3866	3	1	to	to	ADP
fnp-3866	3	2	the	the	DET
fnp-3866	3	3	greatest	great	ADJ
fnp-3866	3	4	extent	extent	NOUN
fnp-3866	3	5	possible	possible	ADJ
fnp-3866	3	6	,	,	PUNCT
fnp-3866	3	7	we	we	PRON
fnp-3866	3	8	chose	choose	VERB
fnp-3866	3	9	to	to	PART
fnp-3866	3	10	focus	focus	VERB
fnp-3866	3	11	on	on	ADP
fnp-3866	3	12	histopathological	histopathological	ADJ
fnp-3866	3	13	studies	study	NOUN
fnp-3866	3	14	that	that	PRON
fnp-3866	3	15	are	be	AUX
fnp-3866	3	16	most	most	ADV
fnp-3866	3	17	relevant	relevant	ADJ
fnp-3866	3	18	to	to	ADP
fnp-3866	3	19	experimental	experimental	ADJ
fnp-3866	3	20	and	and	CCONJ
fnp-3866	3	21	diagnostic	diagnostic	ADJ
fnp-3866	3	22	neuropathology	neuropathology	NOUN
fnp-3866	3	23	.	.	PUNCT
fnp-3866	4	1	while	while	SCONJ
fnp-3866	4	2	there	there	PRON
fnp-3866	4	3	has	have	AUX
fnp-3866	4	4	been	be	AUX
fnp-3866	4	5	an	an	DET
fnp-3866	4	6	abundance	abundance	NOUN
fnp-3866	4	7	of	of	ADP
fnp-3866	4	8	important	important	ADJ
fnp-3866	4	9	recent	recent	ADJ
fnp-3866	4	10	discoveries	discovery	NOUN
fnp-3866	4	11	and	and	CCONJ
fnp-3866	4	12	developments	development	NOUN
fnp-3866	4	13	in	in	ADP
fnp-3866	4	14	neurodegenerative	neurodegenerative	ADJ
fnp-3866	4	15	disease	disease	NOUN
fnp-3866	4	16	research	research	NOUN
fnp-3866	4	17	,	,	PUNCT
fnp-3866	4	18	there	there	PRON
fnp-3866	4	19	was	be	VERB
fnp-3866	4	20	a	a	DET
fnp-3866	4	21	deliberate	deliberate	ADJ
fnp-3866	4	22	effort	effort	NOUN
fnp-3866	4	23	here	here	ADV
fnp-3866	4	24	to	to	PART
fnp-3866	4	25	provide	provide	VERB
fnp-3866	4	26	balance	balance	NOUN
fnp-3866	4	27	to	to	PART
fnp-3866	4	28	prevent	prevent	VERB
fnp-3866	4	29	disease	disease	NOUN
fnp-3866	4	30	categories	category	NOUN
fnp-3866	4	31	and	and	CCONJ
fnp-3866	4	32	experimental	experimental	ADJ
fnp-3866	4	33	approaches	approach	NOUN
fnp-3866	4	34	from	from	ADP
fnp-3866	4	35	overshadowing	overshadow	VERB
fnp-3866	4	36	the	the	DET
fnp-3866	4	37	others	other	NOUN
fnp-3866	4	38	.	.	PUNCT
fnp-3866	5	1	the	the	DET
fnp-3866	5	2	result	result	NOUN
fnp-3866	5	3	is	be	AUX
fnp-3866	5	4	a	a	DET
fnp-3866	5	5	diverse	diverse	ADJ
fnp-3866	5	6	series	series	NOUN
fnp-3866	5	7	of	of	ADP
fnp-3866	5	8	outstanding	outstanding	ADJ
fnp-3866	5	9	studies	study	NOUN
fnp-3866	5	10	,	,	PUNCT
fnp-3866	5	11	together	together	ADV
fnp-3866	5	12	showing	show	VERB
fnp-3866	5	13	the	the	DET
fnp-3866	5	14	landscape	landscape	NOUN
fnp-3866	5	15	of	of	ADP
fnp-3866	5	16	progress	progress	NOUN
fnp-3866	5	17	across	across	ADP
fnp-3866	5	18	neurodegenerative	neurodegenerative	ADJ
fnp-3866	5	19	disorders	disorder	NOUN
fnp-3866	5	20	.	.	PUNCT
fnp-3866	6	1	one	one	NUM
fnp-3866	6	2	is	be	AUX
fnp-3866	6	3	a	a	DET
fnp-3866	6	4	stereological	stereological	ADJ
fnp-3866	6	5	study	study	NOUN
fnp-3866	6	6	examining	examine	VERB
fnp-3866	6	7	dystrophic	dystrophic	ADJ
fnp-3866	6	8	microglia	microglia	NOUN
fnp-3866	6	9	in	in	ADP
fnp-3866	6	10	aging	aging	NOUN
fnp-3866	6	11	.	.	PUNCT
fnp-3866	7	1	we	we	PRON
fnp-3866	7	2	highlight	highlight	VERB
fnp-3866	7	3	the	the	DET
fnp-3866	7	4	first	first	ADJ
fnp-3866	7	5	large	large	ADJ
fnp-3866	7	6	genetic	genetic	ADJ
fnp-3866	7	7	study	study	NOUN
fnp-3866	7	8	of	of	ADP
fnp-3866	7	9	primary	primary	ADJ
fnp-3866	7	10	age	age	NOUN
fnp-3866	7	11	-	-	PUNCT
fnp-3866	7	12	related	relate	VERB
fnp-3866	7	13	tauopathy	tauopathy	NOUN
fnp-3866	7	14	,	,	PUNCT
fnp-3866	7	15	showing	show	VERB
fnp-3866	7	16	convergence	convergence	NOUN
fnp-3866	7	17	and	and	CCONJ
fnp-3866	7	18	divergence	divergence	NOUN
fnp-3866	7	19	from	from	ADP
fnp-3866	7	20	classical	classical	ADJ
fnp-3866	7	21	alzheimer	alzheimer	PROPN
fnp-3866	7	22	’s	’s	PART
fnp-3866	7	23	disease	disease	NOUN
fnp-3866	7	24	.	.	PUNCT
fnp-3866	8	1	there	there	PRON
fnp-3866	8	2	were	be	VERB
fnp-3866	8	3	further	far	ADV
fnp-3866	8	4	advances	advance	NOUN
fnp-3866	8	5	in	in	ADP
fnp-3866	8	6	the	the	DET
fnp-3866	8	7	neuropathological	neuropathological	ADJ
fnp-3866	8	8	criteria	criterion	NOUN
fnp-3866	8	9	and	and	CCONJ
fnp-3866	8	10	staging	staging	NOUN
fnp-3866	8	11	of	of	ADP
fnp-3866	8	12	chronic	chronic	ADJ
fnp-3866	8	13	traumatic	traumatic	ADJ
fnp-3866	8	14	encephalopathy	encephalopathy	NOUN
fnp-3866	8	15	.	.	PUNCT
fnp-3866	9	1	links	link	NOUN
fnp-3866	9	2	suggesting	suggest	VERB
fnp-3866	9	3	a	a	DET
fnp-3866	9	4	causal	causal	ADJ
fnp-3866	9	5	role	role	NOUN
fnp-3866	9	6	for	for	ADP
fnp-3866	9	7	tmem106b	tmem106b	PROPN
fnp-3866	9	8	in	in	ADP
fnp-3866	9	9	tdp-43	tdp-43	PROPN
fnp-3866	9	10	proteinopathy	proteinopathy	ADJ
fnp-3866	9	11	emerged	emerge	VERB
fnp-3866	9	12	.	.	PUNCT
fnp-3866	10	1	attempts	attempt	NOUN
fnp-3866	10	2	to	to	PART
fnp-3866	10	3	subtype	subtype	VERB
fnp-3866	10	4	alzheimer	alzheimer	PROPN
fnp-3866	10	5	’s	’s	PART
fnp-3866	10	6	disease	disease	NOUN
fnp-3866	10	7	on	on	ADP
fnp-3866	10	8	the	the	DET
fnp-3866	10	9	molecular	molecular	ADJ
fnp-3866	10	10	level	level	NOUN
fnp-3866	10	11	were	be	AUX
fnp-3866	10	12	made	make	VERB
fnp-3866	10	13	.	.	PUNCT
fnp-3866	11	1	evidence	evidence	NOUN
fnp-3866	11	2	for	for	ADP
fnp-3866	11	3	a	a	DET
fnp-3866	11	4	role	role	NOUN
fnp-3866	11	5	for	for	ADP
fnp-3866	11	6	the	the	DET
fnp-3866	11	7	vegf	vegf	PROPN
fnp-3866	11	8	family	family	PROPN
fnp-3866	11	9	in	in	ADP
fnp-3866	11	10	cognitive	cognitive	ADJ
fnp-3866	11	11	impairment	impairment	NOUN
fnp-3866	11	12	was	be	AUX
fnp-3866	11	13	advanced	advanced	ADJ
fnp-3866	11	14	.	.	PUNCT
fnp-3866	12	1	comparison	comparison	NOUN
fnp-3866	12	2	of	of	ADP
fnp-3866	12	3	gene	gene	NOUN
fnp-3866	12	4	expression	expression	NOUN
fnp-3866	12	5	profiles	profile	NOUN
fnp-3866	12	6	from	from	ADP
fnp-3866	12	7	myeloid	myeloid	ADJ
fnp-3866	12	8	cells	cell	NOUN
fnp-3866	12	9	in	in	ADP
fnp-3866	12	10	peripheral	peripheral	ADJ
fnp-3866	12	11	blood	blood	NOUN
fnp-3866	12	12	and	and	CCONJ
fnp-3866	12	13	brain	brain	NOUN
fnp-3866	12	14	tissues	tissue	NOUN
fnp-3866	12	15	from	from	ADP
fnp-3866	12	16	parkinson	parkinson	NOUN
fnp-3866	12	17	’s	’s	PART
fnp-3866	12	18	disease	disease	NOUN
fnp-3866	12	19	patients	patient	NOUN
fnp-3866	12	20	revealed	reveal	VERB
fnp-3866	12	21	pathways	pathway	NOUN
fnp-3866	12	22	that	that	PRON
fnp-3866	12	23	may	may	AUX
fnp-3866	12	24	lead	lead	VERB
fnp-3866	12	25	to	to	ADP
fnp-3866	12	26	new	new	ADJ
fnp-3866	12	27	mechanistic	mechanistic	ADJ
fnp-3866	12	28	insights	insight	NOUN
fnp-3866	12	29	and	and	CCONJ
fnp-3866	12	30	biomarkers	biomarker	NOUN
fnp-3866	12	31	.	.	PUNCT
fnp-3866	13	1	a	a	DET
fnp-3866	13	2	large	large	ADJ
fnp-3866	13	3	autopsy	autopsy	ADJ
fnp-3866	13	4	series	series	NOUN
fnp-3866	13	5	identified	identify	VERB
fnp-3866	13	6	an	an	DET
fnp-3866	13	7	increased	increase	VERB
fnp-3866	13	8	frequency	frequency	NOUN
fnp-3866	13	9	of	of	ADP
fnp-3866	13	10	central	central	ADJ
fnp-3866	13	11	nervous	nervous	ADJ
fnp-3866	13	12	system	system	NOUN
fnp-3866	13	13	developmental	developmental	ADJ
fnp-3866	13	14	malformations	malformation	NOUN
fnp-3866	13	15	in	in	ADP
fnp-3866	13	16	huntington	huntington	PROPN
fnp-3866	13	17	’s	’s	PART
fnp-3866	13	18	disease	disease	NOUN
fnp-3866	13	19	.	.	PUNCT
fnp-3866	14	1	a	a	DET
fnp-3866	14	2	robust	robust	ADJ
fnp-3866	14	3	and	and	CCONJ
fnp-3866	14	4	reliable	reliable	ADJ
fnp-3866	14	5	system	system	NOUN
fnp-3866	14	6	for	for	ADP
fnp-3866	14	7	assessing	assess	VERB
fnp-3866	14	8	lewy	lewy	ADJ
fnp-3866	14	9	body	body	NOUN
fnp-3866	14	10	pathology	pathology	NOUN
fnp-3866	14	11	was	be	AUX
fnp-3866	14	12	proposed	propose	VERB
fnp-3866	14	13	.	.	PUNCT
fnp-3866	15	1	finally	finally	ADV
fnp-3866	15	2	,	,	PUNCT
fnp-3866	15	3	we	we	PRON
fnp-3866	15	4	continue	continue	VERB
fnp-3866	15	5	to	to	PART
fnp-3866	15	6	be	be	AUX
fnp-3866	15	7	plagued	plague	VERB
fnp-3866	15	8	by	by	ADP
fnp-3866	15	9	the	the	DET
fnp-3866	15	10	covid-19	covid-19	PROPN
fnp-3866	15	11	pandemic	pandemic	NOUN
fnp-3866	15	12	,	,	PUNCT
fnp-3866	15	13	with	with	ADP
fnp-3866	15	14	lingering	linger	VERB
fnp-3866	15	15	concerns	concern	NOUN
fnp-3866	15	16	of	of	ADP
fnp-3866	15	17	a	a	DET
fnp-3866	15	18	long	long	ADJ
fnp-3866	15	19	-	-	PUNCT
fnp-3866	15	20	term	term	NOUN
fnp-3866	15	21	link	link	NOUN
fnp-3866	15	22	with	with	ADP
fnp-3866	15	23	neurodegeneration	neurodegeneration	NOUN
fnp-3866	15	24	.	.	PUNCT
fnp-3866	16	1	1	1	X
fnp-3866	16	2	.	.	X
fnp-3866	16	3	neurodegeneration	neurodegeneration	NOUN
fnp-3866	16	4	-	-	PUNCT
fnp-3866	16	5	specific	specific	ADJ
fnp-3866	16	6	alterations	alteration	NOUN
fnp-3866	16	7	in	in	ADP
fnp-3866	16	8	microglial	microglial	ADJ
fnp-3866	16	9	morphology	morphology	NOUN
fnp-3866	16	10	as	as	SCONJ
fnp-3866	16	11	the	the	DET
fnp-3866	16	12	data	datum	NOUN
fnp-3866	16	13	from	from	ADP
fnp-3866	16	14	genetic	genetic	ADJ
fnp-3866	16	15	,	,	PUNCT
fnp-3866	16	16	cellular	cellular	ADJ
fnp-3866	16	17	and	and	CCONJ
fnp-3866	16	18	animal	animal	NOUN
fnp-3866	16	19	studies	study	NOUN
fnp-3866	16	20	accumulates	accumulate	VERB
fnp-3866	16	21	,	,	PUNCT
fnp-3866	16	22	the	the	DET
fnp-3866	16	23	importance	importance	NOUN
fnp-3866	16	24	of	of	ADP
fnp-3866	16	25	microglial	microglial	ADJ
fnp-3866	16	26	and	and	CCONJ
fnp-3866	16	27	neuroimmune	neuroimmune	NOUN
fnp-3866	16	28	function	function	NOUN
fnp-3866	16	29	continues	continue	VERB
fnp-3866	16	30	to	to	PART
fnp-3866	16	31	grow	grow	VERB
fnp-3866	16	32	.	.	PUNCT
fnp-3866	17	1	microglia	microglia	NOUN
fnp-3866	17	2	take	take	VERB
fnp-3866	17	3	on	on	ADP
fnp-3866	17	4	a	a	DET
fnp-3866	17	5	number	number	NOUN
fnp-3866	17	6	of	of	ADP
fnp-3866	17	7	different	different	ADJ
fnp-3866	17	8	morphologies	morphology	NOUN
fnp-3866	17	9	,	,	PUNCT
fnp-3866	17	10	including	include	VERB
fnp-3866	17	11	ramified	ramify	VERB
fnp-3866	17	12	,	,	PUNCT
fnp-3866	17	13	hypertrophic	hypertrophic	ADJ
fnp-3866	17	14	and	and	CCONJ
fnp-3866	17	15	dystrophic	dystrophic	ADJ
fnp-3866	17	16	,	,	PUNCT
fnp-3866	17	17	that	that	PRON
fnp-3866	17	18	are	be	AUX
fnp-3866	17	19	demonstrable	demonstrable	ADJ
fnp-3866	17	20	using	use	VERB
fnp-3866	17	21	various	various	ADJ
fnp-3866	17	22	histopathological	histopathological	ADJ
fnp-3866	17	23	techniques	technique	NOUN
fnp-3866	17	24	.	.	PUNCT
fnp-3866	18	1	the	the	DET
fnp-3866	18	2	importance	importance	NOUN
fnp-3866	18	3	of	of	ADP
fnp-3866	18	4	the	the	DET
fnp-3866	18	5	dystrophic	dystrophic	ADJ
fnp-3866	18	6	morphology	morphology	NOUN
fnp-3866	18	7	is	be	AUX
fnp-3866	18	8	currently	currently	ADV
fnp-3866	18	9	unclear	unclear	ADJ
fnp-3866	18	10	and	and	CCONJ
fnp-3866	18	11	has	have	AUX
fnp-3866	18	12	been	be	AUX
fnp-3866	18	13	implicated	implicate	VERB
fnp-3866	18	14	in	in	ADP
fnp-3866	18	15	disease	disease	NOUN
fnp-3866	18	16	and	and	CCONJ
fnp-3866	18	17	age	age	NOUN
fnp-3866	18	18	-	-	PUNCT
fnp-3866	18	19	related	relate	VERB
fnp-3866	18	20	cellular	cellular	ADJ
fnp-3866	18	21	senescence	senescence	NOUN
fnp-3866	18	22	.	.	PUNCT
fnp-3866	19	1	unfortunately	unfortunately	ADV
fnp-3866	19	2	,	,	PUNCT
fnp-3866	19	3	there	there	PRON
fnp-3866	19	4	has	have	AUX
fnp-3866	19	5	been	be	AUX
fnp-3866	19	6	a	a	DET
fnp-3866	19	7	dearth	dearth	NOUN
fnp-3866	19	8	of	of	ADP
fnp-3866	19	9	rigorous	rigorous	ADJ
fnp-3866	19	10	histopathological	histopathological	ADJ
fnp-3866	19	11	human	human	ADJ
fnp-3866	19	12	studies	study	NOUN
fnp-3866	19	13	looking	look	VERB
fnp-3866	19	14	at	at	ADP
fnp-3866	19	15	them	they	PRON
fnp-3866	19	16	across	across	ADP
fnp-3866	19	17	the	the	DET
fnp-3866	19	18	aging	age	VERB
fnp-3866	19	19	spectrum	spectrum	NOUN
fnp-3866	19	20	.	.	PUNCT
fnp-3866	20	1	critically	critically	ADV
fnp-3866	20	2	,	,	PUNCT
fnp-3866	20	3	our	our	PRON
fnp-3866	20	4	understanding	understanding	NOUN
fnp-3866	20	5	of	of	ADP
fnp-3866	20	6	dystrophic	dystrophic	ADJ
fnp-3866	20	7	microglia	microglia	NOUN
fnp-3866	20	8	has	have	AUX
fnp-3866	20	9	been	be	AUX
fnp-3866	20	10	hindered	hinder	VERB
fnp-3866	20	11	by	by	ADP
fnp-3866	20	12	a	a	DET
fnp-3866	20	13	lack	lack	NOUN
fnp-3866	20	14	of	of	ADP
fnp-3866	20	15	well	well	ADV
fnp-3866	20	16	-	-	PUNCT
fnp-3866	20	17	designed	design	VERB
fnp-3866	20	18	and	and	CCONJ
fnp-3866	20	19	implemented	implement	VERB
fnp-3866	20	20	quantitative	quantitative	ADJ
fnp-3866	20	21	studies	study	NOUN
fnp-3866	20	22	of	of	ADP
fnp-3866	20	23	these	these	DET
fnp-3866	20	24	various	various	ADJ
fnp-3866	20	25	microglial	microglial	ADJ
fnp-3866	20	26	morphological	morphological	ADJ
fnp-3866	20	27	patterns	pattern	NOUN
fnp-3866	20	28	across	across	ADP
fnp-3866	20	29	the	the	DET
fnp-3866	20	30	human	human	ADJ
fnp-3866	20	31	lifespan	lifespan	NOUN
fnp-3866	20	32	and	and	CCONJ
fnp-3866	20	33	in	in	ADP
fnp-3866	20	34	disease	disease	NOUN
fnp-3866	20	35	.	.	PUNCT
fnp-3866	21	1	shahhidehpour	shahhidehpour	AUX
fnp-3866	21	2	et	et	PROPN
fnp-3866	21	3	al	al	PROPN
fnp-3866	21	4	.	.	PROPN
fnp-3866	21	5	performed	perform	VERB
fnp-3866	21	6	a	a	DET
fnp-3866	21	7	stereological	stereological	ADJ
fnp-3866	21	8	study	study	NOUN
fnp-3866	21	9	,	,	PUNCT
fnp-3866	21	10	published	publish	VERB
fnp-3866	21	11	in	in	ADP
fnp-3866	21	12	the	the	DET
fnp-3866	21	13	neurobiology	neurobiology	NOUN
fnp-3866	21	14	of	of	ADP
fnp-3866	21	15	aging	aging	NOUN
fnp-3866	21	16	,	,	PUNCT
fnp-3866	21	17	specifically	specifically	ADV
fnp-3866	21	18	investigating	investigate	VERB
fnp-3866	21	19	these	these	DET
fnp-3866	21	20	microglial	microglial	ADJ
fnp-3866	21	21	morphologies	morphology	NOUN
fnp-3866	21	22	in	in	ADP
fnp-3866	21	23	human	human	ADJ
fnp-3866	21	24	post	post	ADJ
fnp-3866	21	25	-	-	ADJ
fnp-3866	21	26	mortem	mortem	ADJ
fnp-3866	21	27	brain	brain	NOUN
fnp-3866	21	28	tissues	tissue	NOUN
fnp-3866	21	29	across	across	ADP
fnp-3866	21	30	the	the	DET
fnp-3866	21	31	lifespan	lifespan	NOUN
fnp-3866	21	32	(	(	PUNCT
fnp-3866	21	33	shahidehpour	shahidehpour	ADV
fnp-3866	21	34	et	et	PROPN
fnp-3866	21	35	al	al	PROPN
fnp-3866	21	36	.	.	PROPN
fnp-3866	21	37	,	,	PUNCT
fnp-3866	21	38	2021	2021	NUM
fnp-3866	21	39	)	)	PUNCT
fnp-3866	21	40	.	.	PUNCT
fnp-3866	22	1	the	the	DET
fnp-3866	22	2	authors	author	NOUN
fnp-3866	22	3	set	set	VERB
fnp-3866	22	4	out	out	ADP
fnp-3866	22	5	to	to	PART
fnp-3866	22	6	test	test	VERB
fnp-3866	22	7	the	the	DET
fnp-3866	22	8	hypothesis	hypothesis	NOUN
fnp-3866	22	9	that	that	PRON
fnp-3866	22	10	age	age	NOUN
fnp-3866	22	11	causes	cause	VERB
fnp-3866	22	12	microglial	microglial	ADJ
fnp-3866	22	13	dystrophy	dystrophy	NOUN
fnp-3866	22	14	.	.	PUNCT
fnp-3866	23	1	abnormalities	abnormality	NOUN
fnp-3866	23	2	in	in	ADP
fnp-3866	23	3	microglial	microglial	ADJ
fnp-3866	23	4	function	function	NOUN
fnp-3866	23	5	may	may	AUX
fnp-3866	23	6	be	be	AUX
fnp-3866	23	7	a	a	DET
fnp-3866	23	8	strong	strong	ADJ
fnp-3866	23	9	contributor	contributor	NOUN
fnp-3866	23	10	to	to	ADP
fnp-3866	23	11	age	age	NOUN
fnp-3866	23	12	-	-	PUNCT
fnp-3866	23	13	related	relate	VERB
fnp-3866	23	14	neurodegenerative	neurodegenerative	ADJ
fnp-3866	23	15	disease	disease	NOUN
fnp-3866	23	16	,	,	PUNCT
fnp-3866	23	17	with	with	ADP
fnp-3866	23	18	cellular	cellular	ADJ
fnp-3866	23	19	senescence	senescence	NOUN
fnp-3866	23	20	being	be	AUX
fnp-3866	23	21	a	a	DET
fnp-3866	23	22	critical	critical	ADJ
fnp-3866	23	23	hallmark	hallmark	NOUN
fnp-3866	23	24	of	of	ADP
fnp-3866	23	25	aging	aging	NOUN
fnp-3866	23	26	.	.	PUNCT
fnp-3866	24	1	the	the	DET
fnp-3866	24	2	strength	strength	NOUN
fnp-3866	24	3	of	of	ADP
fnp-3866	24	4	the	the	DET
fnp-3866	24	5	study	study	NOUN
fnp-3866	24	6	was	be	AUX
fnp-3866	24	7	the	the	DET
fnp-3866	24	8	rigorous	rigorous	ADJ
fnp-3866	24	9	stereological	stereological	ADJ
fnp-3866	24	10	counts	count	NOUN
fnp-3866	24	11	of	of	ADP
fnp-3866	24	12	microglial	microglial	ADJ
fnp-3866	24	13	morphologies	morphology	NOUN
fnp-3866	24	14	including	include	VERB
fnp-3866	24	15	hypertrophic	hypertrophic	ADJ
fnp-3866	24	16	and	and	CCONJ
fnp-3866	24	17	dystrophic	dystrophic	ADJ
fnp-3866	24	18	types	type	NOUN
fnp-3866	24	19	alongside	alongside	ADP
fnp-3866	24	20	total	total	NOUN
fnp-3866	24	21	,	,	PUNCT
fnp-3866	24	22	across	across	ADP
fnp-3866	24	23	a	a	DET
fnp-3866	24	24	collection	collection	NOUN
fnp-3866	24	25	of	of	ADP
fnp-3866	24	26	brains	brain	NOUN
fnp-3866	24	27	ranging	range	VERB
fnp-3866	24	28	in	in	ADP
fnp-3866	24	29	age	age	NOUN
fnp-3866	24	30	in	in	ADP
fnp-3866	24	31	years	year	NOUN
fnp-3866	24	32	from	from	ADP
fnp-3866	24	33	teenage	teenage	ADJ
fnp-3866	24	34	to	to	ADP
fnp-3866	24	35	nineties	ninety	NOUN
fnp-3866	24	36	(	(	PUNCT
fnp-3866	24	37	figure	figure	NOUN
fnp-3866	24	38	1	1	NUM
fnp-3866	24	39	)	)	PUNCT
fnp-3866	24	40	.	.	PUNCT
fnp-3866	25	1	surprisingly	surprisingly	ADV
fnp-3866	25	2	,	,	PUNCT
fnp-3866	25	3	while	while	SCONJ
fnp-3866	25	4	an	an	DET
fnp-3866	25	5	age	age	NOUN
fnp-3866	25	6	-	-	PUNCT
fnp-3866	25	7	associated	associate	VERB
fnp-3866	25	8	increase	increase	NOUN
fnp-3866	25	9	in	in	ADP
fnp-3866	25	10	the	the	DET
fnp-3866	25	11	total	total	ADJ
fnp-3866	25	12	number	number	NOUN
fnp-3866	25	13	of	of	ADP
fnp-3866	25	14	dystrophic	dystrophic	ADJ
fnp-3866	25	15	microglia	microglia	NOUN
fnp-3866	25	16	was	be	AUX
fnp-3866	25	17	found	find	VERB
fnp-3866	25	18	,	,	PUNCT
fnp-3866	25	19	this	this	PRON
fnp-3866	25	20	was	be	AUX
fnp-3866	25	21	not	not	PART
fnp-3866	25	22	significant	significant	ADJ
fnp-3866	25	23	when	when	SCONJ
fnp-3866	25	24	compared	compare	VERB
fnp-3866	25	25	to	to	ADP
fnp-3866	25	26	the	the	DET
fnp-3866	25	27	total	total	ADJ
fnp-3866	25	28	number	number	NOUN
fnp-3866	25	29	of	of	ADP
fnp-3866	25	30	microglia	microglia	NOUN
fnp-3866	25	31	which	which	PRON
fnp-3866	25	32	also	also	ADV
fnp-3866	25	33	increased	increase	VERB
fnp-3866	25	34	with	with	ADP
fnp-3866	25	35	age	age	NOUN
fnp-3866	25	36	.	.	PUNCT
fnp-3866	26	1	in	in	ADP
fnp-3866	26	2	contrast	contrast	NOUN
fnp-3866	26	3	,	,	PUNCT
fnp-3866	26	4	the	the	DET
fnp-3866	26	5	total	total	ADJ
fnp-3866	26	6	number	number	NOUN
fnp-3866	26	7	of	of	ADP
fnp-3866	26	8	dystrophic	dystrophic	ADJ
fnp-3866	26	9	microglia	microglia	NOUN
fnp-3866	26	10	was	be	AUX
fnp-3866	26	11	greater	great	ADJ
fnp-3866	26	12	in	in	ADP
fnp-3866	26	13	subjects	subject	NOUN
fnp-3866	26	14	with	with	ADP
fnp-3866	26	15	a	a	DET
fnp-3866	26	16	number	number	NOUN
fnp-3866	26	17	of	of	ADP
fnp-3866	26	18	neurodegenerative	neurodegenerative	ADJ
fnp-3866	26	19	diseases	disease	NOUN
fnp-3866	26	20	,	,	PUNCT
fnp-3866	26	21	including	include	VERB
fnp-3866	26	22	alzheimer	alzheimer	PROPN
fnp-3866	26	23	's	's	PART
fnp-3866	26	24	disease	disease	NOUN
fnp-3866	26	25	,	,	PUNCT
fnp-3866	26	26	dementia	dementia	NOUN
fnp-3866	26	27	with	with	ADP
fnp-3866	26	28	lewy	lewy	PROPN
fnp-3866	26	29	bodies	body	NOUN
fnp-3866	26	30	,	,	PUNCT
fnp-3866	26	31	and	and	CCONJ
fnp-3866	26	32	limbic	limbic	ADJ
fnp-3866	26	33	predominant	predominant	ADJ
fnp-3866	26	34	age	age	NOUN
fnp-3866	26	35	-	-	PUNCT
fnp-3866	26	36	related	relate	VERB
fnp-3866	26	37	tdp-43	tdp-43	NOUN
fnp-3866	26	38	encephalopathy	encephalopathy	NOUN
fnp-3866	26	39	.	.	PUNCT
fnp-3866	27	1	the	the	DET
fnp-3866	27	2	authors	author	NOUN
fnp-3866	27	3	also	also	ADV
fnp-3866	27	4	provided	provide	VERB
fnp-3866	27	5	evidence	evidence	NOUN
fnp-3866	27	6	for	for	ADP
fnp-3866	27	7	a	a	DET
fnp-3866	27	8	role	role	NOUN
fnp-3866	27	9	of	of	ADP
fnp-3866	27	10	altered	altered	ADJ
fnp-3866	27	11	iron	iron	NOUN
fnp-3866	27	12	homeostasis	homeostasis	NOUN
fnp-3866	27	13	in	in	ADP
fnp-3866	27	14	these	these	DET
fnp-3866	27	15	dystrophic	dystrophic	ADJ
fnp-3866	27	16	microglia	microglia	NOUN
fnp-3866	27	17	using	use	VERB
fnp-3866	27	18	ferritin	ferritin	ADJ
fnp-3866	27	19	light	light	ADJ
fnp-3866	27	20	chain	chain	NOUN
fnp-3866	27	21	as	as	ADP
fnp-3866	27	22	a	a	DET
fnp-3866	27	23	marker	marker	NOUN
fnp-3866	27	24	of	of	ADP
fnp-3866	27	25	intracellular	intracellular	ADJ
fnp-3866	27	26	iron	iron	NOUN
fnp-3866	27	27	indicating	indicate	VERB
fnp-3866	27	28	a	a	DET
fnp-3866	27	29	possible	possible	ADJ
fnp-3866	27	30	mechanism	mechanism	NOUN
fnp-3866	27	31	.	.	PUNCT
fnp-3866	28	1	this	this	DET
fnp-3866	28	2	result	result	NOUN
fnp-3866	28	3	pinpoints	pinpoint	NOUN
fnp-3866	28	4	microglia	microglia	ADJ
fnp-3866	28	5	dystrophy	dystrophy	NOUN
fnp-3866	28	6	as	as	ADP
fnp-3866	28	7	a	a	DET
fnp-3866	28	8	critical	critical	ADJ
fnp-3866	28	9	disease	disease	NOUN
fnp-3866	28	10	-	-	PUNCT
fnp-3866	28	11	associated	associate	VERB
fnp-3866	28	12	signature	signature	NOUN
fnp-3866	28	13	in	in	ADP
fnp-3866	28	14	neurodegeneration	neurodegeneration	NOUN
fnp-3866	28	15	.	.	PUNCT
fnp-3866	29	1	figure	figure	NOUN
fnp-3866	29	2	1	1	NUM
fnp-3866	29	3	.	.	PUNCT
fnp-3866	30	1	examples	example	NOUN
fnp-3866	30	2	of	of	ADP
fnp-3866	30	3	ramified	ramified	ADJ
fnp-3866	30	4	(	(	PUNCT
fnp-3866	30	5	a	a	DET
fnp-3866	30	6	,	,	PUNCT
fnp-3866	30	7	b	b	NOUN
fnp-3866	30	8	)	)	PUNCT
fnp-3866	30	9	,	,	PUNCT
fnp-3866	30	10	hypertrophic	hypertrophic	ADJ
fnp-3866	30	11	(	(	PUNCT
fnp-3866	30	12	c	c	NOUN
fnp-3866	30	13	,	,	PUNCT
fnp-3866	30	14	d	d	NOUN
fnp-3866	30	15	)	)	PUNCT
fnp-3866	30	16	and	and	CCONJ
fnp-3866	30	17	dystrophic	dystrophic	ADJ
fnp-3866	30	18	microglia	microglia	NOUN
fnp-3866	30	19	(	(	PUNCT
fnp-3866	30	20	e	e	NOUN
fnp-3866	30	21	,	,	PUNCT
fnp-3866	30	22	f	f	X
fnp-3866	30	23	)	)	PUNCT
fnp-3866	30	24	reproduced	reproduce	VERB
fnp-3866	30	25	with	with	ADP
fnp-3866	30	26	permission	permission	NOUN
fnp-3866	30	27	from	from	ADP
fnp-3866	30	28	shahidehpour	shahidehpour	PROPN
fnp-3866	30	29	et	et	PROPN
fnp-3866	30	30	al	al	PROPN
fnp-3866	30	31	.	.	PUNCT
fnp-3866	31	1	(	(	PUNCT
fnp-3866	31	2	shahidehpour	shahidehpour	NOUN
fnp-3866	31	3	et	et	PROPN
fnp-3866	31	4	al	al	PROPN
fnp-3866	31	5	.	.	PROPN
fnp-3866	31	6	,	,	PUNCT
fnp-3866	31	7	2021	2021	NUM
fnp-3866	31	8	)	)	PUNCT
fnp-3866	31	9	.	.	PUNCT
fnp-3866	32	1	2	2	X
fnp-3866	32	2	.	.	X
fnp-3866	32	3	pathogenetic	pathogenetic	ADJ
fnp-3866	32	4	study	study	NOUN
fnp-3866	32	5	in	in	ADP
fnp-3866	32	6	part	part	NOUN
fnp-3866	32	7	clarifies	clarify	VERB
fnp-3866	32	8	genetic	genetic	ADJ
fnp-3866	32	9	overlap	overlap	NOUN
fnp-3866	32	10	with	with	ADP
fnp-3866	32	11	ad	ad	NOUN
fnp-3866	32	12	and	and	CCONJ
fnp-3866	32	13	identifies	identify	VERB
fnp-3866	32	14	jade1	jade1	NOUN
fnp-3866	32	15	in	in	ADP
fnp-3866	32	16	2014	2014	NUM
fnp-3866	32	17	,	,	PUNCT
fnp-3866	32	18	a	a	DET
fnp-3866	32	19	group	group	NOUN
fnp-3866	32	20	of	of	ADP
fnp-3866	32	21	neuropathologists	neuropathologist	NOUN
fnp-3866	32	22	,	,	PUNCT
fnp-3866	32	23	led	lead	VERB
fnp-3866	32	24	by	by	ADP
fnp-3866	32	25	the	the	DET
fnp-3866	32	26	author	author	NOUN
fnp-3866	32	27	of	of	ADP
fnp-3866	32	28	this	this	DET
fnp-3866	32	29	article	article	NOUN
fnp-3866	32	30	,	,	PUNCT
fnp-3866	32	31	defined	define	VERB
fnp-3866	32	32	criteria	criterion	NOUN
fnp-3866	32	33	for	for	ADP
fnp-3866	32	34	a	a	DET
fnp-3866	32	35	new	new	ADJ
fnp-3866	32	36	category	category	NOUN
fnp-3866	32	37	of	of	ADP
fnp-3866	32	38	neurodegenerative	neurodegenerative	ADJ
fnp-3866	32	39	change	change	NOUN
fnp-3866	32	40	,	,	PUNCT
fnp-3866	32	41	termed	term	VERB
fnp-3866	32	42	primary	primary	ADJ
fnp-3866	32	43	age	age	NOUN
fnp-3866	32	44	-	-	PUNCT
fnp-3866	32	45	related	relate	VERB
fnp-3866	32	46	tauopathy	tauopathy	NOUN
fnp-3866	32	47	(	(	PUNCT
fnp-3866	32	48	part	part	NOUN
fnp-3866	32	49	)	)	PUNCT
fnp-3866	32	50	(	(	PUNCT
fnp-3866	32	51	crary	crary	NOUN
fnp-3866	32	52	et	et	PROPN
fnp-3866	32	53	al	al	PROPN
fnp-3866	32	54	.	.	PROPN
fnp-3866	32	55	,	,	PUNCT
fnp-3866	32	56	2014	2014	NUM
fnp-3866	32	57	)	)	PUNCT
fnp-3866	32	58	.	.	PUNCT
fnp-3866	33	1	subsequently	subsequently	ADV
fnp-3866	33	2	,	,	PUNCT
fnp-3866	33	3	there	there	PRON
fnp-3866	33	4	have	have	AUX
fnp-3866	33	5	been	be	AUX
fnp-3866	33	6	many	many	ADJ
fnp-3866	33	7	clinical	clinical	ADJ
fnp-3866	33	8	and	and	CCONJ
fnp-3866	33	9	neuropathological	neuropathological	ADJ
fnp-3866	33	10	studies	study	NOUN
fnp-3866	33	11	that	that	PRON
fnp-3866	33	12	have	have	AUX
fnp-3866	33	13	explored	explore	VERB
fnp-3866	33	14	the	the	DET
fnp-3866	33	15	contours	contours	NOUN
fnp-3866	33	16	and	and	CCONJ
fnp-3866	33	17	implications	implication	NOUN
fnp-3866	33	18	of	of	ADP
fnp-3866	33	19	this	this	DET
fnp-3866	33	20	designation	designation	NOUN
fnp-3866	33	21	,	,	PUNCT
fnp-3866	33	22	both	both	PRON
fnp-3866	33	23	challenging	challenge	VERB
fnp-3866	33	24	and	and	CCONJ
fnp-3866	33	25	supporting	support	VERB
fnp-3866	33	26	its	its	PRON
fnp-3866	33	27	scientific	scientific	ADJ
fnp-3866	33	28	validity	validity	NOUN
fnp-3866	33	29	as	as	ADP
fnp-3866	33	30	an	an	DET
fnp-3866	33	31	independent	independent	ADJ
fnp-3866	33	32	age	age	NOUN
fnp-3866	33	33	-	-	PUNCT
fnp-3866	33	34	associated	associate	VERB
fnp-3866	33	35	neurodegenerative	neurodegenerative	ADJ
fnp-3866	33	36	category	category	NOUN
fnp-3866	33	37	.	.	PUNCT
fnp-3866	34	1	while	while	SCONJ
fnp-3866	34	2	the	the	DET
fnp-3866	34	3	terminology	terminology	NOUN
fnp-3866	34	4	has	have	AUX
fnp-3866	34	5	been	be	AUX
fnp-3866	34	6	broadly	broadly	ADV
fnp-3866	34	7	adopted	adopt	VERB
fnp-3866	34	8	,	,	PUNCT
fnp-3866	34	9	part	part	NOUN
fnp-3866	34	10	remains	remain	VERB
fnp-3866	34	11	controversial	controversial	ADJ
fnp-3866	34	12	and	and	CCONJ
fnp-3866	34	13	poorly	poorly	ADV
fnp-3866	34	14	understood	understand	VERB
fnp-3866	34	15	.	.	PUNCT
fnp-3866	35	1	one	one	NUM
fnp-3866	35	2	of	of	ADP
fnp-3866	35	3	the	the	DET
fnp-3866	35	4	biggest	big	ADJ
fnp-3866	35	5	gaps	gap	NOUN
fnp-3866	35	6	in	in	ADP
fnp-3866	35	7	knowledge	knowledge	NOUN
fnp-3866	35	8	is	be	AUX
fnp-3866	35	9	the	the	DET
fnp-3866	35	10	extent	extent	NOUN
fnp-3866	35	11	to	to	PART
fnp-3866	35	12	which	which	DET
fnp-3866	35	13	part	part	NOUN
fnp-3866	35	14	represents	represent	VERB
fnp-3866	35	15	a	a	DET
fnp-3866	35	16	distinct	distinct	ADJ
fnp-3866	35	17	pathological	pathological	ADJ
fnp-3866	35	18	process	process	NOUN
fnp-3866	35	19	or	or	CCONJ
fnp-3866	35	20	shares	share	VERB
fnp-3866	35	21	mechanistic	mechanistic	ADJ
fnp-3866	35	22	underpinnings	underpinning	NOUN
fnp-3866	35	23	with	with	ADP
fnp-3866	35	24	ad	ad	NOUN
fnp-3866	35	25	and	and	CCONJ
fnp-3866	35	26	perhaps	perhaps	ADV
fnp-3866	35	27	the	the	DET
fnp-3866	35	28	other	other	ADJ
fnp-3866	35	29	tauopathies	tauopathie	NOUN
fnp-3866	35	30	.	.	PUNCT
fnp-3866	36	1	this	this	PRON
fnp-3866	36	2	was	be	AUX
fnp-3866	36	3	addressed	address	VERB
fnp-3866	36	4	with	with	ADP
fnp-3866	36	5	the	the	DET
fnp-3866	36	6	first	first	ADJ
fnp-3866	36	7	genome	genome	NOUN
fnp-3866	36	8	-	-	PUNCT
fnp-3866	36	9	wide	wide	ADJ
fnp-3866	36	10	association	association	NOUN
fnp-3866	36	11	study	study	NOUN
fnp-3866	36	12	(	(	PUNCT
fnp-3866	36	13	gwas	gwas	PROPN
fnp-3866	36	14	)	)	PUNCT
fnp-3866	36	15	in	in	ADP
fnp-3866	36	16	primary	primary	ADJ
fnp-3866	36	17	age	age	NOUN
fnp-3866	36	18	-	-	PUNCT
fnp-3866	36	19	related	relate	VERB
fnp-3866	36	20	tauopathy	tauopathy	NOUN
fnp-3866	36	21	published	publish	VERB
fnp-3866	36	22	online	online	ADV
fnp-3866	36	23	in	in	ADP
fnp-3866	36	24	november	november	PROPN
fnp-3866	36	25	2021	2021	NUM
fnp-3866	36	26	in	in	ADP
fnp-3866	36	27	acta	acta	PROPN
fnp-3866	36	28	neuropathologica	neuropathologica	PROPN
fnp-3866	36	29	(	(	PUNCT
fnp-3866	36	30	farrell	farrell	PROPN
fnp-3866	36	31	et	et	PROPN
fnp-3866	36	32	al	al	PROPN
fnp-3866	36	33	.	.	PROPN
fnp-3866	36	34	,	,	PUNCT
fnp-3866	36	35	2022	2022	NUM
fnp-3866	36	36	)	)	PUNCT
fnp-3866	36	37	.	.	PUNCT
fnp-3866	37	1	given	give	VERB
fnp-3866	37	2	that	that	DET
fnp-3866	37	3	part	part	NOUN
fnp-3866	37	4	is	be	AUX
fnp-3866	37	5	a	a	DET
fnp-3866	37	6	ubiquitous	ubiquitous	ADJ
fnp-3866	37	7	neuropathological	neuropathological	ADJ
fnp-3866	37	8	feature	feature	NOUN
fnp-3866	37	9	in	in	ADP
fnp-3866	37	10	essentially	essentially	ADV
fnp-3866	37	11	all	all	DET
fnp-3866	37	12	aged	aged	ADJ
fnp-3866	37	13	human	human	ADJ
fnp-3866	37	14	brains	brain	NOUN
fnp-3866	37	15	,	,	PUNCT
fnp-3866	37	16	farrell	farrell	PROPN
fnp-3866	37	17	et	et	PROPN
fnp-3866	37	18	al	al	PROPN
fnp-3866	37	19	.	.	PROPN
fnp-3866	37	20	conducted	conduct	VERB
fnp-3866	37	21	a	a	DET
fnp-3866	37	22	case	case	NOUN
fnp-3866	37	23	-	-	PUNCT
fnp-3866	37	24	only	only	ADJ
fnp-3866	37	25	quantitative	quantitative	ADJ
fnp-3866	37	26	trait	trait	NOUN
fnp-3866	37	27	analysis	analysis	NOUN
fnp-3866	37	28	using	use	VERB
fnp-3866	37	29	braak	braak	NOUN
fnp-3866	37	30	neurofibrillary	neurofibrillary	ADJ
fnp-3866	37	31	stage	stage	NOUN
fnp-3866	37	32	as	as	ADP
fnp-3866	37	33	an	an	DET
fnp-3866	37	34	endophenotype	endophenotype	NOUN
fnp-3866	37	35	.	.	PUNCT
fnp-3866	38	1	while	while	SCONJ
fnp-3866	38	2	this	this	PRON
fnp-3866	38	3	was	be	AUX
fnp-3866	38	4	a	a	DET
fnp-3866	38	5	relatively	relatively	ADV
fnp-3866	38	6	small	small	ADJ
fnp-3866	38	7	gwas	gwas	NOUN
fnp-3866	38	8	(	(	PUNCT
fnp-3866	38	9	n=647	n=647	NUM
fnp-3866	38	10	)	)	PUNCT
fnp-3866	38	11	,	,	PUNCT
fnp-3866	38	12	it	it	PRON
fnp-3866	38	13	was	be	AUX
fnp-3866	38	14	noted	note	VERB
fnp-3866	38	15	that	that	SCONJ
fnp-3866	38	16	most	most	ADJ
fnp-3866	38	17	similar	similar	ADJ
fnp-3866	38	18	studies	study	NOUN
fnp-3866	38	19	rely	rely	VERB
fnp-3866	38	20	on	on	ADP
fnp-3866	38	21	clinical	clinical	ADJ
fnp-3866	38	22	phenotypes	phenotype	NOUN
fnp-3866	38	23	,	,	PUNCT
fnp-3866	38	24	which	which	PRON
fnp-3866	38	25	are	be	AUX
fnp-3866	38	26	noisy	noisy	ADJ
fnp-3866	38	27	relative	relative	ADJ
fnp-3866	38	28	to	to	ADP
fnp-3866	38	29	autopsy	autopsy	ADJ
fnp-3866	38	30	-	-	PUNCT
fnp-3866	38	31	derived	derive	VERB
fnp-3866	38	32	endophenotypes	endophenotype	NOUN
fnp-3866	38	33	,	,	PUNCT
fnp-3866	38	34	such	such	ADJ
fnp-3866	38	35	as	as	ADP
fnp-3866	38	36	the	the	DET
fnp-3866	38	37	braak	braak	NOUN
fnp-3866	38	38	neurofibrillary	neurofibrillary	ADJ
fnp-3866	38	39	tangle	tangle	NOUN
fnp-3866	38	40	(	(	PUNCT
fnp-3866	38	41	nft	nft	PROPN
fnp-3866	38	42	)	)	PUNCT
fnp-3866	38	43	stage	stage	NOUN
fnp-3866	38	44	used	use	VERB
fnp-3866	38	45	in	in	ADP
fnp-3866	38	46	this	this	DET
fnp-3866	38	47	study	study	NOUN
fnp-3866	38	48	.	.	PUNCT
fnp-3866	39	1	looking	look	VERB
fnp-3866	39	2	at	at	ADP
fnp-3866	39	3	candidate	candidate	NOUN
fnp-3866	39	4	genes	gene	NOUN
fnp-3866	39	5	implicated	implicate	VERB
fnp-3866	39	6	in	in	ADP
fnp-3866	39	7	alzheimer	alzheimer	PROPN
fnp-3866	39	8	’s	’s	PART
fnp-3866	39	9	disease	disease	NOUN
fnp-3866	39	10	and	and	CCONJ
fnp-3866	39	11	tauopathies	tauopathie	NOUN
fnp-3866	39	12	revealed	reveal	VERB
fnp-3866	39	13	some	some	DET
fnp-3866	39	14	associations	association	NOUN
fnp-3866	39	15	,	,	PUNCT
fnp-3866	39	16	inducing	induce	VERB
fnp-3866	39	17	with	with	ADP
fnp-3866	39	18	the	the	DET
fnp-3866	39	19	mapt	mapt	NOUN
fnp-3866	39	20	h1	h1	NOUN
fnp-3866	39	21	haplotype	haplotype	NOUN
fnp-3866	39	22	and	and	CCONJ
fnp-3866	39	23	other	other	ADJ
fnp-3866	39	24	candidate	candidate	NOUN
fnp-3866	39	25	loci	locus	NOUN
fnp-3866	39	26	,	,	PUNCT
fnp-3866	39	27	including	include	VERB
fnp-3866	39	28	slc24a4	slc24a4	PROPN
fnp-3866	39	29	,	,	PUNCT
fnp-3866	39	30	ms4a6a	ms4a6a	PROPN
fnp-3866	39	31	,	,	PUNCT
fnp-3866	39	32	hs3st1	hs3st1	NOUN
fnp-3866	39	33	and	and	CCONJ
fnp-3866	39	34	eif2ak3	eif2ak3	PROPN
fnp-3866	39	35	.	.	PUNCT
fnp-3866	40	1	as	as	ADP
fnp-3866	40	2	with	with	ADP
fnp-3866	40	3	previous	previous	ADJ
fnp-3866	40	4	studies	study	NOUN
fnp-3866	40	5	,	,	PUNCT
fnp-3866	40	6	there	there	PRON
fnp-3866	40	7	was	be	VERB
fnp-3866	40	8	no	no	DET
fnp-3866	40	9	association	association	NOUN
fnp-3866	40	10	between	between	ADP
fnp-3866	40	11	part	part	NOUN
fnp-3866	40	12	and	and	CCONJ
fnp-3866	40	13	the	the	DET
fnp-3866	40	14	most	most	ADV
fnp-3866	40	15	important	important	ADJ
fnp-3866	40	16	and	and	CCONJ
fnp-3866	40	17	common	common	ADJ
fnp-3866	40	18	risk	risk	NOUN
fnp-3866	40	19	allele	allele	NOUN
fnp-3866	40	20	for	for	ADP
fnp-3866	40	21	sporadic	sporadic	ADJ
fnp-3866	40	22	alzheimer	alzheimer	PROPN
fnp-3866	40	23	’s	’s	PART
fnp-3866	40	24	disease	disease	NOUN
fnp-3866	40	25	,	,	PUNCT
fnp-3866	40	26	apoe	apoe	ADV
fnp-3866	40	27	.	.	PUNCT
fnp-3866	41	1	the	the	DET
fnp-3866	41	2	study	study	NOUN
fnp-3866	41	3	also	also	ADV
fnp-3866	41	4	identified	identify	VERB
fnp-3866	41	5	a	a	DET
fnp-3866	41	6	novel	novel	ADJ
fnp-3866	41	7	locus	locus	NOUN
fnp-3866	41	8	on	on	ADP
fnp-3866	41	9	chromosome	chromosome	NOUN
fnp-3866	41	10	4	4	NUM
fnp-3866	41	11	that	that	PRON
fnp-3866	41	12	met	meet	VERB
fnp-3866	41	13	genome	genome	NOUN
fnp-3866	41	14	-	-	PUNCT
fnp-3866	41	15	wide	wide	ADJ
fnp-3866	41	16	significance	significance	NOUN
fnp-3866	41	17	.	.	PUNCT
fnp-3866	42	1	given	give	VERB
fnp-3866	42	2	that	that	SCONJ
fnp-3866	42	3	the	the	DET
fnp-3866	42	4	locus	locus	NOUN
fnp-3866	42	5	contains	contain	VERB
fnp-3866	42	6	a	a	DET
fnp-3866	42	7	number	number	NOUN
fnp-3866	42	8	of	of	ADP
fnp-3866	42	9	genes	gene	NOUN
fnp-3866	42	10	,	,	PUNCT
fnp-3866	42	11	the	the	DET
fnp-3866	42	12	investigators	investigator	NOUN
fnp-3866	42	13	used	use	VERB
fnp-3866	42	14	a	a	DET
fnp-3866	42	15	computational	computational	ADJ
fnp-3866	42	16	approach	approach	NOUN
fnp-3866	42	17	,	,	PUNCT
fnp-3866	42	18	including	include	VERB
fnp-3866	42	19	examination	examination	NOUN
fnp-3866	42	20	of	of	ADP
fnp-3866	42	21	a	a	DET
fnp-3866	42	22	single	single	ADJ
fnp-3866	42	23	-	-	PUNCT
fnp-3866	42	24	cell	cell	NOUN
fnp-3866	42	25	tangle	tangle	NOUN
fnp-3866	42	26	-	-	PUNCT
fnp-3866	42	27	containing	contain	VERB
fnp-3866	42	28	rna	rna	NOUN
fnp-3866	42	29	-	-	PUNCT
fnp-3866	42	30	seq	seq	NOUN
fnp-3866	42	31	dataset	dataset	NOUN
fnp-3866	42	32	,	,	PUNCT
fnp-3866	42	33	to	to	PART
fnp-3866	42	34	nominate	nominate	VERB
fnp-3866	42	35	gene	gene	NOUN
fnp-3866	42	36	for	for	ADP
fnp-3866	42	37	apoptosis	apoptosis	NOUN
fnp-3866	42	38	and	and	CCONJ
fnp-3866	42	39	differentiation	differentiation	NOUN
fnp-3866	42	40	in	in	ADP
fnp-3866	42	41	epithelia	epithelia	PROPN
fnp-3866	42	42	1	1	NUM
fnp-3866	42	43	(	(	PUNCT
fnp-3866	42	44	jade1	jade1	ADV
fnp-3866	42	45	)	)	PUNCT
fnp-3866	42	46	as	as	ADP
fnp-3866	42	47	the	the	DET
fnp-3866	42	48	best	good	ADJ
fnp-3866	42	49	candidate	candidate	NOUN
fnp-3866	42	50	in	in	ADP
fnp-3866	42	51	the	the	DET
fnp-3866	42	52	locus	locus	NOUN
fnp-3866	42	53	.	.	PUNCT
fnp-3866	43	1	the	the	DET
fnp-3866	43	2	jade1	jade1	NOUN
fnp-3866	43	3	protein	protein	NOUN
fnp-3866	43	4	has	have	VERB
fnp-3866	43	5	some	some	DET
fnp-3866	43	6	interesting	interesting	ADJ
fnp-3866	43	7	neuropathological	neuropathological	ADJ
fnp-3866	43	8	features	feature	NOUN
fnp-3866	43	9	,	,	PUNCT
fnp-3866	43	10	co	co	VERB
fnp-3866	43	11	-	-	VERB
fnp-3866	43	12	localizing	localize	VERB
fnp-3866	43	13	by	by	ADP
fnp-3866	43	14	immunohistochemistry	immunohistochemistry	NOUN
fnp-3866	43	15	with	with	ADP
fnp-3866	43	16	nft	nft	PROPN
fnp-3866	43	17	in	in	ADP
fnp-3866	43	18	all	all	DET
fnp-3866	43	19	tauopathies	tauopathie	NOUN
fnp-3866	43	20	except	except	SCONJ
fnp-3866	43	21	pick	pick	NOUN
fnp-3866	43	22	disease	disease	NOUN
fnp-3866	43	23	,	,	PUNCT
fnp-3866	43	24	the	the	DET
fnp-3866	43	25	prototype	prototype	NOUN
fnp-3866	43	26	tauopathy	tauopathy	NOUN
fnp-3866	43	27	with	with	ADP
fnp-3866	43	28	three	three	NUM
fnp-3866	43	29	microtubule	microtubule	NOUN
fnp-3866	43	30	-	-	PUNCT
fnp-3866	43	31	binding	bind	VERB
fnp-3866	43	32	domain	domain	NOUN
fnp-3866	43	33	repeats	repeat	NOUN
fnp-3866	43	34	(	(	PUNCT
fnp-3866	43	35	3r	3r	NUM
fnp-3866	43	36	)	)	PUNCT
fnp-3866	43	37	.	.	PUNCT
fnp-3866	44	1	this	this	PRON
fnp-3866	44	2	was	be	AUX
fnp-3866	44	3	intriguing	intriguing	ADJ
fnp-3866	44	4	given	give	VERB
fnp-3866	44	5	that	that	SCONJ
fnp-3866	44	6	jade1	jade1	NOUN
fnp-3866	44	7	protein	protein	NOUN
fnp-3866	44	8	biochemically	biochemically	ADV
fnp-3866	44	9	interacts	interact	VERB
fnp-3866	44	10	with	with	ADP
fnp-3866	44	11	only	only	ADV
fnp-3866	44	12	tau	tau	PROPN
fnp-3866	44	13	isoforms	isoform	NOUN
fnp-3866	44	14	that	that	PRON
fnp-3866	44	15	contain	contain	VERB
fnp-3866	44	16	4	4	NUM
fnp-3866	44	17	microtubule	microtubule	NOUN
fnp-3866	44	18	-	-	PUNCT
fnp-3866	44	19	binding	bind	VERB
fnp-3866	44	20	domain	domain	NOUN
fnp-3866	44	21	repeats	repeat	NOUN
fnp-3866	44	22	(	(	PUNCT
fnp-3866	44	23	4r	4r	NOUN
fnp-3866	44	24	)	)	PUNCT
fnp-3866	44	25	.	.	PUNCT
fnp-3866	45	1	finally	finally	ADV
fnp-3866	45	2	,	,	PUNCT
fnp-3866	45	3	the	the	DET
fnp-3866	45	4	jade1	jade1	NOUN
fnp-3866	45	5	homolog	homolog	NOUN
fnp-3866	45	6	in	in	ADP
fnp-3866	45	7	drosophila	drosophila	PROPN
fnp-3866	45	8	,	,	PUNCT
fnp-3866	45	9	rhinoceros	rhinoceros	NOUN
fnp-3866	45	10	(	(	PUNCT
fnp-3866	45	11	rno	rno	PROPN
fnp-3866	45	12	)	)	PUNCT
fnp-3866	45	13	,	,	PUNCT
fnp-3866	45	14	was	be	AUX
fnp-3866	45	15	shown	show	VERB
fnp-3866	45	16	to	to	PART
fnp-3866	45	17	be	be	AUX
fnp-3866	45	18	a	a	DET
fnp-3866	45	19	potent	potent	ADJ
fnp-3866	45	20	regulator	regulator	NOUN
fnp-3866	45	21	of	of	ADP
fnp-3866	45	22	cell	cell	NOUN
fnp-3866	45	23	death	death	NOUN
fnp-3866	45	24	in	in	ADP
fnp-3866	45	25	the	the	DET
fnp-3866	45	26	fly	fly	NOUN
fnp-3866	45	27	eye	eye	NOUN
fnp-3866	45	28	and	and	CCONJ
fnp-3866	45	29	brain	brain	NOUN
fnp-3866	45	30	.	.	PUNCT
fnp-3866	46	1	together	together	ADV
fnp-3866	46	2	,	,	PUNCT
fnp-3866	46	3	these	these	DET
fnp-3866	46	4	findings	finding	NOUN
fnp-3866	46	5	suggest	suggest	VERB
fnp-3866	46	6	that	that	SCONJ
fnp-3866	46	7	jade1	jade1	NOUN
fnp-3866	46	8	might	might	AUX
fnp-3866	46	9	be	be	AUX
fnp-3866	46	10	a	a	DET
fnp-3866	46	11	component	component	NOUN
fnp-3866	46	12	of	of	ADP
fnp-3866	46	13	a	a	DET
fnp-3866	46	14	pathway	pathway	NOUN
fnp-3866	46	15	that	that	PRON
fnp-3866	46	16	shared	share	VERB
fnp-3866	46	17	by	by	ADP
fnp-3866	46	18	many	many	ADJ
fnp-3866	46	19	tauopathies	tauopathie	NOUN
fnp-3866	46	20	.	.	PUNCT
fnp-3866	47	1	3	3	X
fnp-3866	47	2	.	.	X
fnp-3866	47	3	neuropathological	neuropathological	ADJ
fnp-3866	47	4	criteria	criterion	NOUN
fnp-3866	47	5	for	for	ADP
fnp-3866	47	6	chronic	chronic	ADJ
fnp-3866	47	7	traumatic	traumatic	ADJ
fnp-3866	47	8	encephalopathy	encephalopathy	NOUN
fnp-3866	47	9	:	:	PUNCT
fnp-3866	47	10	consensus	consensus	NOUN
fnp-3866	47	11	update	update	NOUN
fnp-3866	47	12	as	as	ADP
fnp-3866	47	13	awareness	awareness	NOUN
fnp-3866	47	14	and	and	CCONJ
fnp-3866	47	15	scientific	scientific	ADJ
fnp-3866	47	16	interest	interest	NOUN
fnp-3866	47	17	in	in	ADP
fnp-3866	47	18	chronic	chronic	ADJ
fnp-3866	47	19	traumatic	traumatic	ADJ
fnp-3866	47	20	encephalopathy	encephalopathy	NOUN
fnp-3866	47	21	(	(	PUNCT
fnp-3866	47	22	cte	cte	NOUN
fnp-3866	47	23	)	)	PUNCT
fnp-3866	47	24	continues	continue	VERB
fnp-3866	47	25	to	to	PART
fnp-3866	47	26	expand	expand	VERB
fnp-3866	47	27	,	,	PUNCT
fnp-3866	47	28	the	the	DET
fnp-3866	47	29	neuropathological	neuropathological	ADJ
fnp-3866	47	30	criteria	criterion	NOUN
fnp-3866	47	31	continue	continue	VERB
fnp-3866	47	32	to	to	PART
fnp-3866	47	33	be	be	AUX
fnp-3866	47	34	a	a	DET
fnp-3866	47	35	focus	focus	NOUN
fnp-3866	47	36	area	area	NOUN
fnp-3866	47	37	.	.	PUNCT
fnp-3866	48	1	concussions	concussion	NOUN
fnp-3866	48	2	are	be	AUX
fnp-3866	48	3	extremely	extremely	ADV
fnp-3866	48	4	common	common	ADJ
fnp-3866	48	5	,	,	PUNCT
fnp-3866	48	6	especially	especially	ADV
fnp-3866	48	7	in	in	ADP
fnp-3866	48	8	military	military	ADJ
fnp-3866	48	9	populations	population	NOUN
fnp-3866	48	10	and	and	CCONJ
fnp-3866	48	11	contact	contact	NOUN
fnp-3866	48	12	sports	sport	NOUN
fnp-3866	48	13	athletes	athlete	NOUN
fnp-3866	48	14	,	,	PUNCT
fnp-3866	48	15	and	and	CCONJ
fnp-3866	48	16	the	the	DET
fnp-3866	48	17	long	long	ADJ
fnp-3866	48	18	-	-	PUNCT
fnp-3866	48	19	term	term	NOUN
fnp-3866	48	20	neurological	neurological	ADJ
fnp-3866	48	21	sequelae	sequelae	NOUN
fnp-3866	48	22	remain	remain	VERB
fnp-3866	48	23	under	under	ADV
fnp-3866	48	24	-	-	PUNCT
fnp-3866	48	25	investigated	investigate	VERB
fnp-3866	48	26	.	.	PUNCT
fnp-3866	49	1	previously	previously	ADV
fnp-3866	49	2	,	,	PUNCT
fnp-3866	49	3	the	the	DET
fnp-3866	49	4	nih	nih	PROPN
fnp-3866	49	5	convened	convene	VERB
fnp-3866	49	6	a	a	DET
fnp-3866	49	7	consensus	consensus	NOUN
fnp-3866	49	8	panel	panel	NOUN
fnp-3866	49	9	of	of	ADP
fnp-3866	49	10	neuropathologists	neuropathologist	NOUN
fnp-3866	49	11	to	to	PART
fnp-3866	49	12	establish	establish	VERB
fnp-3866	49	13	preliminary	preliminary	ADJ
fnp-3866	49	14	consensus	consensus	NOUN
fnp-3866	49	15	criteria	criterion	NOUN
fnp-3866	49	16	for	for	ADP
fnp-3866	49	17	the	the	DET
fnp-3866	49	18	neuropathological	neuropathological	ADJ
fnp-3866	49	19	diagnosis	diagnosis	NOUN
fnp-3866	49	20	of	of	ADP
fnp-3866	49	21	cte	cte	PROPN
fnp-3866	49	22	(	(	PUNCT
fnp-3866	49	23	mckee	mckee	NOUN
fnp-3866	49	24	et	et	PROPN
fnp-3866	49	25	al	al	PROPN
fnp-3866	49	26	.	.	PROPN
fnp-3866	49	27	,	,	PUNCT
fnp-3866	49	28	2016	2016	NUM
fnp-3866	49	29	)	)	PUNCT
fnp-3866	49	30	.	.	PUNCT
fnp-3866	50	1	this	this	DET
fnp-3866	50	2	landmark	landmark	NOUN
fnp-3866	50	3	study	study	NOUN
fnp-3866	50	4	has	have	AUX
fnp-3866	50	5	been	be	AUX
fnp-3866	50	6	highly	highly	ADV
fnp-3866	50	7	influential	influential	ADJ
fnp-3866	50	8	,	,	PUNCT
fnp-3866	50	9	but	but	CCONJ
fnp-3866	50	10	questions	question	NOUN
fnp-3866	50	11	persisted	persist	VERB
fnp-3866	50	12	.	.	PUNCT
fnp-3866	51	1	for	for	ADP
fnp-3866	51	2	example	example	NOUN
fnp-3866	51	3	,	,	PUNCT
fnp-3866	51	4	it	it	PRON
fnp-3866	51	5	was	be	AUX
fnp-3866	51	6	unclear	unclear	ADJ
fnp-3866	51	7	as	as	ADP
fnp-3866	51	8	to	to	ADP
fnp-3866	51	9	what	what	PRON
fnp-3866	51	10	is	be	AUX
fnp-3866	51	11	the	the	DET
fnp-3866	51	12	minimum	minimum	ADJ
fnp-3866	51	13	requirement	requirement	NOUN
fnp-3866	51	14	for	for	ADP
fnp-3866	51	15	a	a	DET
fnp-3866	51	16	cte	cte	NOUN
fnp-3866	51	17	diagnosis	diagnosis	NOUN
fnp-3866	51	18	.	.	PUNCT
fnp-3866	52	1	further	far	ADV
fnp-3866	52	2	,	,	PUNCT
fnp-3866	52	3	it	it	PRON
fnp-3866	52	4	was	be	AUX
fnp-3866	52	5	important	important	ADJ
fnp-3866	52	6	to	to	PART
fnp-3866	52	7	know	know	VERB
fnp-3866	52	8	whether	whether	SCONJ
fnp-3866	52	9	cte	cte	PROPN
fnp-3866	52	10	could	could	AUX
fnp-3866	52	11	be	be	AUX
fnp-3866	52	12	reliably	reliably	ADV
fnp-3866	52	13	differentiated	differentiate	VERB
fnp-3866	52	14	from	from	ADP
fnp-3866	52	15	age	age	NOUN
fnp-3866	52	16	-	-	PUNCT
fnp-3866	52	17	related	relate	VERB
fnp-3866	52	18	tauopathies	tauopathie	NOUN
fnp-3866	52	19	like	like	ADP
fnp-3866	52	20	primary	primary	ADJ
fnp-3866	52	21	age	age	NOUN
fnp-3866	52	22	-	-	PUNCT
fnp-3866	52	23	related	relate	VERB
fnp-3866	52	24	tauopathy	tauopathy	NOUN
fnp-3866	52	25	(	(	PUNCT
fnp-3866	52	26	part	part	NOUN
fnp-3866	52	27	)	)	PUNCT
fnp-3866	52	28	and	and	CCONJ
fnp-3866	52	29	aging	age	VERB
fnp-3866	52	30	-	-	PUNCT
fnp-3866	52	31	related	relate	VERB
fnp-3866	52	32	tau	tau	PROPN
fnp-3866	52	33	astrogliopathy	astrogliopathy	ADJ
fnp-3866	52	34	(	(	PUNCT
fnp-3866	52	35	artag	artag	ADJ
fnp-3866	52	36	)	)	PUNCT
fnp-3866	52	37	.	.	PUNCT
fnp-3866	53	1	further	far	ADV
fnp-3866	53	2	,	,	PUNCT
fnp-3866	53	3	a	a	DET
fnp-3866	53	4	four	four	NUM
fnp-3866	53	5	-	-	PUNCT
fnp-3866	53	6	tiered	tiere	VERB
fnp-3866	53	7	staging	staging	NOUN
fnp-3866	53	8	system	system	NOUN
fnp-3866	53	9	has	have	AUX
fnp-3866	53	10	been	be	AUX
fnp-3866	53	11	proposed	propose	VERB
fnp-3866	53	12	but	but	CCONJ
fnp-3866	53	13	has	have	AUX
fnp-3866	53	14	not	not	PART
fnp-3866	53	15	been	be	AUX
fnp-3866	53	16	independently	independently	ADV
fnp-3866	53	17	validated	validate	VERB
fnp-3866	53	18	(	(	PUNCT
fnp-3866	53	19	mckee	mckee	NOUN
fnp-3866	53	20	et	et	PROPN
fnp-3866	53	21	al	al	PROPN
fnp-3866	53	22	.	.	PROPN
fnp-3866	53	23	,	,	PUNCT
fnp-3866	53	24	2013	2013	NUM
fnp-3866	53	25	)	)	PUNCT
fnp-3866	53	26	.	.	PUNCT
fnp-3866	54	1	to	to	PART
fnp-3866	54	2	address	address	VERB
fnp-3866	54	3	this	this	PRON
fnp-3866	54	4	,	,	PUNCT
fnp-3866	54	5	the	the	DET
fnp-3866	54	6	nih	nih	PROPN
fnp-3866	54	7	convened	convene	VERB
fnp-3866	54	8	a	a	DET
fnp-3866	54	9	second	second	ADJ
fnp-3866	54	10	consensus	consensus	NOUN
fnp-3866	54	11	panel	panel	NOUN
fnp-3866	54	12	meeting	meeting	NOUN
fnp-3866	54	13	with	with	ADP
fnp-3866	54	14	eight	eight	NUM
fnp-3866	54	15	neuropathologists	neuropathologist	NOUN
fnp-3866	54	16	expert	expert	NOUN
fnp-3866	54	17	in	in	ADP
fnp-3866	54	18	neurodegenerative	neurodegenerative	ADJ
fnp-3866	54	19	tauopathies	tauopathie	NOUN
fnp-3866	54	20	(	(	PUNCT
fnp-3866	54	21	bieniek	bieniek	NOUN
fnp-3866	54	22	et	et	PROPN
fnp-3866	54	23	al	al	PROPN
fnp-3866	54	24	.	.	PROPN
fnp-3866	54	25	,	,	PUNCT
fnp-3866	54	26	2021	2021	NUM
fnp-3866	54	27	)	)	PUNCT
fnp-3866	54	28	.	.	PUNCT
fnp-3866	55	1	the	the	DET
fnp-3866	55	2	panel	panel	NOUN
fnp-3866	55	3	blindly	blindly	ADV
fnp-3866	55	4	reviewed	review	VERB
fnp-3866	55	5	27	27	NUM
fnp-3866	55	6	cases	case	NOUN
fnp-3866	55	7	(	(	PUNCT
fnp-3866	55	8	17	17	NUM
fnp-3866	55	9	cte	cte	NOUN
fnp-3866	55	10	and	and	CCONJ
fnp-3866	55	11	10	10	NUM
fnp-3866	55	12	other	other	ADJ
fnp-3866	55	13	tauopathies	tauopathie	NOUN
fnp-3866	55	14	)	)	PUNCT
fnp-3866	55	15	,	,	PUNCT
fnp-3866	55	16	applying	apply	VERB
fnp-3866	55	17	the	the	DET
fnp-3866	55	18	2016	2016	NUM
fnp-3866	55	19	cte	cte	NOUN
fnp-3866	55	20	criteria	criterion	NOUN
fnp-3866	55	21	.	.	PUNCT
fnp-3866	56	1	first	first	ADV
fnp-3866	56	2	,	,	PUNCT
fnp-3866	56	3	there	there	PRON
fnp-3866	56	4	was	be	VERB
fnp-3866	56	5	substantial	substantial	ADJ
fnp-3866	56	6	agreement	agreement	NOUN
fnp-3866	56	7	in	in	ADP
fnp-3866	56	8	the	the	DET
fnp-3866	56	9	diagnosis	diagnosis	NOUN
fnp-3866	56	10	across	across	ADP
fnp-3866	56	11	raters	rater	NOUN
fnp-3866	56	12	which	which	PRON
fnp-3866	56	13	validated	validate	VERB
fnp-3866	56	14	the	the	DET
fnp-3866	56	15	robustness	robustness	NOUN
fnp-3866	56	16	of	of	ADP
fnp-3866	56	17	the	the	DET
fnp-3866	56	18	approach	approach	NOUN
fnp-3866	56	19	.	.	PUNCT
fnp-3866	57	1	next	next	ADV
fnp-3866	57	2	,	,	PUNCT
fnp-3866	57	3	the	the	DET
fnp-3866	57	4	panel	panel	NOUN
fnp-3866	57	5	turned	turn	VERB
fnp-3866	57	6	to	to	ADP
fnp-3866	57	7	staging	stage	VERB
fnp-3866	57	8	and	and	CCONJ
fnp-3866	57	9	developed	develop	VERB
fnp-3866	57	10	a	a	DET
fnp-3866	57	11	simplified	simplified	ADJ
fnp-3866	57	12	and	and	CCONJ
fnp-3866	57	13	practical	practical	ADJ
fnp-3866	57	14	tool	tool	NOUN
fnp-3866	57	15	for	for	ADP
fnp-3866	57	16	the	the	DET
fnp-3866	57	17	assessment	assessment	NOUN
fnp-3866	57	18	of	of	ADP
fnp-3866	57	19	the	the	DET
fnp-3866	57	20	cte	cte	NOUN
fnp-3866	57	21	stage	stage	NOUN
fnp-3866	57	22	(	(	PUNCT
fnp-3866	57	23	figure	figure	NOUN
fnp-3866	57	24	2	2	NUM
fnp-3866	57	25	)	)	PUNCT
fnp-3866	57	26	.	.	PUNCT
fnp-3866	58	1	the	the	DET
fnp-3866	58	2	tool	tool	NOUN
fnp-3866	58	3	involves	involve	VERB
fnp-3866	58	4	assessment	assessment	NOUN
fnp-3866	58	5	of	of	ADP
fnp-3866	58	6	the	the	DET
fnp-3866	58	7	11	11	NUM
fnp-3866	58	8	brain	brain	NOUN
fnp-3866	58	9	regions	region	NOUN
fnp-3866	58	10	proposed	propose	VERB
fnp-3866	58	11	by	by	ADP
fnp-3866	58	12	the	the	DET
fnp-3866	58	13	first	first	ADJ
fnp-3866	58	14	consensus	consensus	NOUN
fnp-3866	58	15	meeting	meeting	NOUN
fnp-3866	58	16	with	with	ADP
fnp-3866	58	17	a	a	DET
fnp-3866	58	18	minimum	minimum	ADJ
fnp-3866	58	19	threshold	threshold	NOUN
fnp-3866	58	20	as	as	ADP
fnp-3866	58	21	a	a	DET
fnp-3866	58	22	single	single	ADJ
fnp-3866	58	23	pathognomonic	pathognomonic	ADJ
fnp-3866	58	24	lesion	lesion	NOUN
fnp-3866	58	25	(	(	PUNCT
fnp-3866	58	26	with	with	ADP
fnp-3866	58	27	or	or	CCONJ
fnp-3866	58	28	without	without	ADP
fnp-3866	58	29	glial	glial	ADJ
fnp-3866	58	30	tangles	tangle	NOUN
fnp-3866	58	31	)	)	PUNCT
fnp-3866	58	32	.	.	PUNCT
fnp-3866	59	1	a	a	DET
fnp-3866	59	2	point	point	NOUN
fnp-3866	59	3	system	system	NOUN
fnp-3866	59	4	was	be	AUX
fnp-3866	59	5	devised	devise	VERB
fnp-3866	59	6	encompassing	encompass	VERB
fnp-3866	59	7	the	the	DET
fnp-3866	59	8	numerous	numerous	ADJ
fnp-3866	59	9	features	feature	NOUN
fnp-3866	59	10	of	of	ADP
fnp-3866	59	11	cte	cte	NOUN
fnp-3866	59	12	with	with	ADP
fnp-3866	59	13	a	a	DET
fnp-3866	59	14	cutoff	cutoff	NOUN
fnp-3866	59	15	of	of	ADP
fnp-3866	59	16	five	five	NUM
fnp-3866	59	17	,	,	PUNCT
fnp-3866	59	18	dichotomizing	dichotomize	VERB
fnp-3866	59	19	“	"	PUNCT
fnp-3866	59	20	low	low	ADJ
fnp-3866	59	21	"	"	PUNCT
fnp-3866	59	22	and	and	CCONJ
fnp-3866	59	23	“	"	PUNCT
fnp-3866	59	24	high	high	ADJ
fnp-3866	59	25	"	"	PUNCT
fnp-3866	59	26	cte	cte	NOUN
fnp-3866	59	27	neuropathologic	neuropathologic	NOUN
fnp-3866	59	28	change	change	NOUN
fnp-3866	59	29	.	.	PUNCT
fnp-3866	60	1	this	this	DET
fnp-3866	60	2	simplified	simplify	VERB
fnp-3866	60	3	system	system	NOUN
fnp-3866	60	4	had	have	VERB
fnp-3866	60	5	excellent	excellent	ADJ
fnp-3866	60	6	correlation	correlation	NOUN
fnp-3866	60	7	with	with	ADP
fnp-3866	60	8	the	the	DET
fnp-3866	60	9	cte	cte	NOUN
fnp-3866	60	10	stage	stage	NOUN
fnp-3866	60	11	as	as	ADP
fnp-3866	60	12	previously	previously	ADV
fnp-3866	60	13	described	describe	VERB
fnp-3866	60	14	(	(	PUNCT
fnp-3866	60	15	mckee	mckee	PROPN
fnp-3866	60	16	et	et	PROPN
fnp-3866	60	17	al	al	PROPN
fnp-3866	60	18	.	.	PROPN
fnp-3866	60	19	,	,	PUNCT
fnp-3866	60	20	2013	2013	NUM
fnp-3866	60	21	)	)	PUNCT
fnp-3866	60	22	.	.	PUNCT
fnp-3866	61	1	numerous	numerous	ADJ
fnp-3866	61	2	challenges	challenge	NOUN
fnp-3866	61	3	and	and	CCONJ
fnp-3866	61	4	controversies	controversy	NOUN
fnp-3866	61	5	in	in	ADP
fnp-3866	61	6	the	the	DET
fnp-3866	61	7	field	field	NOUN
fnp-3866	61	8	remain	remain	VERB
fnp-3866	61	9	,	,	PUNCT
fnp-3866	61	10	but	but	CCONJ
fnp-3866	61	11	this	this	PRON
fnp-3866	61	12	represents	represent	VERB
fnp-3866	61	13	a	a	DET
fnp-3866	61	14	milestone	milestone	NOUN
fnp-3866	61	15	in	in	ADP
fnp-3866	61	16	establishing	establish	VERB
fnp-3866	61	17	rigor	rigor	NOUN
fnp-3866	61	18	and	and	CCONJ
fnp-3866	61	19	reproducibility	reproducibility	NOUN
fnp-3866	61	20	in	in	ADP
fnp-3866	61	21	cte	cte	PROPN
fnp-3866	61	22	autopsy	autopsy	ADJ
fnp-3866	61	23	studies	study	NOUN
fnp-3866	61	24	and	and	CCONJ
fnp-3866	61	25	provides	provide	VERB
fnp-3866	61	26	a	a	DET
fnp-3866	61	27	foundation	foundation	NOUN
fnp-3866	61	28	for	for	ADP
fnp-3866	61	29	further	further	ADJ
fnp-3866	61	30	advances	advance	NOUN
fnp-3866	61	31	in	in	ADP
fnp-3866	61	32	the	the	DET
fnp-3866	61	33	field	field	NOUN
fnp-3866	61	34	.	.	PUNCT
fnp-3866	62	1	figure	figure	NOUN
fnp-3866	62	2	2	2	NUM
fnp-3866	62	3	.	.	X
fnp-3866	62	4	flowchart	flowchart	NOUN
fnp-3866	62	5	for	for	ADP
fnp-3866	62	6	diagnosis	diagnosis	NOUN
fnp-3866	62	7	of	of	ADP
fnp-3866	62	8	cte	cte	NOUN
fnp-3866	62	9	reproduced	reproduce	VERB
fnp-3866	62	10	with	with	ADP
fnp-3866	62	11	permission	permission	NOUN
fnp-3866	62	12	from	from	ADP
fnp-3866	62	13	bieniek	bieniek	PROPN
fnp-3866	62	14	et	et	PROPN
fnp-3866	62	15	al	al	PROPN
fnp-3866	62	16	.	.	PUNCT
fnp-3866	63	1	(	(	PUNCT
fnp-3866	63	2	bieniek	bieniek	NOUN
fnp-3866	63	3	et	et	PROPN
fnp-3866	63	4	al	al	PROPN
fnp-3866	63	5	.	.	PROPN
fnp-3866	63	6	,	,	PUNCT
fnp-3866	63	7	2021	2021	NUM
fnp-3866	63	8	)	)	PUNCT
fnp-3866	63	9	.	.	PUNCT
fnp-3866	64	1	4	4	X
fnp-3866	64	2	.	.	X
fnp-3866	64	3	a	a	DET
fnp-3866	64	4	causal	causal	ADJ
fnp-3866	64	5	role	role	NOUN
fnp-3866	64	6	for	for	ADP
fnp-3866	64	7	tmem106b	tmem106b	PROPN
fnp-3866	64	8	in	in	ADP
fnp-3866	64	9	tdp-43	tdp-43	PROPN
fnp-3866	64	10	pathology	pathology	NOUN
fnp-3866	64	11	inclusions	inclusion	NOUN
fnp-3866	64	12	containing	contain	VERB
fnp-3866	64	13	the	the	DET
fnp-3866	64	14	tar	tar	NOUN
fnp-3866	64	15	dna	dna	NOUN
fnp-3866	64	16	-	-	PUNCT
fnp-3866	64	17	binding	bind	VERB
fnp-3866	64	18	protein	protein	NOUN
fnp-3866	64	19	43	43	NUM
fnp-3866	64	20	(	(	PUNCT
fnp-3866	64	21	tdp-43	tdp-43	NOUN
fnp-3866	64	22	)	)	PUNCT
fnp-3866	64	23	are	be	AUX
fnp-3866	64	24	the	the	DET
fnp-3866	64	25	hallmark	hallmark	ADJ
fnp-3866	64	26	neuropathological	neuropathological	ADJ
fnp-3866	64	27	feature	feature	NOUN
fnp-3866	64	28	of	of	ADP
fnp-3866	64	29	a	a	DET
fnp-3866	64	30	number	number	NOUN
fnp-3866	64	31	of	of	ADP
fnp-3866	64	32	neurodegenerative	neurodegenerative	ADJ
fnp-3866	64	33	diseases	disease	NOUN
fnp-3866	64	34	with	with	ADP
fnp-3866	64	35	divergent	divergent	ADJ
fnp-3866	64	36	neuroanatomical	neuroanatomical	ADJ
fnp-3866	64	37	vulnerability	vulnerability	NOUN
fnp-3866	64	38	and	and	CCONJ
fnp-3866	64	39	symptomatology	symptomatology	NOUN
fnp-3866	64	40	including	include	VERB
fnp-3866	64	41	amyotrophic	amyotrophic	ADJ
fnp-3866	64	42	lateral	lateral	ADJ
fnp-3866	64	43	sclerosis	sclerosis	NOUN
fnp-3866	64	44	(	(	PUNCT
fnp-3866	64	45	als	als	NOUN
fnp-3866	64	46	)	)	PUNCT
fnp-3866	64	47	,	,	PUNCT
fnp-3866	64	48	frontotemporal	frontotemporal	ADJ
fnp-3866	64	49	lobar	lobar	ADJ
fnp-3866	64	50	degeneration	degeneration	NOUN
fnp-3866	64	51	(	(	PUNCT
fnp-3866	64	52	ftld	ftld	ADJ
fnp-3866	64	53	-	-	PUNCT
fnp-3866	64	54	tdp	tdp	NOUN
fnp-3866	64	55	)	)	PUNCT
fnp-3866	64	56	,	,	PUNCT
fnp-3866	64	57	and	and	CCONJ
fnp-3866	64	58	limbic	limbic	ADJ
fnp-3866	64	59	age	age	NOUN
fnp-3866	64	60	-	-	PUNCT
fnp-3866	64	61	related	relate	VERB
fnp-3866	64	62	tdp-43	tdp-43	NOUN
fnp-3866	64	63	encephalopathy	encephalopathy	ADJ
fnp-3866	64	64	(	(	PUNCT
fnp-3866	64	65	late	late	ADJ
fnp-3866	64	66	)	)	PUNCT
fnp-3866	64	67	.	.	PUNCT
fnp-3866	65	1	the	the	DET
fnp-3866	65	2	underlying	underlying	ADJ
fnp-3866	65	3	reasons	reason	NOUN
fnp-3866	65	4	for	for	ADP
fnp-3866	65	5	these	these	DET
fnp-3866	65	6	divergent	divergent	ADJ
fnp-3866	65	7	pathoanatomical	pathoanatomical	ADJ
fnp-3866	65	8	signatures	signature	NOUN
fnp-3866	65	9	are	be	AUX
fnp-3866	65	10	unclear	unclear	ADJ
fnp-3866	65	11	and	and	CCONJ
fnp-3866	65	12	numerous	numerous	ADJ
fnp-3866	65	13	factors	factor	NOUN
fnp-3866	65	14	likely	likely	ADV
fnp-3866	65	15	contribute	contribute	VERB
fnp-3866	65	16	.	.	PUNCT
fnp-3866	66	1	while	while	SCONJ
fnp-3866	66	2	mutations	mutation	NOUN
fnp-3866	66	3	in	in	ADP
fnp-3866	66	4	the	the	DET
fnp-3866	66	5	tdp-43	tdp-43	PROPN
fnp-3866	66	6	gene	gene	NOUN
fnp-3866	66	7	are	be	AUX
fnp-3866	66	8	only	only	ADV
fnp-3866	66	9	rarely	rarely	ADV
fnp-3866	66	10	associated	associate	VERB
fnp-3866	66	11	with	with	ADP
fnp-3866	66	12	tdp-43	tdp-43	NOUN
fnp-3866	66	13	proteinopathy	proteinopathy	ADJ
fnp-3866	66	14	,	,	PUNCT
fnp-3866	66	15	genetic	genetic	ADJ
fnp-3866	66	16	variation	variation	NOUN
fnp-3866	66	17	in	in	ADP
fnp-3866	66	18	other	other	ADJ
fnp-3866	66	19	genes	gene	NOUN
fnp-3866	66	20	including	include	VERB
fnp-3866	66	21	tmem106b	tmem106b	PROPN
fnp-3866	66	22	and	and	CCONJ
fnp-3866	66	23	c9orf72	c9orf72	PROPN
fnp-3866	66	24	are	be	AUX
fnp-3866	66	25	much	much	ADV
fnp-3866	66	26	more	more	ADV
fnp-3866	66	27	frequent	frequent	ADJ
fnp-3866	66	28	in	in	ADP
fnp-3866	66	29	this	this	DET
fnp-3866	66	30	context	context	NOUN
fnp-3866	66	31	.	.	PUNCT
fnp-3866	67	1	to	to	PART
fnp-3866	67	2	explore	explore	VERB
fnp-3866	67	3	this	this	PRON
fnp-3866	67	4	,	,	PUNCT
fnp-3866	67	5	mao	mao	PROPN
fnp-3866	67	6	et	et	PROPN
fnp-3866	67	7	al	al	PROPN
fnp-3866	67	8	.	.	PROPN
fnp-3866	67	9	performed	perform	VERB
fnp-3866	67	10	a	a	DET
fnp-3866	67	11	rigorous	rigorous	ADJ
fnp-3866	67	12	pathoanatomical	pathoanatomical	ADJ
fnp-3866	67	13	study	study	NOUN
fnp-3866	67	14	published	publish	VERB
fnp-3866	67	15	in	in	ADP
fnp-3866	67	16	acta	acta	PROPN
fnp-3866	67	17	neuropathologica	neuropathologica	PROPN
fnp-3866	67	18	examining	examine	VERB
fnp-3866	67	19	the	the	DET
fnp-3866	67	20	influence	influence	NOUN
fnp-3866	67	21	of	of	ADP
fnp-3866	67	22	genetic	genetic	ADJ
fnp-3866	67	23	variation	variation	NOUN
fnp-3866	67	24	in	in	ADP
fnp-3866	67	25	tmem106b	tmem106b	PROPN
fnp-3866	67	26	and	and	CCONJ
fnp-3866	67	27	c9orf72	c9orf72	ADJ
fnp-3866	67	28	on	on	ADP
fnp-3866	67	29	the	the	DET
fnp-3866	67	30	burden	burden	NOUN
fnp-3866	67	31	and	and	CCONJ
fnp-3866	67	32	distribution	distribution	NOUN
fnp-3866	67	33	of	of	ADP
fnp-3866	67	34	tdp-43	tdp-43	NOUN
fnp-3866	67	35	proteinopathy	proteinopathy	ADJ
fnp-3866	67	36	in	in	ADP
fnp-3866	67	37	899	899	NUM
fnp-3866	67	38	brains	brain	NOUN
fnp-3866	67	39	from	from	ADP
fnp-3866	67	40	the	the	DET
fnp-3866	67	41	university	university	PROPN
fnp-3866	67	42	of	of	ADP
fnp-3866	67	43	pennsylvania	pennsylvania	PROPN
fnp-3866	67	44	center	center	PROPN
fnp-3866	67	45	for	for	ADP
fnp-3866	67	46	neurodegenerative	neurodegenerative	ADJ
fnp-3866	67	47	disease	disease	NOUN
fnp-3866	67	48	research	research	NOUN
fnp-3866	67	49	(	(	PUNCT
fnp-3866	67	50	cndr	cndr	NOUN
fnp-3866	67	51	)	)	PUNCT
fnp-3866	67	52	brain	brain	NOUN
fnp-3866	67	53	bank	bank	NOUN
fnp-3866	67	54	,	,	PUNCT
fnp-3866	67	55	including	include	VERB
fnp-3866	67	56	cases	case	NOUN
fnp-3866	67	57	with	with	ADP
fnp-3866	67	58	als	al	NOUN
fnp-3866	67	59	,	,	PUNCT
fnp-3866	67	60	ftld	ftld	ADJ
fnp-3866	67	61	-	-	PUNCT
fnp-3866	67	62	tdp	tdp	NOUN
fnp-3866	67	63	,	,	PUNCT
fnp-3866	67	64	alzheimer	alzheimer	PROPN
fnp-3866	67	65	’s	’s	PART
fnp-3866	67	66	disease	disease	NOUN
fnp-3866	67	67	and	and	CCONJ
fnp-3866	67	68	lewy	lewy	ADJ
fnp-3866	67	69	body	body	NOUN
fnp-3866	67	70	disease	disease	NOUN
fnp-3866	67	71	(	(	PUNCT
fnp-3866	67	72	mao	mao	NOUN
fnp-3866	67	73	et	et	PROPN
fnp-3866	67	74	al	al	PROPN
fnp-3866	67	75	.	.	PROPN
fnp-3866	67	76	,	,	PUNCT
fnp-3866	67	77	2021	2021	NUM
fnp-3866	67	78	)	)	PUNCT
fnp-3866	67	79	.	.	PUNCT
fnp-3866	68	1	tmem106b	tmem106b	ADJ
fnp-3866	68	2	risk	risk	NOUN
fnp-3866	68	3	alleles	allele	NOUN
fnp-3866	68	4	for	for	ADP
fnp-3866	68	5	ftld	ftld	ADJ
fnp-3866	68	6	-	-	PUNCT
fnp-3866	68	7	tdp	tdp	NOUN
fnp-3866	68	8	were	be	AUX
fnp-3866	68	9	demonstrated	demonstrate	VERB
fnp-3866	68	10	to	to	PART
fnp-3866	68	11	modify	modify	VERB
fnp-3866	68	12	tdp-43	tdp-43	NOUN
fnp-3866	68	13	burden	burden	NOUN
fnp-3866	68	14	in	in	ADP
fnp-3866	68	15	als	als	NOUN
fnp-3866	68	16	(	(	PUNCT
fnp-3866	68	17	but	but	CCONJ
fnp-3866	68	18	curiously	curiously	ADV
fnp-3866	68	19	not	not	PART
fnp-3866	68	20	in	in	ADP
fnp-3866	68	21	ftld	ftld	ADJ
fnp-3866	68	22	-	-	PUNCT
fnp-3866	68	23	tdp	tdp	NOUN
fnp-3866	68	24	)	)	PUNCT
fnp-3866	68	25	.	.	PUNCT
fnp-3866	69	1	c9orf72	c9orf72	ADJ
fnp-3866	69	2	expansion	expansion	NOUN
fnp-3866	69	3	was	be	AUX
fnp-3866	69	4	associated	associate	VERB
fnp-3866	69	5	with	with	ADP
fnp-3866	69	6	tdp-43	tdp-43	NOUN
fnp-3866	69	7	burden	burden	NOUN
fnp-3866	69	8	in	in	ADP
fnp-3866	69	9	both	both	DET
fnp-3866	69	10	als	als	NOUN
fnp-3866	69	11	and	and	CCONJ
fnp-3866	69	12	ftld	ftld	ADJ
fnp-3866	69	13	-	-	PUNCT
fnp-3866	69	14	tdp	tdp	NOUN
fnp-3866	69	15	.	.	PUNCT
fnp-3866	70	1	the	the	DET
fnp-3866	70	2	interaction	interaction	NOUN
fnp-3866	70	3	between	between	ADP
fnp-3866	70	4	tdp-43	tdp-43	PROPN
fnp-3866	70	5	and	and	CCONJ
fnp-3866	70	6	tmem106b	tmem106b	PROPN
fnp-3866	70	7	was	be	AUX
fnp-3866	70	8	confirmed	confirm	VERB
fnp-3866	70	9	in	in	ADP
fnp-3866	70	10	a	a	DET
fnp-3866	70	11	cellular	cellular	ADJ
fnp-3866	70	12	model	model	NOUN
fnp-3866	70	13	.	.	PUNCT
fnp-3866	71	1	these	these	DET
fnp-3866	71	2	data	datum	NOUN
fnp-3866	71	3	are	be	AUX
fnp-3866	71	4	intriguing	intriguing	ADJ
fnp-3866	71	5	because	because	SCONJ
fnp-3866	71	6	they	they	PRON
fnp-3866	71	7	suggest	suggest	VERB
fnp-3866	71	8	a	a	DET
fnp-3866	71	9	causal	causal	ADJ
fnp-3866	71	10	role	role	NOUN
fnp-3866	71	11	for	for	ADP
fnp-3866	71	12	tmem106b	tmem106b	ADJ
fnp-3866	71	13	in	in	ADP
fnp-3866	71	14	some	some	DET
fnp-3866	71	15	forms	form	NOUN
fnp-3866	71	16	of	of	ADP
fnp-3866	71	17	tdp-43	tdp-43	PROPN
fnp-3866	71	18	pathology	pathology	PROPN
fnp-3866	71	19	(	(	PUNCT
fnp-3866	71	20	figure	figure	NOUN
fnp-3866	71	21	3	3	NUM
fnp-3866	71	22	)	)	PUNCT
fnp-3866	71	23	.	.	PUNCT
fnp-3866	72	1	figure	figure	VERB
fnp-3866	72	2	3	3	NUM
fnp-3866	72	3	.	.	PUNCT
fnp-3866	72	4	schematic	schematic	ADJ
fnp-3866	72	5	showing	show	VERB
fnp-3866	72	6	the	the	DET
fnp-3866	72	7	effects	effect	NOUN
fnp-3866	72	8	of	of	ADP
fnp-3866	72	9	tmem106b	tmem106b	NOUN
fnp-3866	72	10	on	on	ADP
fnp-3866	72	11	tdp-43	tdp-43	NOUN
fnp-3866	72	12	proteinopathy	proteinopathy	ADJ
fnp-3866	72	13	reproduced	reproduce	VERB
fnp-3866	72	14	with	with	ADP
fnp-3866	72	15	permission	permission	NOUN
fnp-3866	72	16	from	from	ADP
fnp-3866	72	17	mao	mao	PROPN
fnp-3866	72	18	et	et	PROPN
fnp-3866	72	19	al	al	PROPN
fnp-3866	72	20	.	.	PUNCT
fnp-3866	73	1	(	(	PUNCT
fnp-3866	73	2	mao	mao	NOUN
fnp-3866	73	3	et	et	PROPN
fnp-3866	73	4	al	al	PROPN
fnp-3866	73	5	.	.	PROPN
fnp-3866	73	6	,	,	PUNCT
fnp-3866	73	7	2021	2021	NUM
fnp-3866	73	8	)	)	PUNCT
fnp-3866	73	9	.	.	PUNCT
fnp-3866	74	1	5	5	X
fnp-3866	74	2	.	.	X
fnp-3866	74	3	defining	define	VERB
fnp-3866	74	4	molecular	molecular	ADJ
fnp-3866	74	5	subtypes	subtype	NOUN
fnp-3866	74	6	for	for	ADP
fnp-3866	74	7	alzheimer	alzheimer	PROPN
fnp-3866	74	8	’s	’s	PART
fnp-3866	74	9	disease	disease	NOUN
fnp-3866	74	10	according	accord	VERB
fnp-3866	74	11	to	to	ADP
fnp-3866	74	12	a	a	DET
fnp-3866	74	13	widely	widely	ADV
fnp-3866	74	14	held	hold	VERB
fnp-3866	74	15	dogma	dogma	NOUN
fnp-3866	74	16	,	,	PUNCT
fnp-3866	74	17	alzheimer	alzheimer	PROPN
fnp-3866	74	18	’s	’s	PART
fnp-3866	74	19	disease	disease	NOUN
fnp-3866	74	20	arises	arise	VERB
fnp-3866	74	21	secondarily	secondarily	ADV
fnp-3866	74	22	from	from	ADP
fnp-3866	74	23	amyloid	amyloid	NOUN
fnp-3866	74	24	-	-	PUNCT
fnp-3866	74	25	beta	beta	NOUN
fnp-3866	74	26	toxicity	toxicity	NOUN
fnp-3866	74	27	that	that	PRON
fnp-3866	74	28	in	in	ADP
fnp-3866	74	29	turn	turn	NOUN
fnp-3866	74	30	leads	lead	VERB
fnp-3866	74	31	to	to	ADP
fnp-3866	74	32	neurofibrillary	neurofibrillary	ADJ
fnp-3866	74	33	degeneration	degeneration	NOUN
fnp-3866	74	34	and	and	CCONJ
fnp-3866	74	35	cell	cell	NOUN
fnp-3866	74	36	death	death	NOUN
fnp-3866	74	37	.	.	PUNCT
fnp-3866	75	1	however	however	ADV
fnp-3866	75	2	,	,	PUNCT
fnp-3866	75	3	there	there	PRON
fnp-3866	75	4	is	be	VERB
fnp-3866	75	5	increasing	increase	VERB
fnp-3866	75	6	evidence	evidence	NOUN
fnp-3866	75	7	that	that	SCONJ
fnp-3866	75	8	ad	ad	NOUN
fnp-3866	75	9	is	be	AUX
fnp-3866	75	10	more	more	ADV
fnp-3866	75	11	heterogeneous	heterogeneous	ADJ
fnp-3866	75	12	than	than	SCONJ
fnp-3866	75	13	recognized	recognize	VERB
fnp-3866	75	14	,	,	PUNCT
fnp-3866	75	15	manifesting	manifest	VERB
fnp-3866	75	16	not	not	PART
fnp-3866	75	17	only	only	ADV
fnp-3866	75	18	in	in	ADP
fnp-3866	75	19	the	the	DET
fnp-3866	75	20	ad	ad	NOUN
fnp-3866	75	21	mimics	mimic	VERB
fnp-3866	75	22	such	such	ADJ
fnp-3866	75	23	as	as	ADP
fnp-3866	75	24	limbic	limbic	ADJ
fnp-3866	75	25	age	age	NOUN
fnp-3866	75	26	-	-	PUNCT
fnp-3866	75	27	related	relate	VERB
fnp-3866	75	28	tdp-43	tdp-43	NOUN
fnp-3866	75	29	encephalopathy	encephalopathy	ADJ
fnp-3866	75	30	and	and	CCONJ
fnp-3866	75	31	comorbid	comorbid	NOUN
fnp-3866	75	32	dementias	dementia	NOUN
fnp-3866	75	33	such	such	ADJ
fnp-3866	75	34	as	as	ADP
fnp-3866	75	35	lewy	lewy	PROPN
fnp-3866	75	36	body	body	NOUN
fnp-3866	75	37	disease	disease	NOUN
fnp-3866	75	38	and	and	CCONJ
fnp-3866	75	39	cerebrovascular	cerebrovascular	ADJ
fnp-3866	75	40	disease	disease	NOUN
fnp-3866	75	41	)	)	PUNCT
fnp-3866	75	42	but	but	CCONJ
fnp-3866	75	43	also	also	ADV
fnp-3866	75	44	within	within	ADP
fnp-3866	75	45	the	the	DET
fnp-3866	75	46	group	group	NOUN
fnp-3866	75	47	of	of	ADP
fnp-3866	75	48	subjects	subject	NOUN
fnp-3866	75	49	that	that	PRON
fnp-3866	75	50	meet	meet	VERB
fnp-3866	75	51	the	the	DET
fnp-3866	75	52	neuropathological	neuropathological	ADJ
fnp-3866	75	53	criteria	criterion	NOUN
fnp-3866	75	54	for	for	ADP
fnp-3866	75	55	ad	ad	NOUN
fnp-3866	75	56	.	.	PUNCT
fnp-3866	76	1	neuropathological	neuropathological	ADJ
fnp-3866	76	2	subtypes	subtype	NOUN
fnp-3866	76	3	of	of	ADP
fnp-3866	76	4	ad	ad	NOUN
fnp-3866	76	5	have	have	AUX
fnp-3866	76	6	been	be	AUX
fnp-3866	76	7	proposed	propose	VERB
fnp-3866	76	8	(	(	PUNCT
fnp-3866	76	9	janocko	janocko	PROPN
fnp-3866	76	10	et	et	PROPN
fnp-3866	76	11	al	al	PROPN
fnp-3866	76	12	.	.	PROPN
fnp-3866	76	13	,	,	PUNCT
fnp-3866	76	14	2012	2012	NUM
fnp-3866	76	15	;	;	PUNCT
fnp-3866	76	16	murray	murray	PROPN
fnp-3866	76	17	et	et	PROPN
fnp-3866	76	18	al	al	PROPN
fnp-3866	76	19	.	.	PROPN
fnp-3866	76	20	,	,	PUNCT
fnp-3866	76	21	2011	2011	NUM
fnp-3866	76	22	)	)	PUNCT
fnp-3866	76	23	and	and	CCONJ
fnp-3866	76	24	gene	gene	NOUN
fnp-3866	76	25	expression	expression	NOUN
fnp-3866	76	26	studies	study	NOUN
fnp-3866	76	27	in	in	ADP
fnp-3866	76	28	ad	ad	NOUN
fnp-3866	76	29	have	have	AUX
fnp-3866	76	30	been	be	AUX
fnp-3866	76	31	previously	previously	ADV
fnp-3866	76	32	performed	perform	VERB
fnp-3866	76	33	,	,	PUNCT
fnp-3866	76	34	but	but	CCONJ
fnp-3866	76	35	defining	define	VERB
fnp-3866	76	36	a	a	DET
fnp-3866	76	37	molecularly	molecularly	ADV
fnp-3866	76	38	defined	define	VERB
fnp-3866	76	39	subtype	subtype	NOUN
fnp-3866	76	40	has	have	AUX
fnp-3866	76	41	never	never	ADV
fnp-3866	76	42	been	be	AUX
fnp-3866	76	43	attempted	attempt	VERB
fnp-3866	76	44	.	.	PUNCT
fnp-3866	77	1	armed	arm	VERB
fnp-3866	77	2	with	with	ADP
fnp-3866	77	3	a	a	DET
fnp-3866	77	4	large	large	ADJ
fnp-3866	77	5	rna	rna	NOUN
fnp-3866	77	6	-	-	PUNCT
fnp-3866	77	7	seq	seq	NOUN
fnp-3866	77	8	dataset	dataset	NOUN
fnp-3866	77	9	of	of	ADP
fnp-3866	77	10	over	over	ADP
fnp-3866	77	11	1543	1543	NUM
fnp-3866	77	12	transcriptomes	transcriptome	NOUN
fnp-3866	77	13	derived	derive	VERB
fnp-3866	77	14	from	from	ADP
fnp-3866	77	15	four	four	NUM
fnp-3866	77	16	brain	brain	NOUN
fnp-3866	77	17	regions	region	NOUN
fnp-3866	77	18	from	from	ADP
fnp-3866	77	19	two	two	NUM
fnp-3866	77	20	independent	independent	ADJ
fnp-3866	77	21	brain	brain	NOUN
fnp-3866	77	22	bank	bank	PROPN
fnp-3866	77	23	series	series	NOUN
fnp-3866	77	24	,	,	PUNCT
fnp-3866	77	25	neff	neff	PROPN
fnp-3866	77	26	et	et	PROPN
fnp-3866	77	27	al	al	PROPN
fnp-3866	77	28	.	.	PROPN
fnp-3866	77	29	set	set	VERB
fnp-3866	77	30	out	out	ADP
fnp-3866	77	31	to	to	PART
fnp-3866	77	32	define	define	VERB
fnp-3866	77	33	molecular	molecular	ADJ
fnp-3866	77	34	subtypes	subtype	NOUN
fnp-3866	77	35	of	of	ADP
fnp-3866	77	36	ad	ad	NOUN
fnp-3866	77	37	(	(	PUNCT
fnp-3866	77	38	neff	neff	PROPN
fnp-3866	77	39	et	et	PROPN
fnp-3866	77	40	al	al	PROPN
fnp-3866	77	41	.	.	PROPN
fnp-3866	77	42	,	,	PUNCT
fnp-3866	77	43	2021	2021	NUM
fnp-3866	77	44	)	)	PUNCT
fnp-3866	77	45	.	.	PUNCT
fnp-3866	78	1	to	to	PART
fnp-3866	78	2	accomplish	accomplish	VERB
fnp-3866	78	3	this	this	PRON
fnp-3866	78	4	,	,	PUNCT
fnp-3866	78	5	they	they	PRON
fnp-3866	78	6	leveraged	leverage	VERB
fnp-3866	78	7	a	a	DET
fnp-3866	78	8	novel	novel	ADJ
fnp-3866	78	9	clustering	clustering	NOUN
fnp-3866	78	10	method	method	NOUN
fnp-3866	78	11	which	which	PRON
fnp-3866	78	12	uncovered	uncover	VERB
fnp-3866	78	13	five	five	NUM
fnp-3866	78	14	stable	stable	ADJ
fnp-3866	78	15	subtypes	subtype	NOUN
fnp-3866	78	16	in	in	ADP
fnp-3866	78	17	three	three	NUM
fnp-3866	78	18	classes	class	NOUN
fnp-3866	78	19	:	:	PUNCT
fnp-3866	78	20	a	a	PRON
fnp-3866	78	21	,	,	PUNCT
fnp-3866	78	22	b1/2	b1/2	ADJ
fnp-3866	78	23	and	and	CCONJ
fnp-3866	78	24	c1/2	c1/2	NOUN
fnp-3866	78	25	(	(	PUNCT
fnp-3866	78	26	figure	figure	NOUN
fnp-3866	78	27	4	4	NUM
fnp-3866	78	28	)	)	PUNCT
fnp-3866	78	29	.	.	PUNCT
fnp-3866	79	1	one	one	NUM
fnp-3866	79	2	of	of	ADP
fnp-3866	79	3	these	these	DET
fnp-3866	79	4	subtypes	subtype	NOUN
fnp-3866	79	5	termed	term	VERB
fnp-3866	79	6	class	class	NOUN
fnp-3866	79	7	c	c	NOUN
fnp-3866	79	8	(	(	PUNCT
fnp-3866	79	9	“	"	PUNCT
fnp-3866	79	10	typical	typical	ADJ
fnp-3866	79	11	"	"	PUNCT
fnp-3866	79	12	)	)	PUNCT
fnp-3866	79	13	which	which	PRON
fnp-3866	79	14	represented	represent	VERB
fnp-3866	79	15	about	about	ADV
fnp-3866	79	16	one	one	NUM
fnp-3866	79	17	third	third	NOUN
fnp-3866	79	18	of	of	ADP
fnp-3866	79	19	all	all	DET
fnp-3866	79	20	cases	case	NOUN
fnp-3866	79	21	,	,	PUNCT
fnp-3866	79	22	displayed	display	VERB
fnp-3866	79	23	expression	expression	NOUN
fnp-3866	79	24	changes	change	NOUN
fnp-3866	79	25	similar	similar	ADJ
fnp-3866	79	26	to	to	ADP
fnp-3866	79	27	those	those	PRON
fnp-3866	79	28	previously	previously	ADV
fnp-3866	79	29	reported	report	VERB
fnp-3866	79	30	in	in	ADP
fnp-3866	79	31	alzheimer	alzheimer	PROPN
fnp-3866	79	32	’s	’s	PART
fnp-3866	79	33	disease	disease	NOUN
fnp-3866	79	34	(	(	PUNCT
fnp-3866	79	35	blalock	blalock	NOUN
fnp-3866	79	36	et	et	PROPN
fnp-3866	79	37	al	al	PROPN
fnp-3866	79	38	.	.	PROPN
fnp-3866	79	39	,	,	PUNCT
fnp-3866	79	40	2011	2011	NUM
fnp-3866	79	41	)	)	PUNCT
fnp-3866	79	42	with	with	ADP
fnp-3866	79	43	increased	increase	VERB
fnp-3866	79	44	immune	immune	ADJ
fnp-3866	79	45	response	response	NOUN
fnp-3866	79	46	and	and	CCONJ
fnp-3866	79	47	decreased	decrease	VERB
fnp-3866	79	48	synaptic	synaptic	ADJ
fnp-3866	79	49	signaling	signaling	NOUN
fnp-3866	79	50	.	.	PUNCT
fnp-3866	80	1	the	the	DET
fnp-3866	80	2	class	class	NOUN
fnp-3866	80	3	c	c	NOUN
fnp-3866	80	4	cases	case	NOUN
fnp-3866	80	5	also	also	ADV
fnp-3866	80	6	showed	show	VERB
fnp-3866	80	7	strong	strong	ADJ
fnp-3866	80	8	up	up	NOUN
fnp-3866	80	9	-	-	PUNCT
fnp-3866	80	10	regulation	regulation	NOUN
fnp-3866	80	11	of	of	ADP
fnp-3866	80	12	pathways	pathway	NOUN
fnp-3866	80	13	involving	involve	VERB
fnp-3866	80	14	amyloid	amyloid	NOUN
fnp-3866	80	15	-	-	PUNCT
fnp-3866	80	16	beta	beta	NOUN
fnp-3866	80	17	clearance	clearance	NOUN
fnp-3866	80	18	,	,	PUNCT
fnp-3866	80	19	fiber	fiber	NOUN
fnp-3866	80	20	formation	formation	NOUN
fnp-3866	80	21	and	and	CCONJ
fnp-3866	80	22	scavenger	scavenger	NOUN
fnp-3866	80	23	receptor	receptor	NOUN
fnp-3866	80	24	activity	activity	NOUN
fnp-3866	80	25	.	.	PUNCT
fnp-3866	81	1	in	in	ADP
fnp-3866	81	2	contrast	contrast	NOUN
fnp-3866	81	3	,	,	PUNCT
fnp-3866	81	4	expression	expression	NOUN
fnp-3866	81	5	changes	change	NOUN
fnp-3866	81	6	in	in	ADP
fnp-3866	81	7	class	class	NOUN
fnp-3866	81	8	a	a	PRON
fnp-3866	81	9	(	(	PUNCT
fnp-3866	81	10	“	"	PUNCT
fnp-3866	81	11	atypical	atypical	ADJ
fnp-3866	81	12	"	"	PUNCT
fnp-3866	81	13	)	)	PUNCT
fnp-3866	81	14	were	be	AUX
fnp-3866	81	15	generally	generally	ADV
fnp-3866	81	16	opposite	opposite	ADJ
fnp-3866	81	17	to	to	ADP
fnp-3866	81	18	class	class	NOUN
fnp-3866	81	19	c	c	PROPN
fnp-3866	81	20	(	(	PUNCT
fnp-3866	81	21	blalock	blalock	NOUN
fnp-3866	81	22	)	)	PUNCT
fnp-3866	81	23	changes	change	NOUN
fnp-3866	81	24	.	.	PUNCT
fnp-3866	82	1	class	class	NOUN
fnp-3866	82	2	b	b	PROPN
fnp-3866	82	3	(	(	PUNCT
fnp-3866	82	4	“	"	PUNCT
fnp-3866	82	5	intermediate	intermediate	ADJ
fnp-3866	82	6	"	"	PUNCT
fnp-3866	82	7	)	)	PUNCT
fnp-3866	82	8	did	do	AUX
fnp-3866	82	9	not	not	PART
fnp-3866	82	10	show	show	VERB
fnp-3866	82	11	changes	change	NOUN
fnp-3866	82	12	in	in	ADP
fnp-3866	82	13	either	either	DET
fnp-3866	82	14	direction	direction	NOUN
fnp-3866	82	15	.	.	PUNCT
fnp-3866	83	1	tau	tau	NOUN
fnp-3866	83	2	-	-	PUNCT
fnp-3866	83	3	related	relate	VERB
fnp-3866	83	4	pathways	pathway	NOUN
fnp-3866	83	5	were	be	AUX
fnp-3866	83	6	strongly	strongly	ADV
fnp-3866	83	7	upregulated	upregulate	VERB
fnp-3866	83	8	in	in	ADP
fnp-3866	83	9	both	both	CCONJ
fnp-3866	83	10	a	a	DET
fnp-3866	83	11	and	and	CCONJ
fnp-3866	83	12	b1/2	b1/2	ADJ
fnp-3866	83	13	subtypes	subtype	NOUN
fnp-3866	83	14	.	.	PUNCT
fnp-3866	84	1	certain	certain	ADJ
fnp-3866	84	2	pathway	pathway	NOUN
fnp-3866	84	3	changes	change	NOUN
fnp-3866	84	4	were	be	AUX
fnp-3866	84	5	subtype	subtype	NOUN
fnp-3866	84	6	-	-	PUNCT
fnp-3866	84	7	specific	specific	ADJ
fnp-3866	84	8	illustrated	illustrate	VERB
fnp-3866	84	9	by	by	ADP
fnp-3866	84	10	the	the	DET
fnp-3866	84	11	up	up	NOUN
fnp-3866	84	12	-	-	PUNCT
fnp-3866	84	13	regulation	regulation	NOUN
fnp-3866	84	14	of	of	ADP
fnp-3866	84	15	protein	protein	NOUN
fnp-3866	84	16	degradation	degradation	NOUN
fnp-3866	84	17	-	-	PUNCT
fnp-3866	84	18	related	relate	VERB
fnp-3866	84	19	genes	gene	NOUN
fnp-3866	84	20	(	(	PUNCT
fnp-3866	84	21	e.g.	e.g.	ADV
fnp-3866	84	22	,	,	PUNCT
fnp-3866	84	23	ubiquitination	ubiquitination	NOUN
fnp-3866	84	24	)	)	PUNCT
fnp-3866	84	25	in	in	ADP
fnp-3866	84	26	class	class	NOUN
fnp-3866	84	27	a	a	PRON
fnp-3866	84	28	or	or	CCONJ
fnp-3866	84	29	the	the	DET
fnp-3866	84	30	up	up	ADJ
fnp-3866	84	31	-	-	PUNCT
fnp-3866	84	32	regulation	regulation	NOUN
fnp-3866	84	33	of	of	ADP
fnp-3866	84	34	organic	organic	ADJ
fnp-3866	84	35	acid	acid	NOUN
fnp-3866	84	36	-	-	PUNCT
fnp-3866	84	37	related	relate	VERB
fnp-3866	84	38	genes	gene	NOUN
fnp-3866	84	39	in	in	ADP
fnp-3866	84	40	class	class	PROPN
fnp-3866	84	41	b.	b.	PROPN
fnp-3866	84	42	of	of	ADP
fnp-3866	84	43	note	note	NOUN
fnp-3866	84	44	,	,	PUNCT
fnp-3866	84	45	the	the	DET
fnp-3866	84	46	different	different	ADJ
fnp-3866	84	47	classes	class	NOUN
fnp-3866	84	48	were	be	AUX
fnp-3866	84	49	associated	associate	VERB
fnp-3866	84	50	with	with	ADP
fnp-3866	84	51	distinct	distinct	ADJ
fnp-3866	84	52	clinical	clinical	ADJ
fnp-3866	84	53	and	and	CCONJ
fnp-3866	84	54	neuropathological	neuropathological	ADJ
fnp-3866	84	55	phenotypes	phenotype	NOUN
fnp-3866	84	56	.	.	PUNCT
fnp-3866	85	1	class	class	NOUN
fnp-3866	85	2	c1	c1	PROPN
fnp-3866	85	3	for	for	ADP
fnp-3866	85	4	instance	instance	NOUN
fnp-3866	85	5	showed	show	VERB
fnp-3866	85	6	a	a	DET
fnp-3866	85	7	more	more	ADV
fnp-3866	85	8	frequent	frequent	ADJ
fnp-3866	85	9	association	association	NOUN
fnp-3866	85	10	with	with	ADP
fnp-3866	85	11	increased	increase	VERB
fnp-3866	85	12	amyloid	amyloid	NOUN
fnp-3866	85	13	plaque	plaque	NOUN
fnp-3866	85	14	burden	burden	NOUN
fnp-3866	85	15	than	than	ADP
fnp-3866	85	16	the	the	DET
fnp-3866	85	17	tau	tau	NOUN
fnp-3866	85	18	-	-	PUNCT
fnp-3866	85	19	related	relate	VERB
fnp-3866	85	20	class	class	NOUN
fnp-3866	85	21	a	a	NOUN
fnp-3866	85	22	and	and	CCONJ
fnp-3866	85	23	also	also	ADV
fnp-3866	85	24	had	have	VERB
fnp-3866	85	25	an	an	DET
fnp-3866	85	26	increased	increase	VERB
fnp-3866	85	27	apoe	apoe	NOUN
fnp-3866	85	28	ε4	ε4	NOUN
fnp-3866	85	29	allele	allele	NOUN
fnp-3866	85	30	frequency	frequency	NOUN
fnp-3866	85	31	whereas	whereas	SCONJ
fnp-3866	85	32	class	class	NOUN
fnp-3866	85	33	a	a	PRON
fnp-3866	85	34	displayed	display	VERB
fnp-3866	85	35	increased	increase	VERB
fnp-3866	85	36	mapt	mapt	NOUN
fnp-3866	85	37	pathway	pathway	NOUN
fnp-3866	85	38	activation	activation	NOUN
fnp-3866	85	39	and	and	CCONJ
fnp-3866	85	40	decreased	decrease	VERB
fnp-3866	85	41	nft	nft	PROPN
fnp-3866	85	42	association	association	PROPN
fnp-3866	85	43	,	,	PUNCT
fnp-3866	85	44	thus	thus	ADV
fnp-3866	85	45	potentially	potentially	ADV
fnp-3866	85	46	representing	represent	VERB
fnp-3866	85	47	a	a	DET
fnp-3866	85	48	resilient	resilient	ADJ
fnp-3866	85	49	subtype	subtype	NOUN
fnp-3866	85	50	.	.	PUNCT
fnp-3866	86	1	many	many	ADJ
fnp-3866	86	2	questions	question	NOUN
fnp-3866	86	3	remain	remain	VERB
fnp-3866	86	4	,	,	PUNCT
fnp-3866	86	5	especially	especially	ADV
fnp-3866	86	6	how	how	SCONJ
fnp-3866	86	7	these	these	DET
fnp-3866	86	8	subtypes	subtype	NOUN
fnp-3866	86	9	align	align	VERB
fnp-3866	86	10	with	with	ADP
fnp-3866	86	11	previously	previously	ADV
fnp-3866	86	12	proposed	propose	VERB
fnp-3866	86	13	ad	ad	NOUN
fnp-3866	86	14	subtypes	subtype	NOUN
fnp-3866	86	15	.	.	PUNCT
fnp-3866	87	1	nevertheless	nevertheless	ADV
fnp-3866	87	2	,	,	PUNCT
fnp-3866	87	3	this	this	DET
fnp-3866	87	4	study	study	NOUN
fnp-3866	87	5	provides	provide	VERB
fnp-3866	87	6	evidence	evidence	NOUN
fnp-3866	87	7	that	that	SCONJ
fnp-3866	87	8	ad	ad	NOUN
fnp-3866	87	9	is	be	AUX
fnp-3866	87	10	likely	likely	ADJ
fnp-3866	87	11	not	not	PART
fnp-3866	87	12	a	a	DET
fnp-3866	87	13	single	single	ADJ
fnp-3866	87	14	entity	entity	NOUN
fnp-3866	87	15	and	and	CCONJ
fnp-3866	87	16	paves	pave	VERB
fnp-3866	87	17	the	the	DET
fnp-3866	87	18	way	way	NOUN
fnp-3866	87	19	towards	towards	ADP
fnp-3866	87	20	additional	additional	ADJ
fnp-3866	87	21	studies	study	NOUN
fnp-3866	87	22	addressing	address	VERB
fnp-3866	87	23	this	this	DET
fnp-3866	87	24	critical	critical	ADJ
fnp-3866	87	25	barrier	barrier	NOUN
fnp-3866	87	26	.	.	PUNCT
fnp-3866	88	1	figure	figure	VERB
fnp-3866	88	2	4	4	NUM
fnp-3866	88	3	.	.	PUNCT
fnp-3866	89	1	molecular	molecular	ADJ
fnp-3866	89	2	subtypes	subtype	NOUN
fnp-3866	89	3	of	of	ADP
fnp-3866	89	4	alzheimer	alzheimer	PROPN
fnp-3866	89	5	’s	’s	PART
fnp-3866	89	6	disease	disease	NOUN
fnp-3866	89	7	defined	define	VERB
fnp-3866	89	8	by	by	ADP
fnp-3866	89	9	gene	gene	NOUN
fnp-3866	89	10	expression	expression	NOUN
fnp-3866	89	11	changes	change	NOUN
fnp-3866	89	12	.	.	PUNCT
fnp-3866	90	1	changes	change	NOUN
fnp-3866	90	2	in	in	ADP
fnp-3866	90	3	the	the	DET
fnp-3866	90	4	mean	mean	ADJ
fnp-3866	90	5	expression	expression	NOUN
fnp-3866	90	6	of	of	ADP
fnp-3866	90	7	gene	gene	NOUN
fnp-3866	90	8	pathways	pathway	NOUN
fnp-3866	90	9	are	be	AUX
fnp-3866	90	10	indicated	indicate	VERB
fnp-3866	90	11	for	for	ADP
fnp-3866	90	12	ad	ad	NOUN
fnp-3866	90	13	subtypes	subtype	NOUN
fnp-3866	90	14	a	a	PRON
fnp-3866	90	15	,	,	PUNCT
fnp-3866	90	16	b1	b1	NOUN
fnp-3866	90	17	,	,	PUNCT
fnp-3866	90	18	b2	b2	NOUN
fnp-3866	90	19	,	,	PUNCT
fnp-3866	90	20	c1	c1	PROPN
fnp-3866	90	21	and	and	CCONJ
fnp-3866	90	22	c2	c2	PROPN
fnp-3866	90	23	in	in	ADP
fnp-3866	90	24	comparison	comparison	NOUN
fnp-3866	90	25	to	to	ADP
fnp-3866	90	26	normal	normal	ADJ
fnp-3866	90	27	control	control	NOUN
fnp-3866	90	28	samples	sample	NOUN
fnp-3866	90	29	.	.	PUNCT
fnp-3866	91	1	data	datum	NOUN
fnp-3866	91	2	from	from	ADP
fnp-3866	91	3	a	a	DET
fnp-3866	91	4	previous	previous	ADJ
fnp-3866	91	5	study	study	NOUN
fnp-3866	91	6	msigdb	msigdb	NOUN
fnp-3866	91	7	are	be	AUX
fnp-3866	91	8	indicated	indicate	VERB
fnp-3866	91	9	on	on	ADP
fnp-3866	91	10	the	the	DET
fnp-3866	91	11	right	right	NOUN
fnp-3866	91	12	.	.	PUNCT
fnp-3866	92	1	changes	change	NOUN
fnp-3866	92	2	in	in	ADP
fnp-3866	92	3	gene	gene	NOUN
fnp-3866	92	4	expression	expression	NOUN
fnp-3866	92	5	are	be	AUX
fnp-3866	92	6	grouped	group	VERB
fnp-3866	92	7	by	by	ADP
fnp-3866	92	8	major	major	ADJ
fnp-3866	92	9	areas	area	NOUN
fnp-3866	92	10	of	of	ADP
fnp-3866	92	11	biological	biological	ADJ
fnp-3866	92	12	activity	activity	NOUN
fnp-3866	92	13	.	.	PUNCT
fnp-3866	93	1	reproduced	reproduce	VERB
fnp-3866	93	2	with	with	ADP
fnp-3866	93	3	permission	permission	NOUN
fnp-3866	93	4	from	from	ADP
fnp-3866	93	5	neff	neff	PROPN
fnp-3866	93	6	et	et	PROPN
fnp-3866	93	7	al	al	PROPN
fnp-3866	93	8	.	.	PUNCT
fnp-3866	94	1	(	(	PUNCT
fnp-3866	94	2	neff	neff	PROPN
fnp-3866	94	3	et	et	PROPN
fnp-3866	94	4	al	al	PROPN
fnp-3866	94	5	.	.	PROPN
fnp-3866	94	6	,	,	PUNCT
fnp-3866	94	7	2021	2021	NUM
fnp-3866	94	8	)	)	PUNCT
fnp-3866	94	9	.	.	PUNCT
fnp-3866	95	1	6	6	X
fnp-3866	95	2	.	.	X
fnp-3866	95	3	cerebrovascular	cerebrovascular	ADJ
fnp-3866	95	4	disease	disease	NOUN
fnp-3866	95	5	:	:	PUNCT
fnp-3866	95	6	vegf	vegf	PROPN
fnp-3866	95	7	gene	gene	PROPN
fnp-3866	95	8	family	family	NOUN
fnp-3866	95	9	expression	expression	NOUN
fnp-3866	95	10	in	in	ADP
fnp-3866	95	11	cognitive	cognitive	ADJ
fnp-3866	95	12	aging	aging	NOUN
fnp-3866	95	13	and	and	CCONJ
fnp-3866	95	14	alzheimer	alzheimer	PROPN
fnp-3866	95	15	’s	’s	PART
fnp-3866	95	16	neuropathology	neuropathology	NOUN
fnp-3866	95	17	vascular	vascular	ADJ
fnp-3866	95	18	endothelial	endothelial	ADJ
fnp-3866	95	19	growth	growth	NOUN
fnp-3866	95	20	factor	factor	NOUN
fnp-3866	95	21	(	(	PUNCT
fnp-3866	95	22	vegf	vegf	PROPN
fnp-3866	95	23	)	)	PUNCT
fnp-3866	95	24	is	be	AUX
fnp-3866	95	25	an	an	DET
fnp-3866	95	26	angiogenic	angiogenic	ADJ
fnp-3866	95	27	factor	factor	NOUN
fnp-3866	95	28	induced	induce	VERB
fnp-3866	95	29	by	by	ADP
fnp-3866	95	30	hypoxia	hypoxia	NOUN
fnp-3866	95	31	that	that	PRON
fnp-3866	95	32	plays	play	VERB
fnp-3866	95	33	an	an	DET
fnp-3866	95	34	important	important	ADJ
fnp-3866	95	35	role	role	NOUN
fnp-3866	95	36	in	in	ADP
fnp-3866	95	37	angiogenesis	angiogenesis	NOUN
fnp-3866	95	38	.	.	PUNCT
fnp-3866	96	1	the	the	DET
fnp-3866	96	2	vegf	vegf	PROPN
fnp-3866	96	3	gene	gene	PROPN
fnp-3866	96	4	family	family	PROPN
fnp-3866	96	5	has	have	VERB
fnp-3866	96	6	several	several	ADJ
fnp-3866	96	7	members	member	NOUN
fnp-3866	96	8	which	which	PRON
fnp-3866	96	9	interact	interact	VERB
fnp-3866	96	10	with	with	ADP
fnp-3866	96	11	a	a	DET
fnp-3866	96	12	complex	complex	ADJ
fnp-3866	96	13	set	set	NOUN
fnp-3866	96	14	of	of	ADP
fnp-3866	96	15	receptors	receptor	NOUN
fnp-3866	96	16	and	and	CCONJ
fnp-3866	96	17	co	co	NOUN
fnp-3866	96	18	-	-	NOUN
fnp-3866	96	19	receptors	receptor	NOUN
fnp-3866	96	20	which	which	DET
fnp-3866	96	21	trigger	trigger	NOUN
fnp-3866	96	22	(	(	PUNCT
fnp-3866	96	23	figure	figure	NOUN
fnp-3866	96	24	5	5	NUM
fnp-3866	96	25	)	)	PUNCT
fnp-3866	96	26	various	various	ADJ
fnp-3866	96	27	signaling	signal	VERB
fnp-3866	96	28	pathways	pathway	NOUN
fnp-3866	96	29	highly	highly	ADV
fnp-3866	96	30	relevant	relevant	ADJ
fnp-3866	96	31	to	to	ADP
fnp-3866	96	32	neurodegeneration	neurodegeneration	NOUN
fnp-3866	96	33	such	such	ADJ
fnp-3866	96	34	as	as	ADP
fnp-3866	96	35	neurogenesis	neurogenesis	NOUN
fnp-3866	96	36	,	,	PUNCT
fnp-3866	96	37	neuroprotection	neuroprotection	NOUN
fnp-3866	96	38	,	,	PUNCT
fnp-3866	96	39	apoptosis	apoptosis	NOUN
fnp-3866	96	40	,	,	PUNCT
fnp-3866	96	41	cell	cell	NOUN
fnp-3866	96	42	proliferation	proliferation	NOUN
fnp-3866	96	43	,	,	PUNCT
fnp-3866	96	44	and	and	CCONJ
fnp-3866	96	45	inflammation	inflammation	NOUN
fnp-3866	96	46	.	.	PUNCT
fnp-3866	97	1	likewise	likewise	ADV
fnp-3866	97	2	,	,	PUNCT
fnp-3866	97	3	previous	previous	ADJ
fnp-3866	97	4	studies	study	NOUN
fnp-3866	97	5	have	have	AUX
fnp-3866	97	6	linked	link	VERB
fnp-3866	97	7	vegf	vegf	PROPN
fnp-3866	97	8	signalling	signal	VERB
fnp-3866	97	9	to	to	ADP
fnp-3866	97	10	various	various	ADJ
fnp-3866	97	11	neurodegenerative	neurodegenerative	ADJ
fnp-3866	97	12	and	and	CCONJ
fnp-3866	97	13	cerebrovascular	cerebrovascular	ADJ
fnp-3866	97	14	diseases	disease	NOUN
fnp-3866	97	15	.	.	PUNCT
fnp-3866	98	1	figure	figure	NOUN
fnp-3866	98	2	5	5	NUM
fnp-3866	98	3	.	.	PUNCT
fnp-3866	98	4	illustration	illustration	NOUN
fnp-3866	98	5	of	of	ADP
fnp-3866	98	6	the	the	DET
fnp-3866	98	7	vegf	vegf	PROPN
fnp-3866	98	8	family	family	PROPN
fnp-3866	98	9	of	of	ADP
fnp-3866	98	10	growth	growth	NOUN
fnp-3866	98	11	factors	factor	NOUN
fnp-3866	98	12	and	and	CCONJ
fnp-3866	98	13	their	their	PRON
fnp-3866	98	14	receptors	receptor	NOUN
fnp-3866	98	15	.	.	PUNCT
fnp-3866	99	1	asterisks	asterisk	NOUN
fnp-3866	99	2	indicate	indicate	VERB
fnp-3866	99	3	genes	gene	NOUN
fnp-3866	99	4	that	that	PRON
fnp-3866	99	5	are	be	AUX
fnp-3866	99	6	differentially	differentially	ADV
fnp-3866	99	7	expressed	express	VERB
fnp-3866	99	8	between	between	ADP
fnp-3866	99	9	ad	ad	NOUN
fnp-3866	99	10	and	and	CCONJ
fnp-3866	99	11	controls	control	NOUN
fnp-3866	99	12	.	.	PUNCT
fnp-3866	100	1	reproduced	reproduce	VERB
fnp-3866	100	2	with	with	ADP
fnp-3866	100	3	permission	permission	NOUN
fnp-3866	100	4	from	from	ADP
fnp-3866	100	5	mahoney	mahoney	PROPN
fnp-3866	100	6	et	et	PROPN
fnp-3866	100	7	al	al	PROPN
fnp-3866	100	8	.	.	PUNCT
fnp-3866	101	1	(	(	PUNCT
fnp-3866	101	2	mahoney	mahoney	PROPN
fnp-3866	101	3	et	et	PROPN
fnp-3866	101	4	al	al	PROPN
fnp-3866	101	5	.	.	PROPN
fnp-3866	101	6	,	,	PUNCT
fnp-3866	101	7	2021	2021	NUM
fnp-3866	101	8	)	)	PUNCT
fnp-3866	101	9	.	.	PUNCT
fnp-3866	102	1	a	a	DET
fnp-3866	102	2	focused	focus	VERB
fnp-3866	102	3	study	study	NOUN
fnp-3866	102	4	published	publish	VERB
fnp-3866	102	5	in	in	ADP
fnp-3866	102	6	molecular	molecular	ADJ
fnp-3866	102	7	psychiatry	psychiatry	NOUN
fnp-3866	102	8	by	by	ADP
fnp-3866	102	9	mahoney	mahoney	PROPN
fnp-3866	102	10	et	et	PROPN
fnp-3866	102	11	al	al	PROPN
fnp-3866	102	12	.	.	PROPN
fnp-3866	102	13	found	find	VERB
fnp-3866	102	14	intriguing	intriguing	ADJ
fnp-3866	102	15	direct	direct	ADJ
fnp-3866	102	16	evidence	evidence	NOUN
fnp-3866	102	17	that	that	PRON
fnp-3866	102	18	changes	change	VERB
fnp-3866	102	19	in	in	ADP
fnp-3866	102	20	vegf	vegf	PROPN
fnp-3866	102	21	signaling	signal	VERB
fnp-3866	102	22	are	be	AUX
fnp-3866	102	23	closely	closely	ADV
fnp-3866	102	24	associated	associate	VERB
fnp-3866	102	25	with	with	ADP
fnp-3866	102	26	the	the	DET
fnp-3866	102	27	development	development	NOUN
fnp-3866	102	28	of	of	ADP
fnp-3866	102	29	ad	ad	NOUN
fnp-3866	102	30	neuropathology	neuropathology	NOUN
fnp-3866	102	31	and	and	CCONJ
fnp-3866	102	32	the	the	DET
fnp-3866	102	33	progression	progression	NOUN
fnp-3866	102	34	of	of	ADP
fnp-3866	102	35	cognitive	cognitive	ADJ
fnp-3866	102	36	impairment	impairment	NOUN
fnp-3866	102	37	(	(	PUNCT
fnp-3866	102	38	mahoney	mahoney	PROPN
fnp-3866	102	39	et	et	PROPN
fnp-3866	102	40	al	al	PROPN
fnp-3866	102	41	.	.	PROPN
fnp-3866	102	42	,	,	PUNCT
fnp-3866	102	43	2021	2021	NUM
fnp-3866	102	44	)	)	PUNCT
fnp-3866	102	45	.	.	PUNCT
fnp-3866	103	1	the	the	DET
fnp-3866	103	2	authors	author	NOUN
fnp-3866	103	3	leveraged	leverage	VERB
fnp-3866	103	4	the	the	DET
fnp-3866	103	5	religious	religious	ADJ
fnp-3866	103	6	orders	order	NOUN
fnp-3866	103	7	study	study	NOUN
fnp-3866	103	8	(	(	PUNCT
fnp-3866	103	9	ros	ros	PROPN
fnp-3866	103	10	)	)	PUNCT
fnp-3866	103	11	and	and	CCONJ
fnp-3866	103	12	the	the	DET
fnp-3866	103	13	rush	rush	NOUN
fnp-3866	103	14	memory	memory	NOUN
fnp-3866	103	15	and	and	CCONJ
fnp-3866	103	16	aging	age	VERB
fnp-3866	103	17	project	project	NOUN
fnp-3866	103	18	(	(	PUNCT
fnp-3866	103	19	map	map	NOUN
fnp-3866	103	20	)	)	PUNCT
fnp-3866	103	21	,	,	PUNCT
fnp-3866	103	22	using	use	VERB
fnp-3866	103	23	global	global	ADJ
fnp-3866	103	24	composited	composite	VERB
fnp-3866	103	25	cognitive	cognitive	ADJ
fnp-3866	103	26	scores	score	NOUN
fnp-3866	103	27	from	from	ADP
fnp-3866	103	28	17	17	NUM
fnp-3866	103	29	neuropsychological	neuropsychological	ADJ
fnp-3866	103	30	tests	test	NOUN
fnp-3866	103	31	and	and	CCONJ
fnp-3866	103	32	autopsy	autopsy	ADJ
fnp-3866	103	33	measurements	measurement	NOUN
fnp-3866	103	34	of	of	ADP
fnp-3866	103	35	amyloid	amyloid	NOUN
fnp-3866	103	36	plaque	plaque	NOUN
fnp-3866	103	37	and	and	CCONJ
fnp-3866	103	38	tau	tau	PROPN
fnp-3866	103	39	burden	burden	NOUN
fnp-3866	103	40	from	from	ADP
fnp-3866	103	41	a	a	DET
fnp-3866	103	42	total	total	NOUN
fnp-3866	103	43	of	of	ADP
fnp-3866	103	44	531	531	NUM
fnp-3866	103	45	subjects	subject	NOUN
fnp-3866	103	46	with	with	ADP
fnp-3866	103	47	normal	normal	ADJ
fnp-3866	103	48	cognition	cognition	NOUN
fnp-3866	103	49	,	,	PUNCT
fnp-3866	103	50	mild	mild	ADJ
fnp-3866	103	51	cognitive	cognitive	ADJ
fnp-3866	103	52	impairment	impairment	NOUN
fnp-3866	103	53	(	(	PUNCT
fnp-3866	103	54	mci	mci	NOUN
fnp-3866	103	55	)	)	PUNCT
fnp-3866	103	56	and	and	CCONJ
fnp-3866	103	57	ad	ad	NOUN
fnp-3866	103	58	-	-	PUNCT
fnp-3866	103	59	type	type	NOUN
fnp-3866	103	60	dementia	dementia	NOUN
fnp-3866	103	61	.	.	PUNCT
fnp-3866	104	1	the	the	DET
fnp-3866	104	2	authors	author	NOUN
fnp-3866	104	3	found	find	VERB
fnp-3866	104	4	that	that	SCONJ
fnp-3866	104	5	expression	expression	NOUN
fnp-3866	104	6	in	in	ADP
fnp-3866	104	7	the	the	DET
fnp-3866	104	8	frontal	frontal	ADJ
fnp-3866	104	9	cortex	cortex	NOUN
fnp-3866	104	10	of	of	ADP
fnp-3866	104	11	four	four	NUM
fnp-3866	104	12	key	key	ADJ
fnp-3866	104	13	components	component	NOUN
fnp-3866	104	14	of	of	ADP
fnp-3866	104	15	vegf	vegf	PROPN
fnp-3866	104	16	signaling	signaling	PROPN
fnp-3866	104	17	,	,	PUNCT
fnp-3866	104	18	vegfb	vegfb	NOUN
fnp-3866	104	19	,	,	PUNCT
fnp-3866	104	20	flt4	flt4	PROPN
fnp-3866	104	21	,	,	PUNCT
fnp-3866	104	22	flt1	flt1	NOUN
fnp-3866	104	23	and	and	CCONJ
fnp-3866	104	24	pgf	pgf	NOUN
fnp-3866	104	25	,	,	PUNCT
fnp-3866	104	26	were	be	AUX
fnp-3866	104	27	associated	associate	VERB
fnp-3866	104	28	with	with	ADP
fnp-3866	104	29	accelerated	accelerated	ADJ
fnp-3866	104	30	cognitive	cognitive	ADJ
fnp-3866	104	31	decline	decline	NOUN
fnp-3866	104	32	.	.	PUNCT
fnp-3866	105	1	all	all	DET
fnp-3866	105	2	four	four	NUM
fnp-3866	105	3	of	of	ADP
fnp-3866	105	4	these	these	DET
fnp-3866	105	5	genes	gene	NOUN
fnp-3866	105	6	were	be	AUX
fnp-3866	105	7	also	also	ADV
fnp-3866	105	8	associated	associate	VERB
fnp-3866	105	9	with	with	ADP
fnp-3866	105	10	increased	increase	VERB
fnp-3866	105	11	tau	tau	PROPN
fnp-3866	105	12	and	and	CCONJ
fnp-3866	105	13	amyloid	amyloid	NOUN
fnp-3866	105	14	burden	burden	NOUN
fnp-3866	105	15	.	.	PUNCT
fnp-3866	106	1	additional	additional	ADJ
fnp-3866	106	2	work	work	NOUN
fnp-3866	106	3	is	be	AUX
fnp-3866	106	4	required	require	VERB
fnp-3866	106	5	to	to	PART
fnp-3866	106	6	elucidate	elucidate	VERB
fnp-3866	106	7	exactly	exactly	ADV
fnp-3866	106	8	how	how	SCONJ
fnp-3866	106	9	vegf	vegf	PROPN
fnp-3866	106	10	signaling	signal	VERB
fnp-3866	106	11	relates	relate	VERB
fnp-3866	106	12	to	to	ADP
fnp-3866	106	13	ad	ad	NOUN
fnp-3866	106	14	neuropathology	neuropathology	NOUN
fnp-3866	106	15	and	and	CCONJ
fnp-3866	106	16	cerebrovascular	cerebrovascular	ADJ
fnp-3866	106	17	disease	disease	NOUN
fnp-3866	106	18	.	.	PUNCT
fnp-3866	107	1	this	this	DET
fnp-3866	107	2	study	study	NOUN
fnp-3866	107	3	,	,	PUNCT
fnp-3866	107	4	which	which	PRON
fnp-3866	107	5	requires	require	VERB
fnp-3866	107	6	additional	additional	ADJ
fnp-3866	107	7	confirmation	confirmation	NOUN
fnp-3866	107	8	and	and	CCONJ
fnp-3866	107	9	replication	replication	NOUN
fnp-3866	107	10	with	with	ADP
fnp-3866	107	11	molecular	molecular	ADJ
fnp-3866	107	12	studies	study	NOUN
fnp-3866	107	13	and	and	CCONJ
fnp-3866	107	14	cellular	cellular	ADJ
fnp-3866	107	15	/	/	SYM
fnp-3866	107	16	animal	animal	NOUN
fnp-3866	107	17	modeling	modeling	NOUN
fnp-3866	107	18	,	,	PUNCT
fnp-3866	107	19	spotlights	spotlight	VERB
fnp-3866	107	20	the	the	DET
fnp-3866	107	21	potential	potential	ADJ
fnp-3866	107	22	importance	importance	NOUN
fnp-3866	107	23	of	of	ADP
fnp-3866	107	24	vegf	vegf	PROPN
fnp-3866	107	25	in	in	ADP
fnp-3866	107	26	dementia	dementia	PROPN
fnp-3866	107	27	.	.	PUNCT
fnp-3866	108	1	7	7	X
fnp-3866	108	2	.	.	NUM
fnp-3866	108	3	monocytes	monocyte	NOUN
fnp-3866	108	4	and	and	CCONJ
fnp-3866	108	5	microglia	microglia	NOUN
fnp-3866	108	6	in	in	ADP
fnp-3866	108	7	parkinson	parkinson	NOUN
fnp-3866	108	8	’s	’s	PART
fnp-3866	108	9	disease	disease	NOUN
fnp-3866	108	10	evidence	evidence	NOUN
fnp-3866	108	11	is	be	AUX
fnp-3866	108	12	accumulating	accumulate	VERB
fnp-3866	108	13	that	that	SCONJ
fnp-3866	108	14	the	the	DET
fnp-3866	108	15	immune	immune	ADJ
fnp-3866	108	16	system	system	NOUN
fnp-3866	108	17	plays	play	VERB
fnp-3866	108	18	a	a	DET
fnp-3866	108	19	critical	critical	ADJ
fnp-3866	108	20	role	role	NOUN
fnp-3866	108	21	in	in	ADP
fnp-3866	108	22	parkinson	parkinson	NOUN
fnp-3866	108	23	’s	’s	PART
fnp-3866	108	24	disease	disease	NOUN
fnp-3866	108	25	(	(	PUNCT
fnp-3866	108	26	pd	pd	NOUN
fnp-3866	108	27	)	)	PUNCT
fnp-3866	108	28	.	.	PUNCT
fnp-3866	109	1	investigating	investigate	VERB
fnp-3866	109	2	the	the	DET
fnp-3866	109	3	pathogenic	pathogenic	ADJ
fnp-3866	109	4	events	event	NOUN
fnp-3866	109	5	occuring	occur	VERB
fnp-3866	109	6	in	in	ADP
fnp-3866	109	7	critical	critical	ADJ
fnp-3866	109	8	immune	immune	ADJ
fnp-3866	109	9	cells	cell	NOUN
fnp-3866	109	10	especially	especially	ADV
fnp-3866	109	11	in	in	ADP
fnp-3866	109	12	the	the	DET
fnp-3866	109	13	pd	pd	PROPN
fnp-3866	109	14	brain	brain	NOUN
fnp-3866	109	15	remains	remain	VERB
fnp-3866	109	16	of	of	ADP
fnp-3866	109	17	great	great	ADJ
fnp-3866	109	18	interest	interest	NOUN
fnp-3866	109	19	.	.	PUNCT
fnp-3866	110	1	myeloid	myeloid	ADJ
fnp-3866	110	2	cells	cell	NOUN
fnp-3866	110	3	and	and	CCONJ
fnp-3866	110	4	microglia	microglia	NOUN
fnp-3866	110	5	have	have	AUX
fnp-3866	110	6	been	be	AUX
fnp-3866	110	7	understudied	understudy	VERB
fnp-3866	110	8	.	.	PUNCT
fnp-3866	111	1	genetic	genetic	ADJ
fnp-3866	111	2	studies	study	NOUN
fnp-3866	111	3	have	have	AUX
fnp-3866	111	4	identified	identify	VERB
fnp-3866	111	5	a	a	DET
fnp-3866	111	6	large	large	ADJ
fnp-3866	111	7	number	number	NOUN
fnp-3866	111	8	of	of	ADP
fnp-3866	111	9	risk	risk	NOUN
fnp-3866	111	10	loci	locus	NOUN
fnp-3866	111	11	that	that	PRON
fnp-3866	111	12	alter	alter	VERB
fnp-3866	111	13	the	the	DET
fnp-3866	111	14	expression	expression	NOUN
fnp-3866	111	15	of	of	ADP
fnp-3866	111	16	nearby	nearby	ADJ
fnp-3866	111	17	genes	gene	NOUN
fnp-3866	111	18	in	in	ADP
fnp-3866	111	19	easily	easily	ADV
fnp-3866	111	20	accessible	accessible	ADJ
fnp-3866	111	21	peripheral	peripheral	ADJ
fnp-3866	111	22	monocytes	monocyte	NOUN
fnp-3866	111	23	and	and	CCONJ
fnp-3866	111	24	there	there	PRON
fnp-3866	111	25	is	be	VERB
fnp-3866	111	26	enrichment	enrichment	NOUN
fnp-3866	111	27	of	of	ADP
fnp-3866	111	28	gene	gene	NOUN
fnp-3866	111	29	sets	set	NOUN
fnp-3866	111	30	expressed	express	VERB
fnp-3866	111	31	in	in	ADP
fnp-3866	111	32	microglia	microglia	NOUN
fnp-3866	111	33	.	.	PUNCT
fnp-3866	112	1	there	there	PRON
fnp-3866	112	2	are	be	VERB
fnp-3866	112	3	many	many	ADJ
fnp-3866	112	4	functions	function	NOUN
fnp-3866	112	5	of	of	ADP
fnp-3866	112	6	myeloid	myeloid	ADJ
fnp-3866	112	7	cells	cell	NOUN
fnp-3866	112	8	,	,	PUNCT
fnp-3866	112	9	including	include	VERB
fnp-3866	112	10	clearing	clearing	NOUN
fnp-3866	112	11	of	of	ADP
fnp-3866	112	12	debris	debris	NOUN
fnp-3866	112	13	and	and	CCONJ
fnp-3866	112	14	maintaining	maintain	VERB
fnp-3866	112	15	brain	brain	NOUN
fnp-3866	112	16	homeostasis	homeostasis	NOUN
fnp-3866	112	17	,	,	PUNCT
fnp-3866	112	18	that	that	PRON
fnp-3866	112	19	are	be	AUX
fnp-3866	112	20	highly	highly	ADV
fnp-3866	112	21	relevant	relevant	ADJ
fnp-3866	112	22	to	to	ADP
fnp-3866	112	23	pd	pd	NOUN
fnp-3866	112	24	pathogenesis	pathogenesis	NOUN
fnp-3866	112	25	.	.	PUNCT
fnp-3866	113	1	further	far	ADV
fnp-3866	113	2	,	,	PUNCT
fnp-3866	113	3	alpha	alpha	NOUN
fnp-3866	113	4	-	-	PUNCT
fnp-3866	113	5	synuclein	synuclein	NOUN
fnp-3866	113	6	can	can	AUX
fnp-3866	113	7	promote	promote	VERB
fnp-3866	113	8	microglial	microglial	ADJ
fnp-3866	113	9	release	release	NOUN
fnp-3866	113	10	of	of	ADP
fnp-3866	113	11	neurotoxic	neurotoxic	ADJ
fnp-3866	113	12	factors	factor	NOUN
fnp-3866	113	13	potentially	potentially	ADV
fnp-3866	113	14	leading	lead	VERB
fnp-3866	113	15	to	to	ADP
fnp-3866	113	16	death	death	NOUN
fnp-3866	113	17	of	of	ADP
fnp-3866	113	18	dopaminergic	dopaminergic	ADJ
fnp-3866	113	19	neurons	neuron	NOUN
fnp-3866	113	20	.	.	PUNCT
fnp-3866	114	1	intriguingly	intriguingly	ADV
fnp-3866	114	2	,	,	PUNCT
fnp-3866	114	3	the	the	DET
fnp-3866	114	4	possibility	possibility	NOUN
fnp-3866	114	5	that	that	SCONJ
fnp-3866	114	6	alpha	alpha	NOUN
fnp-3866	114	7	-	-	PUNCT
fnp-3866	114	8	synuclein	synuclein	NOUN
fnp-3866	114	9	pathology	pathology	NOUN
fnp-3866	114	10	might	might	AUX
fnp-3866	114	11	be	be	AUX
fnp-3866	114	12	initiated	initiate	VERB
fnp-3866	114	13	in	in	ADP
fnp-3866	114	14	the	the	DET
fnp-3866	114	15	enteric	enteric	ADJ
fnp-3866	114	16	nervous	nervous	ADJ
fnp-3866	114	17	system	system	NOUN
fnp-3866	114	18	further	far	ADV
fnp-3866	114	19	highlights	highlight	VERB
fnp-3866	114	20	the	the	DET
fnp-3866	114	21	potential	potential	ADJ
fnp-3866	114	22	importance	importance	NOUN
fnp-3866	114	23	of	of	ADP
fnp-3866	114	24	peripheral	peripheral	ADJ
fnp-3866	114	25	myeloid	myeloid	ADJ
fnp-3866	114	26	cells	cell	NOUN
fnp-3866	114	27	to	to	PART
fnp-3866	114	28	influence	influence	VERB
fnp-3866	114	29	pathogenesis	pathogenesis	NOUN
fnp-3866	114	30	.	.	PUNCT
fnp-3866	115	1	how	how	SCONJ
fnp-3866	115	2	myeloid	myeloid	ADJ
fnp-3866	115	3	cells	cell	NOUN
fnp-3866	115	4	are	be	AUX
fnp-3866	115	5	involved	involve	VERB
fnp-3866	115	6	in	in	ADP
fnp-3866	115	7	pd	pd	PROPN
fnp-3866	115	8	is	be	AUX
fnp-3866	115	9	unclear	unclear	ADJ
fnp-3866	115	10	and	and	CCONJ
fnp-3866	115	11	the	the	DET
fnp-3866	115	12	extent	extent	NOUN
fnp-3866	115	13	to	to	PART
fnp-3866	115	14	which	which	PRON
fnp-3866	115	15	specific	specific	ADJ
fnp-3866	115	16	immune	immune	ADJ
fnp-3866	115	17	cell	cell	NOUN
fnp-3866	115	18	types	type	NOUN
fnp-3866	115	19	,	,	PUNCT
fnp-3866	115	20	in	in	ADP
fnp-3866	115	21	the	the	DET
fnp-3866	115	22	periphery	periphery	NOUN
fnp-3866	115	23	or	or	CCONJ
fnp-3866	115	24	in	in	ADP
fnp-3866	115	25	the	the	DET
fnp-3866	115	26	central	central	ADJ
fnp-3866	115	27	nervous	nervous	ADJ
fnp-3866	115	28	system	system	NOUN
fnp-3866	115	29	,	,	PUNCT
fnp-3866	115	30	participate	participate	VERB
fnp-3866	115	31	remains	remain	VERB
fnp-3866	115	32	a	a	DET
fnp-3866	115	33	critical	critical	ADJ
fnp-3866	115	34	knowledge	knowledge	NOUN
fnp-3866	115	35	gap	gap	NOUN
fnp-3866	115	36	.	.	PUNCT
fnp-3866	116	1	in	in	ADP
fnp-3866	116	2	a	a	DET
fnp-3866	116	3	paper	paper	NOUN
fnp-3866	116	4	published	publish	VERB
fnp-3866	116	5	in	in	ADP
fnp-3866	116	6	nature	nature	NOUN
fnp-3866	116	7	aging	age	VERB
fnp-3866	116	8	by	by	ADP
fnp-3866	116	9	navarro	navarro	PROPN
fnp-3866	116	10	et	et	PROPN
fnp-3866	116	11	al	al	PROPN
fnp-3866	116	12	.	.	PROPN
fnp-3866	116	13	,	,	PUNCT
fnp-3866	116	14	an	an	DET
fnp-3866	116	15	international	international	ADJ
fnp-3866	116	16	team	team	NOUN
fnp-3866	116	17	of	of	ADP
fnp-3866	116	18	researchers	researcher	NOUN
fnp-3866	116	19	conducted	conduct	VERB
fnp-3866	116	20	a	a	DET
fnp-3866	116	21	study	study	NOUN
fnp-3866	116	22	looking	look	VERB
fnp-3866	116	23	at	at	ADP
fnp-3866	116	24	monocytes	monocyte	NOUN
fnp-3866	116	25	in	in	ADP
fnp-3866	116	26	peripheral	peripheral	ADJ
fnp-3866	116	27	blood	blood	NOUN
fnp-3866	116	28	as	as	ADV
fnp-3866	116	29	well	well	ADV
fnp-3866	116	30	as	as	ADP
fnp-3866	116	31	monocytes	monocyte	NOUN
fnp-3866	116	32	and	and	CCONJ
fnp-3866	116	33	microglia	microglia	NOUN
fnp-3866	116	34	in	in	ADP
fnp-3866	116	35	post	post	ADJ
fnp-3866	116	36	mortem	mortem	X
fnp-3866	116	37	brains	brain	NOUN
fnp-3866	116	38	from	from	ADP
fnp-3866	116	39	pd	pd	PROPN
fnp-3866	116	40	patients	patient	NOUN
fnp-3866	116	41	(	(	PUNCT
fnp-3866	116	42	navarro	navarro	PROPN
fnp-3866	116	43	et	et	PROPN
fnp-3866	116	44	al	al	PROPN
fnp-3866	116	45	.	.	PROPN
fnp-3866	116	46	,	,	PUNCT
fnp-3866	116	47	2021	2021	NUM
fnp-3866	116	48	)	)	PUNCT
fnp-3866	116	49	.	.	PUNCT
fnp-3866	117	1	the	the	DET
fnp-3866	117	2	authors	author	NOUN
fnp-3866	117	3	sorted	sort	VERB
fnp-3866	117	4	cd14	cd14	PROPN
fnp-3866	117	5	+	+	CCONJ
fnp-3866	117	6	peripheral	peripheral	ADJ
fnp-3866	117	7	monocytes	monocyte	NOUN
fnp-3866	117	8	and	and	CCONJ
fnp-3866	117	9	microglia	microglia	NOUN
fnp-3866	117	10	from	from	ADP
fnp-3866	117	11	the	the	DET
fnp-3866	117	12	blood	blood	NOUN
fnp-3866	117	13	and	and	CCONJ
fnp-3866	117	14	brains	brain	NOUN
fnp-3866	117	15	and	and	CCONJ
fnp-3866	117	16	performed	perform	VERB
fnp-3866	117	17	a	a	DET
fnp-3866	117	18	large	large	ADJ
fnp-3866	117	19	-	-	PUNCT
fnp-3866	117	20	scale	scale	NOUN
fnp-3866	117	21	unbiased	unbiased	ADJ
fnp-3866	117	22	single	single	ADJ
fnp-3866	117	23	cell	cell	NOUN
fnp-3866	117	24	transcriptomic	transcriptomic	ADJ
fnp-3866	117	25	study	study	NOUN
fnp-3866	117	26	.	.	PUNCT
fnp-3866	118	1	the	the	DET
fnp-3866	118	2	strength	strength	NOUN
fnp-3866	118	3	of	of	ADP
fnp-3866	118	4	this	this	DET
fnp-3866	118	5	study	study	NOUN
fnp-3866	118	6	are	be	AUX
fnp-3866	118	7	the	the	DET
fnp-3866	118	8	direct	direct	ADJ
fnp-3866	118	9	comparisons	comparison	NOUN
fnp-3866	118	10	between	between	ADP
fnp-3866	118	11	gene	gene	NOUN
fnp-3866	118	12	expression	expression	NOUN
fnp-3866	118	13	in	in	ADP
fnp-3866	118	14	the	the	DET
fnp-3866	118	15	peripheral	peripheral	ADJ
fnp-3866	118	16	blood	blood	NOUN
fnp-3866	118	17	with	with	ADP
fnp-3866	118	18	the	the	DET
fnp-3866	118	19	brain	brain	NOUN
fnp-3866	118	20	as	as	SCONJ
fnp-3866	118	21	most	most	ADJ
fnp-3866	118	22	studies	study	NOUN
fnp-3866	118	23	in	in	ADP
fnp-3866	118	24	pd	pd	PROPN
fnp-3866	118	25	have	have	AUX
fnp-3866	118	26	focused	focus	VERB
fnp-3866	118	27	on	on	ADP
fnp-3866	118	28	dopaminergic	dopaminergic	ADJ
fnp-3866	118	29	neurons	neuron	NOUN
fnp-3866	118	30	,	,	PUNCT
fnp-3866	118	31	fibroblasts	fibroblast	NOUN
fnp-3866	118	32	,	,	PUNCT
fnp-3866	118	33	or	or	CCONJ
fnp-3866	118	34	whole	whole	ADJ
fnp-3866	118	35	blood	blood	NOUN
fnp-3866	118	36	.	.	PUNCT
fnp-3866	119	1	they	they	PRON
fnp-3866	119	2	identified	identify	VERB
fnp-3866	119	3	genes	gene	NOUN
fnp-3866	119	4	and	and	CCONJ
fnp-3866	119	5	co	co	NOUN
fnp-3866	119	6	-	-	NOUN
fnp-3866	119	7	expression	expression	ADJ
fnp-3866	119	8	networks	network	NOUN
fnp-3866	119	9	dysregulated	dysregulate	VERB
fnp-3866	119	10	in	in	ADP
fnp-3866	119	11	pd	pd	X
fnp-3866	119	12	myeloid	myeloid	NOUN
fnp-3866	119	13	cells	cell	NOUN
fnp-3866	119	14	.	.	PUNCT
fnp-3866	120	1	they	they	PRON
fnp-3866	120	2	identified	identify	VERB
fnp-3866	120	3	genes	gene	NOUN
fnp-3866	120	4	that	that	PRON
fnp-3866	120	5	are	be	AUX
fnp-3866	120	6	involved	involve	VERB
fnp-3866	120	7	in	in	ADP
fnp-3866	120	8	mitochondrial	mitochondrial	ADJ
fnp-3866	120	9	and	and	CCONJ
fnp-3866	120	10	proteasomal	proteasomal	ADJ
fnp-3866	120	11	function	function	NOUN
fnp-3866	120	12	that	that	PRON
fnp-3866	120	13	are	be	AUX
fnp-3866	120	14	highly	highly	ADV
fnp-3866	120	15	expressed	express	VERB
fnp-3866	120	16	in	in	ADP
fnp-3866	120	17	a	a	DET
fnp-3866	120	18	proinflammatory	proinflammatory	ADJ
fnp-3866	120	19	intermediate	intermediate	ADJ
fnp-3866	120	20	subpopulation	subpopulation	NOUN
fnp-3866	120	21	.	.	PUNCT
fnp-3866	121	1	they	they	PRON
fnp-3866	121	2	identified	identify	VERB
fnp-3866	121	3	17	17	NUM
fnp-3866	121	4	variants	variant	NOUN
fnp-3866	121	5	that	that	PRON
fnp-3866	121	6	influence	influence	VERB
fnp-3866	121	7	mrna	mrna	NOUN
fnp-3866	121	8	expression	expression	NOUN
fnp-3866	121	9	and	and	CCONJ
fnp-3866	121	10	pd	pd	NOUN
fnp-3866	121	11	risk	risk	NOUN
fnp-3866	121	12	.	.	PUNCT
fnp-3866	122	1	this	this	PRON
fnp-3866	122	2	enabled	enable	VERB
fnp-3866	122	3	the	the	DET
fnp-3866	122	4	authors	author	NOUN
fnp-3866	122	5	to	to	PART
fnp-3866	122	6	show	show	VERB
fnp-3866	122	7	that	that	SCONJ
fnp-3866	122	8	there	there	PRON
fnp-3866	122	9	are	be	VERB
fnp-3866	122	10	actually	actually	ADV
fnp-3866	122	11	opposite	opposite	ADJ
fnp-3866	122	12	mitochondrial	mitochondrial	ADJ
fnp-3866	122	13	transcriptomic	transcriptomic	ADJ
fnp-3866	122	14	profiles	profile	NOUN
fnp-3866	122	15	between	between	ADP
fnp-3866	122	16	microglia	microglia	NOUN
fnp-3866	122	17	and	and	CCONJ
fnp-3866	122	18	macrophages	macrophage	NOUN
fnp-3866	122	19	(	(	PUNCT
fnp-3866	122	20	down	down	ADV
fnp-3866	122	21	regulated	regulated	ADJ
fnp-3866	122	22	)	)	PUNCT
fnp-3866	122	23	versus	versus	ADP
fnp-3866	122	24	peripheral	peripheral	ADJ
fnp-3866	122	25	monocytes	monocyte	NOUN
fnp-3866	122	26	(	(	PUNCT
fnp-3866	122	27	upregulated	upregulate	VERB
fnp-3866	122	28	)	)	PUNCT
fnp-3866	122	29	.	.	PUNCT
fnp-3866	123	1	these	these	DET
fnp-3866	123	2	results	result	NOUN
fnp-3866	123	3	provide	provide	VERB
fnp-3866	123	4	further	further	ADJ
fnp-3866	123	5	support	support	NOUN
fnp-3866	123	6	for	for	ADP
fnp-3866	123	7	a	a	DET
fnp-3866	123	8	prominent	prominent	ADJ
fnp-3866	123	9	role	role	NOUN
fnp-3866	123	10	for	for	ADP
fnp-3866	123	11	immune	immune	ADJ
fnp-3866	123	12	dysfunction	dysfunction	NOUN
fnp-3866	123	13	in	in	ADP
fnp-3866	123	14	the	the	DET
fnp-3866	123	15	pathogenesis	pathogenesis	NOUN
fnp-3866	123	16	of	of	ADP
fnp-3866	123	17	pd	pd	PROPN
fnp-3866	123	18	.	.	PROPN
fnp-3866	123	19	8	8	NUM
fnp-3866	123	20	.	.	PUNCT
fnp-3866	123	21	neurodevelopmental	neurodevelopmental	ADJ
fnp-3866	123	22	alterations	alteration	NOUN
fnp-3866	123	23	in	in	ADP
fnp-3866	123	24	huntington	huntington	PROPN
fnp-3866	123	25	’s	’s	PART
fnp-3866	123	26	disease	disease	PROPN
fnp-3866	123	27	huntington	huntington	PROPN
fnp-3866	123	28	’s	’s	PART
fnp-3866	123	29	disease	disease	NOUN
fnp-3866	123	30	(	(	PUNCT
fnp-3866	123	31	hd	hd	NOUN
fnp-3866	123	32	)	)	PUNCT
fnp-3866	123	33	is	be	AUX
fnp-3866	123	34	the	the	DET
fnp-3866	123	35	prototype	prototype	NOUN
fnp-3866	123	36	hyperkinetic	hyperkinetic	ADJ
fnp-3866	123	37	movement	movement	NOUN
fnp-3866	123	38	disorder	disorder	NOUN
fnp-3866	123	39	caused	cause	VERB
fnp-3866	123	40	by	by	ADP
fnp-3866	123	41	polyq	polyq	NOUN
fnp-3866	123	42	repeat	repeat	NOUN
fnp-3866	123	43	expansion	expansion	NOUN
fnp-3866	123	44	in	in	ADP
fnp-3866	123	45	the	the	DET
fnp-3866	123	46	huntingtin	huntingtin	ADJ
fnp-3866	123	47	gene	gene	NOUN
fnp-3866	123	48	(	(	PUNCT
fnp-3866	123	49	htt	htt	NOUN
fnp-3866	123	50	)	)	PUNCT
fnp-3866	123	51	.	.	PUNCT
fnp-3866	124	1	while	while	SCONJ
fnp-3866	124	2	the	the	DET
fnp-3866	124	3	neuropathology	neuropathology	NOUN
fnp-3866	124	4	of	of	ADP
fnp-3866	124	5	hd	hd	PROPN
fnp-3866	124	6	has	have	AUX
fnp-3866	124	7	been	be	AUX
fnp-3866	124	8	extensively	extensively	ADV
fnp-3866	124	9	studied	study	VERB
fnp-3866	124	10	,	,	PUNCT
fnp-3866	124	11	accumulating	accumulate	VERB
fnp-3866	124	12	evidence	evidence	NOUN
fnp-3866	124	13	from	from	ADP
fnp-3866	124	14	cellular	cellular	ADJ
fnp-3866	124	15	,	,	PUNCT
fnp-3866	124	16	animal	animal	NOUN
fnp-3866	124	17	and	and	CCONJ
fnp-3866	124	18	human	human	ADJ
fnp-3866	124	19	studies	study	NOUN
fnp-3866	124	20	pointed	point	VERB
fnp-3866	124	21	to	to	ADP
fnp-3866	124	22	the	the	DET
fnp-3866	124	23	existence	existence	NOUN
fnp-3866	124	24	of	of	ADP
fnp-3866	124	25	neurodevelopmental	neurodevelopmental	ADJ
fnp-3866	124	26	abnormalities	abnormality	NOUN
fnp-3866	124	27	in	in	ADP
fnp-3866	124	28	hd	hd	PROPN
fnp-3866	124	29	.	.	PROPN
fnp-3866	124	30	of	of	ADP
fnp-3866	124	31	note	note	NOUN
fnp-3866	124	32	,	,	PUNCT
fnp-3866	124	33	barnat	barnat	NOUN
fnp-3866	124	34	et	et	PROPN
fnp-3866	124	35	al	al	PROPN
fnp-3866	124	36	.	.	PROPN
fnp-3866	124	37	have	have	AUX
fnp-3866	124	38	reported	report	VERB
fnp-3866	124	39	defects	defect	NOUN
fnp-3866	124	40	in	in	ADP
fnp-3866	124	41	neuronal	neuronal	ADJ
fnp-3866	124	42	migration	migration	NOUN
fnp-3866	124	43	in	in	ADP
fnp-3866	124	44	the	the	DET
fnp-3866	124	45	brains	brain	NOUN
fnp-3866	124	46	of	of	ADP
fnp-3866	124	47	mutant	mutant	ADJ
fnp-3866	124	48	htt	htt	NOUN
fnp-3866	124	49	-	-	PUNCT
fnp-3866	124	50	fetuses	fetus	NOUN
fnp-3866	124	51	and	and	CCONJ
fnp-3866	124	52	linked	link	VERB
fnp-3866	124	53	them	they	PRON
fnp-3866	124	54	to	to	ADP
fnp-3866	124	55	alterations	alteration	NOUN
fnp-3866	124	56	in	in	ADP
fnp-3866	124	57	the	the	DET
fnp-3866	124	58	interkinetic	interkinetic	ADJ
fnp-3866	124	59	nuclear	nuclear	ADJ
fnp-3866	124	60	migration	migration	NOUN
fnp-3866	124	61	of	of	ADP
fnp-3866	124	62	progenitor	progenitor	NOUN
fnp-3866	124	63	cells	cell	NOUN
fnp-3866	124	64	(	(	PUNCT
fnp-3866	124	65	barnat	barnat	NOUN
fnp-3866	124	66	et	et	PROPN
fnp-3866	124	67	al	al	PROPN
fnp-3866	124	68	,	,	PUNCT
fnp-3866	124	69	science	science	NOUN
fnp-3866	124	70	2020	2020	NUM
fnp-3866	124	71	)	)	PUNCT
fnp-3866	124	72	.	.	PUNCT
fnp-3866	125	1	neuropathological	neuropathological	ADJ
fnp-3866	125	2	evidence	evidence	NOUN
fnp-3866	125	3	in	in	ADP
fnp-3866	125	4	adult	adult	NOUN
fnp-3866	125	5	human	human	ADJ
fnp-3866	125	6	hd	hd	PROPN
fnp-3866	125	7	has	have	AUX
fnp-3866	125	8	however	however	ADV
fnp-3866	125	9	been	be	AUX
fnp-3866	125	10	lacking	lack	VERB
fnp-3866	125	11	.	.	PUNCT
fnp-3866	126	1	in	in	ADP
fnp-3866	126	2	a	a	DET
fnp-3866	126	3	paper	paper	NOUN
fnp-3866	126	4	published	publish	VERB
fnp-3866	126	5	in	in	ADP
fnp-3866	126	6	acta	acta	PROPN
fnp-3866	126	7	neuropathologica	neuropathologica	PROPN
fnp-3866	126	8	,	,	PUNCT
fnp-3866	126	9	hickman	hickman	PROPN
fnp-3866	126	10	et	et	PROPN
fnp-3866	126	11	al	al	PROPN
fnp-3866	126	12	.	.	PROPN
fnp-3866	126	13	provided	provide	VERB
fnp-3866	126	14	the	the	DET
fnp-3866	126	15	first	first	ADJ
fnp-3866	126	16	neuropathological	neuropathological	ADJ
fnp-3866	126	17	evidence	evidence	NOUN
fnp-3866	126	18	that	that	SCONJ
fnp-3866	126	19	malformations	malformation	NOUN
fnp-3866	126	20	are	be	AUX
fnp-3866	126	21	present	present	ADJ
fnp-3866	126	22	in	in	ADP
fnp-3866	126	23	adult	adult	NOUN
fnp-3866	126	24	human	human	ADJ
fnp-3866	126	25	hd	hd	PROPN
fnp-3866	126	26	(	(	PUNCT
fnp-3866	126	27	hickman	hickman	PROPN
fnp-3866	126	28	et	et	PROPN
fnp-3866	126	29	al	al	PROPN
fnp-3866	126	30	.	.	PROPN
fnp-3866	126	31	,	,	PUNCT
fnp-3866	126	32	2021	2021	NUM
fnp-3866	126	33	)	)	PUNCT
fnp-3866	126	34	through	through	ADP
fnp-3866	126	35	systematic	systematic	ADJ
fnp-3866	126	36	evaluation	evaluation	NOUN
fnp-3866	126	37	of	of	ADP
fnp-3866	126	38	two	two	NUM
fnp-3866	126	39	large	large	ADJ
fnp-3866	126	40	brain	brain	NOUN
fnp-3866	126	41	collections	collection	NOUN
fnp-3866	126	42	:	:	PUNCT
fnp-3866	126	43	a	a	DET
fnp-3866	126	44	discovery	discovery	NOUN
fnp-3866	126	45	cohort	cohort	NOUN
fnp-3866	126	46	from	from	ADP
fnp-3866	126	47	the	the	DET
fnp-3866	126	48	new	new	PROPN
fnp-3866	126	49	york	york	PROPN
fnp-3866	126	50	brain	brain	PROPN
fnp-3866	126	51	bank	bank	PROPN
fnp-3866	126	52	(	(	PUNCT
fnp-3866	126	53	nybb	nybb	PROPN
fnp-3866	126	54	)	)	PUNCT
fnp-3866	126	55	at	at	ADP
fnp-3866	126	56	columbia	columbia	PROPN
fnp-3866	126	57	university	university	PROPN
fnp-3866	126	58	and	and	CCONJ
fnp-3866	126	59	a	a	DET
fnp-3866	126	60	validation	validation	NOUN
fnp-3866	126	61	cohort	cohort	NOUN
fnp-3866	126	62	from	from	ADP
fnp-3866	126	63	the	the	DET
fnp-3866	126	64	harvard	harvard	PROPN
fnp-3866	126	65	brain	brain	NOUN
fnp-3866	126	66	tissue	tissue	NOUN
fnp-3866	126	67	resource	resource	NOUN
fnp-3866	126	68	center	center	NOUN
fnp-3866	126	69	(	(	PUNCT
fnp-3866	126	70	hbtrc	hbtrc	NOUN
fnp-3866	126	71	)	)	PUNCT
fnp-3866	126	72	,	,	PUNCT
fnp-3866	126	73	total	total	ADJ
fnp-3866	126	74	n=3918	n=3918	PROPN
fnp-3866	126	75	.	.	PUNCT
fnp-3866	127	1	of	of	ADP
fnp-3866	127	2	130	130	NUM
fnp-3866	127	3	hd	hd	NOUN
fnp-3866	127	4	brains	brain	NOUN
fnp-3866	127	5	examined	examine	VERB
fnp-3866	127	6	from	from	ADP
fnp-3866	127	7	the	the	DET
fnp-3866	127	8	nybb	nybb	NOUN
fnp-3866	127	9	,	,	PUNCT
fnp-3866	127	10	eight	eight	NUM
fnp-3866	127	11	(	(	PUNCT
fnp-3866	127	12	6.2	6.2	NUM
fnp-3866	127	13	%	%	NOUN
fnp-3866	127	14	)	)	PUNCT
fnp-3866	127	15	had	have	VERB
fnp-3866	127	16	at	at	ADV
fnp-3866	127	17	least	least	ADV
fnp-3866	127	18	one	one	NUM
fnp-3866	127	19	malformation	malformation	NOUN
fnp-3866	127	20	compared	compare	VERB
fnp-3866	127	21	to	to	ADP
fnp-3866	127	22	12	12	NUM
fnp-3866	127	23	(	(	PUNCT
fnp-3866	127	24	0.75	0.75	NUM
fnp-3866	127	25	%	%	NOUN
fnp-3866	127	26	)	)	PUNCT
fnp-3866	127	27	in	in	ADP
fnp-3866	127	28	the	the	DET
fnp-3866	127	29	1600	1600	NUM
fnp-3866	127	30	non	non	ADJ
fnp-3866	127	31	-	-	ADJ
fnp-3866	127	32	hd	hd	ADJ
fnp-3866	127	33	brains	brain	NOUN
fnp-3866	127	34	.	.	PUNCT
fnp-3866	128	1	periventricular	periventricular	ADJ
fnp-3866	128	2	nodular	nodular	ADJ
fnp-3866	128	3	heterotopias	heterotopia	NOUN
fnp-3866	128	4	(	(	PUNCT
fnp-3866	128	5	pnh	pnh	PROPN
fnp-3866	128	6	)	)	PUNCT
fnp-3866	128	7	were	be	AUX
fnp-3866	128	8	the	the	DET
fnp-3866	128	9	most	most	ADV
fnp-3866	128	10	frequent	frequent	ADJ
fnp-3866	128	11	malformation	malformation	NOUN
fnp-3866	128	12	(	(	PUNCT
fnp-3866	128	13	figure	figure	NOUN
fnp-3866	128	14	6	6	NUM
fnp-3866	128	15	)	)	PUNCT
fnp-3866	128	16	,	,	PUNCT
fnp-3866	128	17	confirming	confirm	VERB
fnp-3866	128	18	abnormalities	abnormality	NOUN
fnp-3866	128	19	in	in	ADP
fnp-3866	128	20	neuronal	neuronal	ADJ
fnp-3866	128	21	migration	migration	NOUN
fnp-3866	128	22	in	in	ADP
fnp-3866	128	23	hd	hd	NOUN
fnp-3866	128	24	.	.	PUNCT
fnp-3866	129	1	intriguingly	intriguingly	ADV
fnp-3866	129	2	,	,	PUNCT
fnp-3866	129	3	the	the	DET
fnp-3866	129	4	neurons	neuron	NOUN
fnp-3866	129	5	in	in	ADP
fnp-3866	129	6	the	the	DET
fnp-3866	129	7	pnh	pnh	PROPN
fnp-3866	129	8	contained	contain	VERB
fnp-3866	129	9	p62	p62	NOUN
fnp-3866	129	10	-	-	PUNCT
fnp-3866	129	11	positive	positive	ADJ
fnp-3866	129	12	aggregates	aggregate	NOUN
fnp-3866	129	13	indicative	indicative	ADJ
fnp-3866	129	14	of	of	ADP
fnp-3866	129	15	ongoing	ongoing	ADJ
fnp-3866	129	16	proteinopathy	proteinopathy	ADJ
fnp-3866	129	17	.	.	PUNCT
fnp-3866	130	1	other	other	ADJ
fnp-3866	130	2	cerebral	cerebral	ADJ
fnp-3866	130	3	malformations	malformation	NOUN
fnp-3866	130	4	included	include	VERB
fnp-3866	130	5	hamartomas	hamartoma	NOUN
fnp-3866	130	6	,	,	PUNCT
fnp-3866	130	7	cerebellar	cerebellar	ADJ
fnp-3866	130	8	nodular	nodular	ADJ
fnp-3866	130	9	heterotopias	heterotopia	NOUN
fnp-3866	130	10	,	,	PUNCT
fnp-3866	130	11	and	and	CCONJ
fnp-3866	130	12	one	one	NUM
fnp-3866	130	13	multinodular	multinodular	ADJ
fnp-3866	130	14	vacuolating	vacuolating	NOUN
fnp-3866	130	15	tumor	tumor	NOUN
fnp-3866	130	16	of	of	ADP
fnp-3866	130	17	the	the	DET
fnp-3866	130	18	cerebellum	cerebellum	NOUN
fnp-3866	130	19	(	(	PUNCT
fnp-3866	130	20	mvnt	mvnt	NOUN
fnp-3866	130	21	)	)	PUNCT
fnp-3866	130	22	.	.	PUNCT
fnp-3866	131	1	the	the	DET
fnp-3866	131	2	frequency	frequency	NOUN
fnp-3866	131	3	of	of	ADP
fnp-3866	131	4	hd	hd	NOUN
fnp-3866	131	5	-	-	PUNCT
fnp-3866	131	6	associated	associate	VERB
fnp-3866	131	7	cerebral	cerebral	ADJ
fnp-3866	131	8	malformations	malformation	NOUN
fnp-3866	131	9	was	be	AUX
fnp-3866	131	10	also	also	ADV
fnp-3866	131	11	significantly	significantly	ADV
fnp-3866	131	12	increased	increase	VERB
fnp-3866	131	13	in	in	ADP
fnp-3866	131	14	the	the	DET
fnp-3866	131	15	hbtrc	hbtrc	NOUN
fnp-3866	131	16	cohort	cohort	NOUN
fnp-3866	131	17	but	but	CCONJ
fnp-3866	131	18	at	at	ADP
fnp-3866	131	19	a	a	DET
fnp-3866	131	20	lower	low	ADJ
fnp-3866	131	21	frequency	frequency	NOUN
fnp-3866	131	22	than	than	ADP
fnp-3866	131	23	in	in	ADP
fnp-3866	131	24	the	the	DET
fnp-3866	131	25	nybb	nybb	PROPN
fnp-3866	131	26	cohort	cohort	NOUN
fnp-3866	131	27	,	,	PUNCT
fnp-3866	131	28	which	which	PRON
fnp-3866	131	29	was	be	AUX
fnp-3866	131	30	likely	likely	ADV
fnp-3866	131	31	explained	explain	VERB
fnp-3866	131	32	by	by	ADP
fnp-3866	131	33	differences	difference	NOUN
fnp-3866	131	34	in	in	ADP
fnp-3866	131	35	sampling	sampling	NOUN
fnp-3866	131	36	and	and	CCONJ
fnp-3866	131	37	assessment	assessment	NOUN
fnp-3866	131	38	protocols	protocol	NOUN
fnp-3866	131	39	.	.	PUNCT
fnp-3866	132	1	the	the	DET
fnp-3866	132	2	asymmetric	asymmetric	ADJ
fnp-3866	132	3	nature	nature	NOUN
fnp-3866	132	4	of	of	ADP
fnp-3866	132	5	the	the	DET
fnp-3866	132	6	cerebral	cerebral	ADJ
fnp-3866	132	7	malformations	malformation	NOUN
fnp-3866	132	8	in	in	ADP
fnp-3866	132	9	hd	hd	NOUN
fnp-3866	132	10	suggested	suggest	VERB
fnp-3866	132	11	that	that	SCONJ
fnp-3866	132	12	they	they	PRON
fnp-3866	132	13	were	be	AUX
fnp-3866	132	14	secondary	secondary	ADJ
fnp-3866	132	15	to	to	ADP
fnp-3866	132	16	somatic	somatic	ADJ
fnp-3866	132	17	mutation	mutation	NOUN
fnp-3866	132	18	.	.	PUNCT
fnp-3866	133	1	their	their	PRON
fnp-3866	133	2	higher	high	ADJ
fnp-3866	133	3	frequency	frequency	NOUN
fnp-3866	133	4	in	in	ADP
fnp-3866	133	5	women	woman	NOUN
fnp-3866	133	6	may	may	AUX
fnp-3866	133	7	be	be	AUX
fnp-3866	133	8	related	relate	VERB
fnp-3866	133	9	to	to	ADP
fnp-3866	133	10	sexual	sexual	ADJ
fnp-3866	133	11	dimorphism	dimorphism	NOUN
fnp-3866	133	12	.	.	PUNCT
fnp-3866	134	1	the	the	DET
fnp-3866	134	2	possibility	possibility	NOUN
fnp-3866	134	3	that	that	PRON
fnp-3866	134	4	hd	hd	VERB
fnp-3866	134	5	brains	brain	NOUN
fnp-3866	134	6	contain	contain	VERB
fnp-3866	134	7	additional	additional	ADJ
fnp-3866	134	8	developmental	developmental	ADJ
fnp-3866	134	9	or	or	CCONJ
fnp-3866	134	10	neurodevelopmental	neurodevelopmental	ADJ
fnp-3866	134	11	abnormalities	abnormality	NOUN
fnp-3866	134	12	merits	merit	VERB
fnp-3866	134	13	further	further	ADJ
fnp-3866	134	14	investigation	investigation	NOUN
fnp-3866	134	15	.	.	PUNCT
fnp-3866	135	1	nevertheless	nevertheless	ADV
fnp-3866	135	2	,	,	PUNCT
fnp-3866	135	3	this	this	DET
fnp-3866	135	4	study	study	NOUN
fnp-3866	135	5	provides	provide	VERB
fnp-3866	135	6	concrete	concrete	ADJ
fnp-3866	135	7	evidence	evidence	NOUN
fnp-3866	135	8	that	that	SCONJ
fnp-3866	135	9	developmental	developmental	ADJ
fnp-3866	135	10	abnormalities	abnormality	NOUN
fnp-3866	135	11	occur	occur	VERB
fnp-3866	135	12	in	in	ADP
fnp-3866	135	13	human	human	ADJ
fnp-3866	135	14	brains	brain	NOUN
fnp-3866	135	15	with	with	ADP
fnp-3866	135	16	hd	hd	NOUN
fnp-3866	135	17	and	and	CCONJ
fnp-3866	135	18	provide	provide	VERB
fnp-3866	135	19	the	the	DET
fnp-3866	135	20	foundation	foundation	NOUN
fnp-3866	135	21	for	for	ADP
fnp-3866	135	22	a	a	DET
fnp-3866	135	23	new	new	ADJ
fnp-3866	135	24	avenue	avenue	NOUN
fnp-3866	135	25	into	into	ADP
fnp-3866	135	26	studying	study	VERB
fnp-3866	135	27	htt	htt	NOUN
fnp-3866	135	28	-	-	PUNCT
fnp-3866	135	29	related	relate	VERB
fnp-3866	135	30	mechanisms	mechanism	NOUN
fnp-3866	135	31	.	.	PUNCT
fnp-3866	136	1	figure	figure	VERB
fnp-3866	136	2	6	6	NUM
fnp-3866	136	3	.	.	PUNCT
fnp-3866	137	1	a	a	DET
fnp-3866	137	2	periventricular	periventricular	ADJ
fnp-3866	137	3	nodular	nodular	ADJ
fnp-3866	137	4	heterotopia	heterotopia	NOUN
fnp-3866	137	5	(	(	PUNCT
fnp-3866	137	6	pnh	pnh	PROPN
fnp-3866	137	7	)	)	PUNCT
fnp-3866	137	8	in	in	ADP
fnp-3866	137	9	a	a	DET
fnp-3866	137	10	41	41	NUM
fnp-3866	137	11	-	-	PUNCT
fnp-3866	137	12	year	year	NOUN
fnp-3866	137	13	-	-	PUNCT
fnp-3866	137	14	old	old	ADJ
fnp-3866	137	15	woman	woman	NOUN
fnp-3866	137	16	with	with	ADP
fnp-3866	137	17	hd	hd	PROPN
fnp-3866	137	18	.	.	PUNCT
fnp-3866	137	19	gross	gross	ADJ
fnp-3866	137	20	(	(	PUNCT
fnp-3866	137	21	a	a	NOUN
fnp-3866	137	22	)	)	PUNCT
fnp-3866	137	23	and	and	CCONJ
fnp-3866	137	24	low	low	ADJ
fnp-3866	137	25	power	power	NOUN
fnp-3866	137	26	(	(	PUNCT
fnp-3866	137	27	lh&e	lh&e	PROPN
fnp-3866	137	28	stain	stain	NOUN
fnp-3866	137	29	)	)	PUNCT
fnp-3866	137	30	images	image	NOUN
fnp-3866	137	31	(	(	PUNCT
fnp-3866	137	32	b	b	NOUN
fnp-3866	137	33	)	)	PUNCT
fnp-3866	137	34	of	of	ADP
fnp-3866	137	35	a	a	DET
fnp-3866	137	36	subependymal	subependymal	ADJ
fnp-3866	137	37	heterotopia	heterotopia	NOUN
fnp-3866	137	38	containing	contain	VERB
fnp-3866	137	39	non	non	ADJ
fnp-3866	137	40	-	-	ADJ
fnp-3866	137	41	dysmorphic	dysmorphic	ADJ
fnp-3866	137	42	neurons	neuron	NOUN
fnp-3866	137	43	(	(	PUNCT
fnp-3866	137	44	c	c	NOUN
fnp-3866	137	45	)	)	PUNCT
fnp-3866	137	46	that	that	PRON
fnp-3866	137	47	are	be	AUX
fnp-3866	137	48	immunopositive	immunopositive	ADJ
fnp-3866	137	49	for	for	ADP
fnp-3866	137	50	htt	htt	NOUN
fnp-3866	137	51	and	and	CCONJ
fnp-3866	137	52	p62	p62	NOUN
fnp-3866	137	53	(	(	PUNCT
fnp-3866	137	54	d	d	NOUN
fnp-3866	137	55	,	,	PUNCT
fnp-3866	137	56	arrows	arrow	NOUN
fnp-3866	137	57	)	)	PUNCT
fnp-3866	137	58	.	.	PUNCT
fnp-3866	138	1	reproduced	reproduce	VERB
fnp-3866	138	2	with	with	ADP
fnp-3866	138	3	permission	permission	NOUN
fnp-3866	138	4	from	from	ADP
fnp-3866	138	5	hickman	hickman	PROPN
fnp-3866	138	6	et	et	PROPN
fnp-3866	138	7	al	al	PROPN
fnp-3866	138	8	.	.	PUNCT
fnp-3866	139	1	(	(	PUNCT
fnp-3866	139	2	hickman	hickman	PROPN
fnp-3866	139	3	et	et	PROPN
fnp-3866	139	4	al	al	PROPN
fnp-3866	139	5	.	.	PROPN
fnp-3866	139	6	,	,	PUNCT
fnp-3866	139	7	2021	2021	NUM
fnp-3866	139	8	)	)	PUNCT
fnp-3866	139	9	.	.	PUNCT
fnp-3866	140	1	9	9	X
fnp-3866	140	2	.	.	X
fnp-3866	140	3	criteria	criterion	NOUN
fnp-3866	140	4	for	for	ADP
fnp-3866	140	5	lewy	lewy	ADJ
fnp-3866	140	6	body	body	NOUN
fnp-3866	140	7	pathology	pathology	NOUN
fnp-3866	140	8	:	:	PUNCT
fnp-3866	140	9	approaching	approach	VERB
fnp-3866	140	10	consensus	consensus	NOUN
fnp-3866	140	11	the	the	DET
fnp-3866	140	12	spectrum	spectrum	NOUN
fnp-3866	140	13	of	of	ADP
fnp-3866	140	14	lewy	lewy	PROPN
fnp-3866	140	15	body	body	NOUN
fnp-3866	140	16	disease	disease	NOUN
fnp-3866	140	17	(	(	PUNCT
fnp-3866	140	18	lbd	lbd	PROPN
fnp-3866	140	19	)	)	PUNCT
fnp-3866	140	20	pathology	pathology	NOUN
fnp-3866	140	21	includes	include	VERB
fnp-3866	140	22	parkinson	parkinson	NOUN
fnp-3866	140	23	’s	’s	PART
fnp-3866	140	24	disease	disease	NOUN
fnp-3866	140	25	(	(	PUNCT
fnp-3866	140	26	pd	pd	NOUN
fnp-3866	140	27	)	)	PUNCT
fnp-3866	140	28	,	,	PUNCT
fnp-3866	140	29	dementia	dementia	NOUN
fnp-3866	140	30	with	with	ADP
fnp-3866	140	31	lewy	lewy	ADJ
fnp-3866	140	32	bodies	body	NOUN
fnp-3866	140	33	(	(	PUNCT
fnp-3866	140	34	dlb	dlb	NOUN
fnp-3866	140	35	)	)	PUNCT
fnp-3866	140	36	and	and	CCONJ
fnp-3866	140	37	pd	pd	PROPN
fnp-3866	140	38	with	with	ADP
fnp-3866	140	39	mild	mild	ADJ
fnp-3866	140	40	cognitive	cognitive	ADJ
fnp-3866	140	41	impairment	impairment	NOUN
fnp-3866	140	42	or	or	CCONJ
fnp-3866	140	43	dementia	dementia	NOUN
fnp-3866	140	44	.	.	PUNCT
fnp-3866	141	1	currently	currently	ADV
fnp-3866	141	2	,	,	PUNCT
fnp-3866	141	3	a	a	DET
fnp-3866	141	4	neuropathological	neuropathological	ADJ
fnp-3866	141	5	diagnosis	diagnosis	NOUN
fnp-3866	141	6	of	of	ADP
fnp-3866	141	7	lewy	lewy	ADJ
fnp-3866	141	8	body	body	NOUN
fnp-3866	141	9	disease	disease	NOUN
fnp-3866	141	10	can	can	AUX
fnp-3866	141	11	be	be	AUX
fnp-3866	141	12	rendered	render	VERB
fnp-3866	141	13	using	use	VERB
fnp-3866	141	14	any	any	PRON
fnp-3866	141	15	of	of	ADP
fnp-3866	141	16	four	four	NUM
fnp-3866	141	17	different	different	ADJ
fnp-3866	141	18	proposed	propose	VERB
fnp-3866	141	19	systems	system	NOUN
fnp-3866	141	20	(	(	PUNCT
fnp-3866	141	21	adler	adler	PROPN
fnp-3866	141	22	et	et	PROPN
fnp-3866	141	23	al	al	PROPN
fnp-3866	141	24	.	.	PROPN
fnp-3866	141	25	,	,	PUNCT
fnp-3866	141	26	2019	2019	NUM
fnp-3866	141	27	;	;	PUNCT
fnp-3866	141	28	braak	braak	PROPN
fnp-3866	141	29	et	et	PROPN
fnp-3866	141	30	al	al	PROPN
fnp-3866	141	31	.	.	PROPN
fnp-3866	141	32	,	,	PUNCT
fnp-3866	141	33	2003	2003	NUM
fnp-3866	141	34	;	;	PUNCT
fnp-3866	141	35	leverenz	leverenz	NOUN
fnp-3866	141	36	et	et	PROPN
fnp-3866	141	37	al	al	PROPN
fnp-3866	141	38	.	.	PROPN
fnp-3866	141	39	,	,	PUNCT
fnp-3866	141	40	2008	2008	NUM
fnp-3866	141	41	;	;	PUNCT
fnp-3866	141	42	mckeith	mckeith	PROPN
fnp-3866	141	43	et	et	PROPN
fnp-3866	141	44	al	al	PROPN
fnp-3866	141	45	.	.	PROPN
fnp-3866	141	46	,	,	PUNCT
fnp-3866	141	47	2005	2005	NUM
fnp-3866	141	48	)	)	PUNCT
fnp-3866	141	49	.	.	PUNCT
fnp-3866	142	1	all	all	PRON
fnp-3866	142	2	use	use	VERB
fnp-3866	142	3	semi	semi	ADJ
fnp-3866	142	4	-	-	ADJ
fnp-3866	142	5	quantitative	quantitative	ADJ
fnp-3866	142	6	assessment	assessment	NOUN
fnp-3866	142	7	of	of	ADP
fnp-3866	142	8	the	the	DET
fnp-3866	142	9	neuroanatomical	neuroanatomical	ADJ
fnp-3866	142	10	distribution	distribution	NOUN
fnp-3866	142	11	of	of	ADP
fnp-3866	142	12	lewy	lewy	PROPN
fnp-3866	142	13	pathology	pathology	PROPN
fnp-3866	142	14	in	in	ADP
fnp-3866	142	15	neurites	neurite	NOUN
fnp-3866	142	16	and	and	CCONJ
fnp-3866	142	17	cell	cell	NOUN
fnp-3866	142	18	bodies	body	NOUN
fnp-3866	142	19	,	,	PUNCT
fnp-3866	142	20	but	but	CCONJ
fnp-3866	142	21	each	each	PRON
fnp-3866	142	22	has	have	VERB
fnp-3866	142	23	specific	specific	ADJ
fnp-3866	142	24	strengths	strength	NOUN
fnp-3866	142	25	and	and	CCONJ
fnp-3866	142	26	weaknesses	weakness	NOUN
fnp-3866	142	27	.	.	PUNCT
fnp-3866	143	1	each	each	DET
fnp-3866	143	2	system	system	NOUN
fnp-3866	143	3	suffers	suffer	VERB
fnp-3866	143	4	from	from	ADP
fnp-3866	143	5	issues	issue	NOUN
fnp-3866	143	6	related	relate	VERB
fnp-3866	143	7	to	to	ADP
fnp-3866	143	8	interrater	interrater	VERB
fnp-3866	143	9	reliability	reliability	NOUN
fnp-3866	143	10	and/or	and/or	CCONJ
fnp-3866	143	11	the	the	DET
fnp-3866	143	12	inability	inability	NOUN
fnp-3866	143	13	to	to	PART
fnp-3866	143	14	classify	classify	VERB
fnp-3866	143	15	certain	certain	ADJ
fnp-3866	143	16	cases	case	NOUN
fnp-3866	143	17	with	with	ADP
fnp-3866	143	18	lewy	lewy	ADJ
fnp-3866	143	19	pathology	pathology	PROPN
fnp-3866	143	20	(	(	PUNCT
fnp-3866	143	21	lp	lp	NOUN
fnp-3866	143	22	)	)	PUNCT
fnp-3866	143	23	,	,	PUNCT
fnp-3866	143	24	for	for	ADP
fnp-3866	143	25	example	example	NOUN
fnp-3866	143	26	cases	case	NOUN
fnp-3866	143	27	with	with	ADP
fnp-3866	143	28	olfactory	olfactory	ADJ
fnp-3866	143	29	bulb	bulb	NOUN
fnp-3866	143	30	-	-	PUNCT
fnp-3866	143	31	only	only	ADV
fnp-3866	143	32	or	or	CCONJ
fnp-3866	143	33	amygdala	amygdala	NOUN
fnp-3866	143	34	-	-	PUNCT
fnp-3866	143	35	only	only	ADJ
fnp-3866	143	36	disease	disease	NOUN
fnp-3866	143	37	.	.	PUNCT
fnp-3866	144	1	this	this	PRON
fnp-3866	144	2	stems	stem	VERB
fnp-3866	144	3	from	from	ADP
fnp-3866	144	4	the	the	DET
fnp-3866	144	5	heterogenous	heterogenous	ADJ
fnp-3866	144	6	pathoanatomical	pathoanatomical	ADJ
fnp-3866	144	7	distribution	distribution	NOUN
fnp-3866	144	8	of	of	ADP
fnp-3866	144	9	lp	lp	NOUN
fnp-3866	144	10	.	.	PUNCT
fnp-3866	145	1	in	in	ADP
fnp-3866	145	2	2021	2021	NUM
fnp-3866	145	3	,	,	PUNCT
fnp-3866	145	4	new	new	ADJ
fnp-3866	145	5	neuropathological	neuropathological	ADJ
fnp-3866	145	6	consensus	consensus	NOUN
fnp-3866	145	7	criteria	criterion	NOUN
fnp-3866	145	8	that	that	PRON
fnp-3866	145	9	aim	aim	VERB
fnp-3866	145	10	to	to	PART
fnp-3866	145	11	address	address	VERB
fnp-3866	145	12	the	the	DET
fnp-3866	145	13	limitations	limitation	NOUN
fnp-3866	145	14	of	of	ADP
fnp-3866	145	15	these	these	DET
fnp-3866	145	16	systems	system	NOUN
fnp-3866	145	17	,	,	PUNCT
fnp-3866	145	18	termed	term	VERB
fnp-3866	145	19	the	the	DET
fnp-3866	145	20	lp	lp	PROPN
fnp-3866	145	21	consensus	consensus	NOUN
fnp-3866	145	22	criteria	criterion	NOUN
fnp-3866	145	23	(	(	PUNCT
fnp-3866	145	24	lpc	lpc	PROPN
fnp-3866	145	25	)	)	PUNCT
fnp-3866	145	26	,	,	PUNCT
fnp-3866	145	27	were	be	AUX
fnp-3866	145	28	developed	develop	VERB
fnp-3866	145	29	and	and	CCONJ
fnp-3866	145	30	published	publish	VERB
fnp-3866	145	31	in	in	ADP
fnp-3866	145	32	acta	acta	PROPN
fnp-3866	145	33	neuropathologica	neuropathologica	PROPN
fnp-3866	145	34	in	in	ADP
fnp-3866	145	35	order	order	NOUN
fnp-3866	145	36	to	to	PART
fnp-3866	145	37	improve	improve	VERB
fnp-3866	145	38	interrater	interrater	ADJ
fnp-3866	145	39	reliability	reliability	NOUN
fnp-3866	145	40	and	and	CCONJ
fnp-3866	145	41	to	to	PART
fnp-3866	145	42	unequivocally	unequivocally	ADV
fnp-3866	145	43	classify	classify	VERB
fnp-3866	145	44	all	all	DET
fnp-3866	145	45	possible	possible	ADJ
fnp-3866	145	46	cases	case	NOUN
fnp-3866	145	47	with	with	ADP
fnp-3866	145	48	lp	lp	PROPN
fnp-3866	145	49	(	(	PUNCT
fnp-3866	145	50	attems	attem	NOUN
fnp-3866	145	51	et	et	NOUN
fnp-3866	145	52	al	al	PROPN
fnp-3866	145	53	.	.	PROPN
fnp-3866	145	54	,	,	PUNCT
fnp-3866	145	55	2021	2021	NUM
fnp-3866	145	56	)	)	PUNCT
fnp-3866	145	57	.	.	PUNCT
fnp-3866	146	1	to	to	PART
fnp-3866	146	2	improve	improve	VERB
fnp-3866	146	3	inter	inter	ADJ
fnp-3866	146	4	-	-	ADJ
fnp-3866	146	5	rater	rater	ADJ
fnp-3866	146	6	reliability	reliability	NOUN
fnp-3866	146	7	,	,	PUNCT
fnp-3866	146	8	the	the	DET
fnp-3866	146	9	authors	author	NOUN
fnp-3866	146	10	implemented	implement	VERB
fnp-3866	146	11	a	a	DET
fnp-3866	146	12	dichotomized	dichotomize	VERB
fnp-3866	146	13	scoring	scoring	NOUN
fnp-3866	146	14	system	system	NOUN
fnp-3866	146	15	,	,	PUNCT
fnp-3866	146	16	with	with	ADP
fnp-3866	146	17	lp	lp	ADV
fnp-3866	146	18	scored	score	VERB
fnp-3866	146	19	as	as	ADP
fnp-3866	146	20	either	either	CCONJ
fnp-3866	146	21	present	present	ADJ
fnp-3866	146	22	or	or	CCONJ
fnp-3866	146	23	absent	absent	ADJ
fnp-3866	146	24	.	.	PUNCT
fnp-3866	147	1	the	the	DET
fnp-3866	147	2	diagnostic	diagnostic	ADJ
fnp-3866	147	3	categories	category	NOUN
fnp-3866	147	4	were	be	AUX
fnp-3866	147	5	:	:	PUNCT
fnp-3866	147	6	olfactory	olfactory	ADJ
fnp-3866	147	7	-	-	PUNCT
fnp-3866	147	8	only	only	ADV
fnp-3866	147	9	,	,	PUNCT
fnp-3866	147	10	amygdala	amygdala	NOUN
fnp-3866	147	11	-	-	PUNCT
fnp-3866	147	12	predominant	predominant	ADJ
fnp-3866	147	13	,	,	PUNCT
fnp-3866	147	14	brainstem	brainstem	NOUN
fnp-3866	147	15	,	,	PUNCT
fnp-3866	147	16	limbic	limbic	NOUN
fnp-3866	147	17	,	,	PUNCT
fnp-3866	147	18	and	and	CCONJ
fnp-3866	147	19	neocortical	neocortical	ADJ
fnp-3866	147	20	lp	lp	NOUN
fnp-3866	147	21	.	.	PUNCT
fnp-3866	148	1	the	the	DET
fnp-3866	148	2	16	16	NUM
fnp-3866	148	3	raters	rater	NOUN
fnp-3866	148	4	from	from	ADP
fnp-3866	148	5	13	13	NUM
fnp-3866	148	6	centers	center	NOUN
fnp-3866	148	7	applied	apply	VERB
fnp-3866	148	8	the	the	DET
fnp-3866	148	9	lpc	lpc	PROPN
fnp-3866	148	10	and	and	CCONJ
fnp-3866	148	11	each	each	PRON
fnp-3866	148	12	of	of	ADP
fnp-3866	148	13	the	the	DET
fnp-3866	148	14	four	four	NUM
fnp-3866	148	15	existing	exist	VERB
fnp-3866	148	16	systems	system	NOUN
fnp-3866	148	17	to	to	ADP
fnp-3866	148	18	34	34	NUM
fnp-3866	148	19	cases	case	NOUN
fnp-3866	148	20	with	with	ADP
fnp-3866	148	21	lp	lp	NOUN
fnp-3866	148	22	from	from	ADP
fnp-3866	148	23	the	the	DET
fnp-3866	148	24	newcastle	newcastle	PROPN
fnp-3866	148	25	brain	brain	NOUN
fnp-3866	148	26	tissue	tissue	NOUN
fnp-3866	148	27	resource	resource	NOUN
fnp-3866	148	28	and	and	CCONJ
fnp-3866	148	29	the	the	DET
fnp-3866	148	30	university	university	PROPN
fnp-3866	148	31	of	of	ADP
fnp-3866	148	32	pennsylvania	pennsylvania	PROPN
fnp-3866	148	33	brain	brain	PROPN
fnp-3866	148	34	bank	bank	PROPN
fnp-3866	148	35	.	.	PUNCT
fnp-3866	149	1	interrater	interrater	PROPN
fnp-3866	149	2	reliability	reliability	NOUN
fnp-3866	149	3	was	be	AUX
fnp-3866	149	4	good	good	ADJ
fnp-3866	149	5	for	for	ADP
fnp-3866	149	6	the	the	DET
fnp-3866	149	7	lpc	lpc	PROPN
fnp-3866	149	8	,	,	PUNCT
fnp-3866	149	9	being	be	AUX
fnp-3866	149	10	comparable	comparable	ADJ
fnp-3866	149	11	to	to	ADP
fnp-3866	149	12	the	the	DET
fnp-3866	149	13	mckeith	mckeith	PROPN
fnp-3866	149	14	and	and	CCONJ
fnp-3866	149	15	leverenz	leverenz	NOUN
fnp-3866	149	16	system	system	NOUN
fnp-3866	149	17	(	(	PUNCT
fnp-3866	149	18	krippendorff	krippendorff	NOUN
fnp-3866	149	19	’s	’s	PART
fnp-3866	149	20	alpha	alpha	NOUN
fnp-3866	149	21	≈	≈	PROPN
fnp-3866	149	22	0.6	0.6	NUM
fnp-3866	149	23	)	)	PUNCT
fnp-3866	149	24	,	,	PUNCT
fnp-3866	149	25	and	and	CCONJ
fnp-3866	149	26	considerably	considerably	ADV
fnp-3866	149	27	better	well	ADV
fnp-3866	149	28	than	than	ADP
fnp-3866	149	29	for	for	ADP
fnp-3866	149	30	braak	braak	NOUN
fnp-3866	149	31	and	and	CCONJ
fnp-3866	149	32	adler	adler	PROPN
fnp-3866	149	33	(	(	PUNCT
fnp-3866	149	34	beach	beach	NOUN
fnp-3866	149	35	)	)	PUNCT
fnp-3866	149	36	.	.	PUNCT
fnp-3866	150	1	the	the	DET
fnp-3866	150	2	lpc	lpc	PROPN
fnp-3866	150	3	system	system	NOUN
fnp-3866	150	4	was	be	AUX
fnp-3866	150	5	as	as	ADV
fnp-3866	150	6	applicable	applicable	ADJ
fnp-3866	150	7	as	as	ADP
fnp-3866	150	8	the	the	DET
fnp-3866	150	9	beach	beach	NOUN
fnp-3866	150	10	system	system	NOUN
fnp-3866	150	11	and	and	CCONJ
fnp-3866	150	12	able	able	ADJ
fnp-3866	150	13	to	to	PART
fnp-3866	150	14	unequivocally	unequivocally	ADV
fnp-3866	150	15	classify	classify	VERB
fnp-3866	150	16	essentially	essentially	ADV
fnp-3866	150	17	all	all	DET
fnp-3866	150	18	cases	case	NOUN
fnp-3866	150	19	,	,	PUNCT
fnp-3866	150	20	which	which	PRON
fnp-3866	150	21	was	be	AUX
fnp-3866	150	22	not	not	PART
fnp-3866	150	23	the	the	DET
fnp-3866	150	24	case	case	NOUN
fnp-3866	150	25	for	for	ADP
fnp-3866	150	26	the	the	DET
fnp-3866	150	27	leverenz	leverenz	NOUN
fnp-3866	150	28	,	,	PUNCT
fnp-3866	150	29	mckeith	mckeith	NOUN
fnp-3866	150	30	and	and	CCONJ
fnp-3866	150	31	braak	braak	PROPN
fnp-3866	150	32	systems	system	NOUN
fnp-3866	150	33	which	which	PRON
fnp-3866	150	34	failed	fail	VERB
fnp-3866	150	35	in	in	ADP
fnp-3866	150	36	10	10	NUM
fnp-3866	150	37	%	%	NOUN
fnp-3866	150	38	,	,	PUNCT
fnp-3866	150	39	25	25	NUM
fnp-3866	150	40	%	%	NOUN
fnp-3866	150	41	and	and	CCONJ
fnp-3866	150	42	nearly	nearly	ADV
fnp-3866	150	43	30	30	NUM
fnp-3866	150	44	%	%	NOUN
fnp-3866	150	45	of	of	ADP
fnp-3866	150	46	cases	case	NOUN
fnp-3866	150	47	respectively	respectively	ADV
fnp-3866	150	48	.	.	PUNCT
fnp-3866	151	1	given	give	VERB
fnp-3866	151	2	the	the	DET
fnp-3866	151	3	reliability	reliability	NOUN
fnp-3866	151	4	and	and	CCONJ
fnp-3866	151	5	applicability	applicability	NOUN
fnp-3866	151	6	of	of	ADP
fnp-3866	151	7	the	the	DET
fnp-3866	151	8	lpc	lpc	PROPN
fnp-3866	151	9	system	system	NOUN
fnp-3866	151	10	,	,	PUNCT
fnp-3866	151	11	we	we	PRON
fnp-3866	151	12	expect	expect	VERB
fnp-3866	151	13	that	that	SCONJ
fnp-3866	151	14	it	it	PRON
fnp-3866	151	15	will	will	AUX
fnp-3866	151	16	be	be	AUX
fnp-3866	151	17	adopted	adopt	VERB
fnp-3866	151	18	broadly	broadly	ADV
fnp-3866	151	19	in	in	ADP
fnp-3866	151	20	the	the	DET
fnp-3866	151	21	post	post	ADJ
fnp-3866	151	22	-	-	ADJ
fnp-3866	151	23	mortem	mortem	ADJ
fnp-3866	151	24	evaluation	evaluation	NOUN
fnp-3866	151	25	of	of	ADP
fnp-3866	151	26	cases	case	NOUN
fnp-3866	151	27	with	with	ADP
fnp-3866	151	28	lewy	lewy	ADJ
fnp-3866	151	29	body	body	NOUN
fnp-3866	151	30	pathology	pathology	NOUN
fnp-3866	151	31	.	.	PUNCT
fnp-3866	152	1	10	10	NUM
fnp-3866	152	2	.	.	PUNCT
fnp-3866	152	3	long	long	ADV
fnp-3866	152	4	-	-	PUNCT
fnp-3866	152	5	covid	covid	NOUN
fnp-3866	152	6	intersecting	intersecting	NOUN
fnp-3866	152	7	with	with	ADP
fnp-3866	152	8	neurodegeneration	neurodegeneration	NOUN
fnp-3866	152	9	during	during	ADP
fnp-3866	152	10	the	the	DET
fnp-3866	152	11	covid-19	covid-19	PROPN
fnp-3866	152	12	pandemic	pandemic	NOUN
fnp-3866	152	13	,	,	PUNCT
fnp-3866	152	14	a	a	DET
fnp-3866	152	15	number	number	NOUN
fnp-3866	152	16	of	of	ADP
fnp-3866	152	17	neuropathological	neuropathological	ADJ
fnp-3866	152	18	studies	study	NOUN
fnp-3866	152	19	addressed	address	VERB
fnp-3866	152	20	the	the	DET
fnp-3866	152	21	changes	change	NOUN
fnp-3866	152	22	in	in	ADP
fnp-3866	152	23	the	the	DET
fnp-3866	152	24	human	human	ADJ
fnp-3866	152	25	brain	brain	NOUN
fnp-3866	152	26	from	from	ADP
fnp-3866	152	27	patients	patient	NOUN
fnp-3866	152	28	succumbing	succumb	VERB
fnp-3866	152	29	to	to	ADP
fnp-3866	152	30	acute	acute	VERB
fnp-3866	152	31	sars	sar	NOUN
fnp-3866	152	32	-	-	PUNCT
fnp-3866	152	33	cov-2	cov-2	NOUN
fnp-3866	152	34	infection	infection	NOUN
fnp-3866	152	35	.	.	PUNCT
fnp-3866	153	1	microthrombi	microthrombi	NOUN
fnp-3866	153	2	and	and	CCONJ
fnp-3866	153	3	strokes	stroke	NOUN
fnp-3866	153	4	were	be	AUX
fnp-3866	153	5	among	among	ADP
fnp-3866	153	6	the	the	DET
fnp-3866	153	7	most	most	ADV
fnp-3866	153	8	common	common	ADJ
fnp-3866	153	9	findings	finding	NOUN
fnp-3866	153	10	together	together	ADV
fnp-3866	153	11	with	with	ADP
fnp-3866	153	12	indirect	indirect	ADJ
fnp-3866	153	13	inflammatory	inflammatory	ADJ
fnp-3866	153	14	and	and	CCONJ
fnp-3866	153	15	autoimmune	autoimmune	ADJ
fnp-3866	153	16	changes	change	NOUN
fnp-3866	153	17	but	but	CCONJ
fnp-3866	153	18	encephalitis	encephalitis	NOUN
fnp-3866	153	19	was	be	AUX
fnp-3866	153	20	rare	rare	ADJ
fnp-3866	153	21	.	.	PUNCT
fnp-3866	154	1	after	after	ADP
fnp-3866	154	2	the	the	DET
fnp-3866	154	3	peak	peak	NOUN
fnp-3866	154	4	of	of	ADP
fnp-3866	154	5	the	the	DET
fnp-3866	154	6	pandemic	pandemic	ADJ
fnp-3866	154	7	,	,	PUNCT
fnp-3866	154	8	roughly	roughly	ADV
fnp-3866	154	9	one	one	NUM
fnp-3866	154	10	third	third	NOUN
fnp-3866	154	11	of	of	ADP
fnp-3866	154	12	patients	patient	NOUN
fnp-3866	154	13	emerged	emerge	VERB
fnp-3866	154	14	with	with	ADP
fnp-3866	154	15	a	a	DET
fnp-3866	154	16	clinical	clinical	ADJ
fnp-3866	154	17	syndrom	syndrom	NOUN
fnp-3866	154	18	often	often	ADV
fnp-3866	154	19	termed	term	VERB
fnp-3866	154	20	post	post	ADJ
fnp-3866	154	21	-	-	ADJ
fnp-3866	154	22	acute	acute	ADJ
fnp-3866	154	23	sequelae	sequelae	NOUN
fnp-3866	154	24	of	of	ADP
fnp-3866	154	25	sars	sar	NOUN
fnp-3866	154	26	-	-	PUNCT
fnp-3866	154	27	cov-2	cov-2	PART
fnp-3866	154	28	infection	infection	NOUN
fnp-3866	154	29	(	(	PUNCT
fnp-3866	154	30	pasc	pasc	NOUN
fnp-3866	154	31	)	)	PUNCT
fnp-3866	154	32	and	and	CCONJ
fnp-3866	154	33	commonly	commonly	ADV
fnp-3866	154	34	referred	refer	VERB
fnp-3866	154	35	to	to	ADP
fnp-3866	154	36	as	as	ADP
fnp-3866	154	37	“	"	PUNCT
fnp-3866	154	38	long	long	ADJ
fnp-3866	154	39	-	-	PUNCT
fnp-3866	154	40	covid	covid	NOUN
fnp-3866	154	41	"	"	PUNCT
fnp-3866	154	42	.	.	PUNCT
fnp-3866	155	1	cardiac	cardiac	ADJ
fnp-3866	155	2	and	and	CCONJ
fnp-3866	155	3	pulmonary	pulmonary	ADJ
fnp-3866	155	4	symptoms	symptom	NOUN
fnp-3866	155	5	are	be	AUX
fnp-3866	155	6	prominent	prominent	ADJ
fnp-3866	155	7	in	in	ADP
fnp-3866	155	8	pasc	pasc	PROPN
fnp-3866	155	9	but	but	CCONJ
fnp-3866	155	10	there	there	PRON
fnp-3866	155	11	are	be	VERB
fnp-3866	155	12	also	also	ADV
fnp-3866	155	13	many	many	ADJ
fnp-3866	155	14	alarming	alarming	ADJ
fnp-3866	155	15	non	non	ADJ
fnp-3866	155	16	-	-	ADJ
fnp-3866	155	17	specific	specific	ADJ
fnp-3866	155	18	neurological	neurological	ADJ
fnp-3866	155	19	and	and	CCONJ
fnp-3866	155	20	psychiatric	psychiatric	ADJ
fnp-3866	155	21	symptoms	symptom	NOUN
fnp-3866	155	22	including	include	VERB
fnp-3866	155	23	fatigue	fatigue	NOUN
fnp-3866	155	24	,	,	PUNCT
fnp-3866	155	25	cognitive	cognitive	ADJ
fnp-3866	155	26	complaints	complaint	NOUN
fnp-3866	155	27	(	(	PUNCT
fnp-3866	155	28	“	"	PUNCT
fnp-3866	155	29	brain	brain	NOUN
fnp-3866	155	30	fog	fog	NOUN
fnp-3866	155	31	"	"	PUNCT
fnp-3866	155	32	)	)	PUNCT
fnp-3866	155	33	,	,	PUNCT
fnp-3866	155	34	sensorimotor	sensorimotor	NOUN
fnp-3866	155	35	defects	defect	NOUN
fnp-3866	155	36	,	,	PUNCT
fnp-3866	155	37	headaches	headache	NOUN
fnp-3866	155	38	,	,	PUNCT
fnp-3866	155	39	insomnia	insomnia	NOUN
fnp-3866	155	40	,	,	PUNCT
fnp-3866	155	41	depression	depression	NOUN
fnp-3866	155	42	,	,	PUNCT
fnp-3866	155	43	and	and	CCONJ
fnp-3866	155	44	post	post	ADJ
fnp-3866	155	45	-	-	ADJ
fnp-3866	155	46	traumatic	traumatic	ADJ
fnp-3866	155	47	stress	stress	NOUN
fnp-3866	155	48	disorder	disorder	NOUN
fnp-3866	155	49	(	(	PUNCT
fnp-3866	155	50	taquet	taquet	NOUN
fnp-3866	155	51	et	et	PROPN
fnp-3866	155	52	al	al	PROPN
fnp-3866	155	53	.	.	PROPN
fnp-3866	155	54	,	,	PUNCT
fnp-3866	155	55	2021	2021	NUM
fnp-3866	155	56	)	)	PUNCT
fnp-3866	155	57	.	.	PUNCT
fnp-3866	156	1	a	a	DET
fnp-3866	156	2	meta	meta	ADJ
fnp-3866	156	3	analysis	analysis	NOUN
fnp-3866	156	4	confirmed	confirm	VERB
fnp-3866	156	5	decreased	decrease	VERB
fnp-3866	156	6	cognitive	cognitive	ADJ
fnp-3866	156	7	function	function	NOUN
fnp-3866	156	8	seven	seven	NUM
fnp-3866	156	9	months	month	NOUN
fnp-3866	156	10	following	follow	VERB
fnp-3866	156	11	covid-19	covid-19	PROPN
fnp-3866	156	12	infection	infection	NOUN
fnp-3866	156	13	(	(	PUNCT
fnp-3866	156	14	crivelli	crivelli	PROPN
fnp-3866	156	15	et	et	PROPN
fnp-3866	156	16	al	al	PROPN
fnp-3866	156	17	.	.	PROPN
fnp-3866	156	18	,	,	PUNCT
fnp-3866	156	19	2022	2022	NUM
fnp-3866	156	20	)	)	PUNCT
fnp-3866	156	21	.	.	PUNCT
fnp-3866	157	1	pasc	pasc	PROPN
fnp-3866	157	2	has	have	AUX
fnp-3866	157	3	drawn	draw	VERB
fnp-3866	157	4	attention	attention	NOUN
fnp-3866	157	5	in	in	ADP
fnp-3866	157	6	the	the	DET
fnp-3866	157	7	field	field	NOUN
fnp-3866	157	8	of	of	ADP
fnp-3866	157	9	neurodegeneration	neurodegeneration	NOUN
fnp-3866	157	10	given	give	VERB
fnp-3866	157	11	the	the	DET
fnp-3866	157	12	possibility	possibility	NOUN
fnp-3866	157	13	that	that	SCONJ
fnp-3866	157	14	infection	infection	NOUN
fnp-3866	157	15	with	with	ADP
fnp-3866	157	16	the	the	DET
fnp-3866	157	17	virus	virus	NOUN
fnp-3866	157	18	may	may	AUX
fnp-3866	157	19	trigger	trigger	VERB
fnp-3866	157	20	a	a	DET
fnp-3866	157	21	long	long	ADJ
fnp-3866	157	22	-	-	PUNCT
fnp-3866	157	23	term	term	NOUN
fnp-3866	157	24	neurodegenerative	neurodegenerative	ADJ
fnp-3866	157	25	process	process	NOUN
fnp-3866	157	26	(	(	PUNCT
fnp-3866	157	27	lennon	lennon	PROPN
fnp-3866	157	28	,	,	PUNCT
fnp-3866	157	29	2020	2020	NUM
fnp-3866	157	30	)	)	PUNCT
fnp-3866	157	31	.	.	PUNCT
fnp-3866	158	1	the	the	DET
fnp-3866	158	2	mechanisms	mechanism	NOUN
fnp-3866	158	3	whereby	whereby	SCONJ
fnp-3866	158	4	pasc	pasc	PROPN
fnp-3866	158	5	may	may	AUX
fnp-3866	158	6	be	be	AUX
fnp-3866	158	7	linked	link	VERB
fnp-3866	158	8	to	to	ADP
fnp-3866	158	9	neurodegeneration	neurodegeneration	NOUN
fnp-3866	158	10	remained	remain	VERB
fnp-3866	158	11	however	however	ADV
fnp-3866	158	12	elusive	elusive	ADJ
fnp-3866	158	13	.	.	PUNCT
fnp-3866	159	1	many	many	ADJ
fnp-3866	159	2	investigators	investigator	NOUN
fnp-3866	159	3	have	have	AUX
fnp-3866	159	4	raised	raise	VERB
fnp-3866	159	5	the	the	DET
fnp-3866	159	6	questions	question	NOUN
fnp-3866	159	7	as	as	ADP
fnp-3866	159	8	to	to	ADP
fnp-3866	159	9	whether	whether	SCONJ
fnp-3866	159	10	sars	sar	NOUN
fnp-3866	159	11	-	-	PUNCT
fnp-3866	159	12	cov-2	cov-2	PART
fnp-3866	159	13	can	can	AUX
fnp-3866	159	14	cause	cause	VERB
fnp-3866	159	15	neurodegeneration	neurodegeneration	NOUN
fnp-3866	159	16	through	through	ADP
fnp-3866	159	17	its	its	PRON
fnp-3866	159	18	neurotropism	neurotropism	NOUN
fnp-3866	159	19	or	or	CCONJ
fnp-3866	159	20	otherwise	otherwise	ADV
fnp-3866	159	21	(	(	PUNCT
fnp-3866	159	22	krey	krey	PROPN
fnp-3866	159	23	et	et	PROPN
fnp-3866	159	24	al	al	PROPN
fnp-3866	159	25	.	.	PROPN
fnp-3866	159	26	,	,	PUNCT
fnp-3866	159	27	2021	2021	NUM
fnp-3866	159	28	)	)	PUNCT
fnp-3866	159	29	.	.	PUNCT
fnp-3866	160	1	some	some	DET
fnp-3866	160	2	investigators	investigator	NOUN
fnp-3866	160	3	have	have	AUX
fnp-3866	160	4	proposed	propose	VERB
fnp-3866	160	5	that	that	SCONJ
fnp-3866	160	6	sars	sar	NOUN
fnp-3866	160	7	-	-	PUNCT
fnp-3866	160	8	cov-2	cov-2	PART
fnp-3866	160	9	enters	enter	VERB
fnp-3866	160	10	the	the	DET
fnp-3866	160	11	brain	brain	NOUN
fnp-3866	160	12	and	and	CCONJ
fnp-3866	160	13	may	may	AUX
fnp-3866	160	14	activate	activate	VERB
fnp-3866	160	15	an	an	DET
fnp-3866	160	16	ad	ad	NOUN
fnp-3866	160	17	-	-	PUNCT
fnp-3866	160	18	like	like	ADJ
fnp-3866	160	19	program	program	NOUN
fnp-3866	160	20	(	(	PUNCT
fnp-3866	160	21	shen	shen	PROPN
fnp-3866	160	22	et	et	PROPN
fnp-3866	160	23	al	al	PROPN
fnp-3866	160	24	.	.	PROPN
fnp-3866	160	25	,	,	PUNCT
fnp-3866	160	26	2022	2022	NUM
fnp-3866	160	27	)	)	PUNCT
fnp-3866	160	28	.	.	PUNCT
fnp-3866	161	1	the	the	DET
fnp-3866	161	2	ace2	ace2	PROPN
fnp-3866	161	3	covid-19	covid-19	PROPN
fnp-3866	161	4	receptor	receptor	NOUN
fnp-3866	161	5	was	be	AUX
fnp-3866	161	6	indeed	indeed	ADV
fnp-3866	161	7	shown	show	VERB
fnp-3866	161	8	to	to	PART
fnp-3866	161	9	be	be	AUX
fnp-3866	161	10	upregulated	upregulate	VERB
fnp-3866	161	11	in	in	ADP
fnp-3866	161	12	the	the	DET
fnp-3866	161	13	hippocampal	hippocampal	ADJ
fnp-3866	161	14	formation	formation	NOUN
fnp-3866	161	15	of	of	ADP
fnp-3866	161	16	ad	ad	NOUN
fnp-3866	161	17	patients	patient	NOUN
fnp-3866	161	18	(	(	PUNCT
fnp-3866	161	19	zhao	zhao	PROPN
fnp-3866	161	20	et	et	PROPN
fnp-3866	161	21	al	al	PROPN
fnp-3866	161	22	.	.	PROPN
fnp-3866	161	23	,	,	PUNCT
fnp-3866	161	24	2021	2021	NUM
fnp-3866	161	25	)	)	PUNCT
fnp-3866	161	26	,	,	PUNCT
fnp-3866	161	27	which	which	PRON
fnp-3866	161	28	may	may	AUX
fnp-3866	161	29	explain	explain	VERB
fnp-3866	161	30	why	why	SCONJ
fnp-3866	161	31	medial	medial	ADJ
fnp-3866	161	32	temporal	temporal	ADJ
fnp-3866	161	33	lobe	lobe	NOUN
fnp-3866	161	34	structures	structure	NOUN
fnp-3866	161	35	might	might	AUX
fnp-3866	161	36	be	be	AUX
fnp-3866	161	37	vulnerable	vulnerable	ADJ
fnp-3866	161	38	,	,	PUNCT
fnp-3866	161	39	potentially	potentially	ADV
fnp-3866	161	40	contributing	contribute	VERB
fnp-3866	161	41	to	to	ADP
fnp-3866	161	42	some	some	DET
fnp-3866	161	43	post	post	ADJ
fnp-3866	161	44	-	-	ADJ
fnp-3866	161	45	infection	infection	ADJ
fnp-3866	161	46	memory	memory	NOUN
fnp-3866	161	47	impairment	impairment	NOUN
fnp-3866	161	48	and	and	CCONJ
fnp-3866	161	49	neurodegeneration	neurodegeneration	NOUN
fnp-3866	161	50	(	(	PUNCT
fnp-3866	161	51	ritchie	ritchie	PROPN
fnp-3866	161	52	et	et	PROPN
fnp-3866	161	53	al	al	PROPN
fnp-3866	161	54	.	.	PROPN
fnp-3866	161	55	,	,	PUNCT
fnp-3866	161	56	2020	2020	NUM
fnp-3866	161	57	)	)	PUNCT
fnp-3866	161	58	.	.	PUNCT
fnp-3866	162	1	notably	notably	ADV
fnp-3866	162	2	,	,	PUNCT
fnp-3866	162	3	signaling	signal	VERB
fnp-3866	162	4	pathways	pathway	NOUN
fnp-3866	162	5	leading	lead	VERB
fnp-3866	162	6	to	to	ADP
fnp-3866	162	7	tau	tau	PROPN
fnp-3866	162	8	hyperphosphorylation	hyperphosphorylation	NOUN
fnp-3866	162	9	in	in	ADP
fnp-3866	162	10	ad	ad	NOUN
fnp-3866	162	11	including	include	VERB
fnp-3866	162	12	gsk3β	gsk3β	PROPN
fnp-3866	162	13	may	may	AUX
fnp-3866	162	14	be	be	AUX
fnp-3866	162	15	activated	activate	VERB
fnp-3866	162	16	in	in	ADP
fnp-3866	162	17	post	post	ADJ
fnp-3866	162	18	-	-	ADJ
fnp-3866	162	19	mortem	mortem	ADJ
fnp-3866	162	20	covid-19	covid-19	PROPN
fnp-3866	162	21	brains	brain	NOUN
fnp-3866	162	22	(	(	PUNCT
fnp-3866	162	23	reiken	reiken	VERB
fnp-3866	162	24	et	et	PROPN
fnp-3866	162	25	al	al	PROPN
fnp-3866	162	26	.	.	PROPN
fnp-3866	162	27	,	,	PUNCT
fnp-3866	162	28	2022	2022	NUM
fnp-3866	162	29	)	)	PUNCT
fnp-3866	162	30	.	.	PUNCT
fnp-3866	163	1	adand	adand	ADP
fnp-3866	163	2	covid-19	covid-19	PROPN
fnp-3866	163	3	signaling	signal	VERB
fnp-3866	163	4	pathways	pathway	NOUN
fnp-3866	163	5	may	may	AUX
fnp-3866	163	6	converge	converge	VERB
fnp-3866	163	7	at	at	ADP
fnp-3866	163	8	the	the	DET
fnp-3866	163	9	level	level	NOUN
fnp-3866	163	10	of	of	ADP
fnp-3866	163	11	the	the	DET
fnp-3866	163	12	nrlp3	nrlp3	NOUN
fnp-3866	163	13	inflammasome	inflammasome	VERB
fnp-3866	163	14	through	through	ADP
fnp-3866	163	15	dysregulation	dysregulation	NOUN
fnp-3866	163	16	of	of	ADP
fnp-3866	163	17	amyloid	amyloid	NOUN
fnp-3866	163	18	clearance	clearance	NOUN
fnp-3866	163	19	by	by	ADP
fnp-3866	163	20	microglia	microglia	NOUN
fnp-3866	163	21	(	(	PUNCT
fnp-3866	163	22	cama	cama	PROPN
fnp-3866	163	23	et	et	PROPN
fnp-3866	163	24	al	al	PROPN
fnp-3866	163	25	.	.	PROPN
fnp-3866	163	26	,	,	PUNCT
fnp-3866	163	27	2021	2021	NUM
fnp-3866	163	28	,	,	PUNCT
fnp-3866	163	29	p.	p.	NOUN
fnp-3866	163	30	3	3	NUM
fnp-3866	163	31	)	)	PUNCT
fnp-3866	163	32	.	.	PUNCT
fnp-3866	164	1	alternatively	alternatively	ADV
fnp-3866	164	2	,	,	PUNCT
fnp-3866	164	3	sars	sar	NOUN
fnp-3866	164	4	-	-	PUNCT
fnp-3866	164	5	cov-2	cov-2	PART
fnp-3866	164	6	infection	infection	NOUN
fnp-3866	164	7	may	may	AUX
fnp-3866	164	8	worsen	worsen	VERB
fnp-3866	164	9	ad	ad	NOUN
fnp-3866	164	10	for	for	ADP
fnp-3866	164	11	various	various	ADJ
fnp-3866	164	12	reasons	reason	NOUN
fnp-3866	164	13	(	(	PUNCT
fnp-3866	164	14	villa	villa	PROPN
fnp-3866	164	15	et	et	PROPN
fnp-3866	164	16	al	al	PROPN
fnp-3866	164	17	.	.	PROPN
fnp-3866	164	18	,	,	PUNCT
fnp-3866	164	19	2022	2022	NUM
fnp-3866	164	20	)	)	PUNCT
fnp-3866	164	21	.	.	PUNCT
fnp-3866	165	1	while	while	SCONJ
fnp-3866	165	2	this	this	PRON
fnp-3866	165	3	constitutes	constitute	VERB
fnp-3866	165	4	perhaps	perhaps	ADV
fnp-3866	165	5	the	the	DET
fnp-3866	165	6	most	most	ADV
fnp-3866	165	7	urgent	urgent	ADJ
fnp-3866	165	8	and	and	CCONJ
fnp-3866	165	9	potentially	potentially	ADV
fnp-3866	165	10	important	important	ADJ
fnp-3866	165	11	research	research	NOUN
fnp-3866	165	12	trend	trend	NOUN
fnp-3866	165	13	at	at	ADP
fnp-3866	165	14	this	this	DET
fnp-3866	165	15	time	time	NOUN
fnp-3866	165	16	,	,	PUNCT
fnp-3866	165	17	it	it	PRON
fnp-3866	165	18	remains	remain	VERB
fnp-3866	165	19	to	to	PART
fnp-3866	165	20	be	be	AUX
fnp-3866	165	21	seen	see	VERB
fnp-3866	165	22	whether	whether	SCONJ
fnp-3866	165	23	there	there	PRON
fnp-3866	165	24	will	will	AUX
fnp-3866	165	25	be	be	AUX
fnp-3866	165	26	sustainable	sustainable	ADJ
fnp-3866	165	27	momentum	momentum	NOUN
fnp-3866	165	28	.	.	PUNCT
fnp-3866	166	1	acknowledgement	acknowledgement	PROPN
fnp-3866	166	2	dr	dr	PROPN
fnp-3866	166	3	.	.	PROPN
fnp-3866	166	4	crary	crary	PROPN
fnp-3866	166	5	receives	receive	VERB
fnp-3866	166	6	research	research	NOUN
fnp-3866	166	7	funding	funding	NOUN
fnp-3866	166	8	from	from	ADP
fnp-3866	166	9	the	the	DET
fnp-3866	166	10	nih	nih	PROPN
fnp-3866	166	11	(	(	PUNCT
fnp-3866	166	12	r01ag054008	r01ag054008	PROPN
fnp-3866	166	13	,	,	PUNCT
fnp-3866	166	14	r01ns095252	r01ns095252	NOUN
fnp-3866	166	15	,	,	PUNCT
fnp-3866	166	16	r01ag062348	r01ag062348	NOUN
fnp-3866	166	17	,	,	PUNCT
fnp-3866	166	18	r01ns086736	r01ns086736	NOUN
fnp-3866	166	19	,	,	PUNCT
fnp-3866	166	20	u54ns115266	u54ns115266	PROPN
fnp-3866	166	21	,	,	PUNCT
fnp-3866	166	22	u54ns115322	u54ns115322	NOUN
fnp-3866	166	23	)	)	PUNCT
fnp-3866	166	24	.	.	PUNCT
fnp-3866	167	1	we	we	PRON
fnp-3866	167	2	further	far	ADV
fnp-3866	167	3	acknowledge	acknowledge	VERB
fnp-3866	167	4	the	the	DET
fnp-3866	167	5	rainwater	rainwater	NOUN
fnp-3866	167	6	charitable	charitable	PROPN
fnp-3866	167	7	trust	trust	PROPN
fnp-3866	167	8	/	/	SYM
fnp-3866	167	9	tau	tau	PROPN
fnp-3866	167	10	consortium	consortium	PROPN
fnp-3866	167	11	,	,	PUNCT
fnp-3866	167	12	david	david	PROPN
fnp-3866	167	13	and	and	CCONJ
fnp-3866	167	14	elsie	elsie	PROPN
fnp-3866	167	15	werber	werber	PROPN
fnp-3866	167	16	,	,	PUNCT
fnp-3866	167	17	alexander	alexander	PROPN
fnp-3866	167	18	saint	saint	PROPN
fnp-3866	167	19	amand	amand	PROPN
fnp-3866	167	20	scholar	scholar	PROPN
fnp-3866	167	21	award	award	PROPN
fnp-3866	167	22	and	and	CCONJ
fnp-3866	167	23	karen	karen	PROPN
fnp-3866	167	24	strauss	strauss	PROPN
fnp-3866	167	25	cook	cook	PROPN
fnp-3866	167	26	research	research	NOUN
fnp-3866	167	27	scholar	scholar	NOUN
fnp-3866	167	28	award	award	NOUN
fnp-3866	167	29	.	.	PUNCT
fnp-3866	168	1	references	reference	NOUN
fnp-3866	168	2	adler	adler	PROPN
fnp-3866	168	3	,	,	PUNCT
fnp-3866	168	4	c.	c.	PROPN
fnp-3866	168	5	h.	h.	PROPN
fnp-3866	168	6	,	,	PUNCT
fnp-3866	168	7	beach	beach	PROPN
fnp-3866	168	8	,	,	PUNCT
fnp-3866	168	9	t.	t.	PROPN
fnp-3866	168	10	g.	g.	PROPN
fnp-3866	168	11	,	,	PUNCT
fnp-3866	168	12	zhang	zhang	PROPN
fnp-3866	168	13	,	,	PUNCT
fnp-3866	168	14	n.	n.	PROPN
fnp-3866	168	15	,	,	PUNCT
fnp-3866	168	16	shill	shill	NOUN
fnp-3866	168	17	,	,	PUNCT
fnp-3866	168	18	h.	h.	PROPN
fnp-3866	168	19	a.	a.	PROPN
fnp-3866	168	20	,	,	PUNCT
fnp-3866	168	21	driver	driver	NOUN
fnp-3866	168	22	-	-	PUNCT
fnp-3866	168	23	dunckley	dunckley	NOUN
fnp-3866	168	24	,	,	PUNCT
fnp-3866	168	25	e.	e.	PROPN
fnp-3866	168	26	,	,	PUNCT
fnp-3866	168	27	caviness	caviness	NOUN
fnp-3866	168	28	,	,	PUNCT
fnp-3866	168	29	j.	j.	PROPN
fnp-3866	168	30	n.	n.	PROPN
fnp-3866	168	31	,	,	PUNCT
fnp-3866	168	32	mehta	mehta	PROPN
fnp-3866	168	33	,	,	PUNCT
fnp-3866	168	34	s.	s.	PROPN
fnp-3866	168	35	h.	h.	PROPN
fnp-3866	168	36	,	,	PUNCT
fnp-3866	168	37	sabbagh	sabbagh	PROPN
fnp-3866	168	38	,	,	PUNCT
fnp-3866	168	39	m.	m.	NOUN
fnp-3866	168	40	n.	n.	PROPN
fnp-3866	168	41	,	,	PUNCT
fnp-3866	168	42	serrano	serrano	PROPN
fnp-3866	168	43	,	,	PUNCT
fnp-3866	168	44	g.	g.	PROPN
fnp-3866	168	45	e.	e.	PROPN
fnp-3866	168	46	,	,	PUNCT
fnp-3866	168	47	sue	sue	PROPN
fnp-3866	168	48	,	,	PUNCT
fnp-3866	168	49	l.	l.	PROPN
fnp-3866	168	50	i.	i.	PROPN
fnp-3866	168	51	,	,	PUNCT
fnp-3866	168	52	belden	belden	PROPN
fnp-3866	168	53	,	,	PUNCT
fnp-3866	168	54	c.	c.	PROPN
fnp-3866	168	55	m.	m.	PROPN
fnp-3866	168	56	,	,	PUNCT
fnp-3866	168	57	powell	powell	PROPN
fnp-3866	168	58	,	,	PUNCT
fnp-3866	168	59	j.	j.	PROPN
fnp-3866	168	60	,	,	PUNCT
fnp-3866	168	61	jacobson	jacobson	PROPN
fnp-3866	168	62	,	,	PUNCT
fnp-3866	168	63	s.	s.	PROPN
fnp-3866	168	64	a.	a.	PROPN
fnp-3866	168	65	,	,	PUNCT
fnp-3866	168	66	zamrini	zamrini	PROPN
fnp-3866	168	67	,	,	PUNCT
fnp-3866	168	68	e.	e.	PROPN
fnp-3866	168	69	,	,	PUNCT
fnp-3866	168	70	shprecher	shprecher	PROPN
fnp-3866	168	71	,	,	PUNCT
fnp-3866	168	72	d.	d.	PROPN
fnp-3866	168	73	,	,	PUNCT
fnp-3866	168	74	davis	davis	PROPN
fnp-3866	168	75	,	,	PUNCT
fnp-3866	168	76	k.	k.	PROPN
fnp-3866	168	77	j.	j.	PROPN
fnp-3866	168	78	,	,	PUNCT
fnp-3866	168	79	dugger	dugger	PROPN
fnp-3866	168	80	,	,	PUNCT
fnp-3866	168	81	b.	b.	PROPN
fnp-3866	168	82	n.	n.	PROPN
fnp-3866	168	83	,	,	PUNCT
fnp-3866	168	84	&	&	CCONJ
fnp-3866	168	85	hentz	hentz	PROPN
fnp-3866	168	86	,	,	PUNCT
fnp-3866	168	87	j.	j.	PROPN
fnp-3866	168	88	g.	g.	PROPN
fnp-3866	168	89	(	(	PUNCT
fnp-3866	168	90	2019	2019	NUM
fnp-3866	168	91	)	)	PUNCT
fnp-3866	168	92	.	.	PUNCT
fnp-3866	169	1	unified	unify	VERB
fnp-3866	169	2	staging	staging	NOUN
fnp-3866	169	3	system	system	NOUN
fnp-3866	169	4	for	for	ADP
fnp-3866	169	5	lewy	lewy	ADJ
fnp-3866	169	6	body	body	NOUN
fnp-3866	169	7	disorders	disorder	NOUN
fnp-3866	169	8	:	:	PUNCT
fnp-3866	169	9	clinicopathologic	clinicopathologic	ADJ
fnp-3866	169	10	correlations	correlation	NOUN
fnp-3866	169	11	and	and	CCONJ
fnp-3866	169	12	comparison	comparison	NOUN
fnp-3866	169	13	to	to	ADP
fnp-3866	169	14	braak	braak	PROPN
fnp-3866	169	15	staging	stage	VERB
fnp-3866	169	16	.	.	PUNCT
fnp-3866	170	1	journal	journal	NOUN
fnp-3866	170	2	of	of	ADP
fnp-3866	170	3	neuropathology	neuropathology	NOUN
fnp-3866	170	4	and	and	CCONJ
fnp-3866	170	5	experimental	experimental	ADJ
fnp-3866	170	6	neurology	neurology	NOUN
fnp-3866	170	7	,	,	PUNCT
fnp-3866	170	8	78(10	78(10	NUM
fnp-3866	170	9	)	)	PUNCT
fnp-3866	170	10	,	,	PUNCT
fnp-3866	170	11	891–899	891–899	NUM
fnp-3866	170	12	.	.	PUNCT
fnp-3866	171	1	https://doi.org/10.1093/jnen/nlz080	https://doi.org/10.1093/jnen/nlz080	NOUN
fnp-3866	171	2	attems	attems	PROPN
fnp-3866	171	3	,	,	PUNCT
fnp-3866	171	4	j.	j.	PROPN
fnp-3866	171	5	,	,	PUNCT
fnp-3866	171	6	toledo	toledo	PROPN
fnp-3866	171	7	,	,	PUNCT
fnp-3866	171	8	j.	j.	PROPN
fnp-3866	171	9	b.	b.	PROPN
fnp-3866	171	10	,	,	PUNCT
fnp-3866	171	11	walker	walker	PROPN
fnp-3866	171	12	,	,	PUNCT
fnp-3866	171	13	l.	l.	PROPN
fnp-3866	171	14	,	,	PUNCT
fnp-3866	171	15	gelpi	gelpi	NOUN
fnp-3866	171	16	,	,	PUNCT
fnp-3866	171	17	e.	e.	PROPN
fnp-3866	171	18	,	,	PUNCT
fnp-3866	171	19	gentleman	gentleman	PROPN
fnp-3866	171	20	,	,	PUNCT
fnp-3866	171	21	s.	s.	PROPN
fnp-3866	171	22	,	,	PUNCT
fnp-3866	171	23	halliday	halliday	PROPN
fnp-3866	171	24	,	,	PUNCT
fnp-3866	171	25	g.	g.	PROPN
fnp-3866	171	26	,	,	PUNCT
fnp-3866	171	27	hortobagyi	hortobagyi	PROPN
fnp-3866	171	28	,	,	PUNCT
fnp-3866	171	29	t.	t.	PROPN
fnp-3866	171	30	,	,	PUNCT
fnp-3866	171	31	jellinger	jellinger	PROPN
fnp-3866	171	32	,	,	PUNCT
fnp-3866	171	33	k.	k.	PROPN
fnp-3866	171	34	,	,	PUNCT
fnp-3866	171	35	kovacs	kovacs	PROPN
fnp-3866	171	36	,	,	PUNCT
fnp-3866	171	37	g.	g.	PROPN
fnp-3866	171	38	g.	g.	PROPN
fnp-3866	171	39	,	,	PUNCT
fnp-3866	171	40	lee	lee	PROPN
fnp-3866	171	41	,	,	PUNCT
fnp-3866	171	42	e.	e.	PROPN
fnp-3866	171	43	b.	b.	PROPN
fnp-3866	171	44	,	,	PUNCT
fnp-3866	171	45	love	love	PROPN
fnp-3866	171	46	,	,	PUNCT
fnp-3866	171	47	s.	s.	PROPN
fnp-3866	171	48	,	,	PUNCT
fnp-3866	171	49	mcaleese	mcaleese	PROPN
fnp-3866	171	50	,	,	PUNCT
fnp-3866	171	51	k.	k.	PROPN
fnp-3866	171	52	e.	e.	PROPN
fnp-3866	171	53	,	,	PUNCT
fnp-3866	171	54	nelson	nelson	PROPN
fnp-3866	171	55	,	,	PUNCT
fnp-3866	171	56	p.	p.	PROPN
fnp-3866	171	57	t.	t.	PROPN
fnp-3866	171	58	,	,	PUNCT
fnp-3866	171	59	neumann	neumann	PROPN
fnp-3866	171	60	,	,	PUNCT
fnp-3866	171	61	m.	m.	NOUN
fnp-3866	171	62	,	,	PUNCT
fnp-3866	171	63	parkkinen	parkkinen	NOUN
fnp-3866	171	64	,	,	PUNCT
fnp-3866	171	65	l.	l.	PROPN
fnp-3866	171	66	,	,	PUNCT
fnp-3866	171	67	polvikoski	polvikoski	ADJ
fnp-3866	171	68	,	,	PUNCT
fnp-3866	171	69	t.	t.	NOUN
fnp-3866	171	70	,	,	PUNCT
fnp-3866	171	71	sikorska	sikorska	PROPN
fnp-3866	171	72	,	,	PUNCT
fnp-3866	171	73	b.	b.	PROPN
fnp-3866	171	74	,	,	PUNCT
fnp-3866	171	75	smith	smith	PROPN
fnp-3866	171	76	,	,	PUNCT
fnp-3866	171	77	c.	c.	PROPN
fnp-3866	171	78	,	,	PUNCT
fnp-3866	171	79	grinberg	grinberg	PROPN
fnp-3866	171	80	,	,	PUNCT
fnp-3866	171	81	l.	l.	PROPN
fnp-3866	171	82	t.	t.	PROPN
fnp-3866	171	83	,	,	PUNCT
fnp-3866	171	84	…	…	PUNCT
fnp-3866	171	85	mckeith	mckeith	PROPN
fnp-3866	171	86	,	,	PUNCT
fnp-3866	171	87	i.	i.	PROPN
fnp-3866	171	88	g.	g.	PROPN
fnp-3866	171	89	(	(	PUNCT
fnp-3866	171	90	2021	2021	NUM
fnp-3866	171	91	)	)	PUNCT
fnp-3866	171	92	.	.	PUNCT
fnp-3866	172	1	neuropathological	neuropathological	ADJ
fnp-3866	172	2	consensus	consensus	NOUN
fnp-3866	172	3	criteria	criterion	NOUN
fnp-3866	172	4	for	for	ADP
fnp-3866	172	5	the	the	DET
fnp-3866	172	6	evaluation	evaluation	NOUN
fnp-3866	172	7	of	of	ADP
fnp-3866	172	8	lewy	lewy	PROPN
fnp-3866	172	9	pathology	pathology	PROPN
fnp-3866	172	10	in	in	ADP
fnp-3866	172	11	post	post	ADJ
fnp-3866	172	12	-	-	ADJ
fnp-3866	172	13	mortem	mortem	ADJ
fnp-3866	172	14	brains	brain	NOUN
fnp-3866	172	15	:	:	PUNCT
fnp-3866	172	16	a	a	DET
fnp-3866	172	17	multi	multi	ADJ
fnp-3866	172	18	-	-	ADJ
fnp-3866	172	19	centre	centre	ADJ
fnp-3866	172	20	study	study	NOUN
fnp-3866	172	21	.	.	PUNCT
fnp-3866	173	1	acta	acta	PROPN
fnp-3866	173	2	neuropathologica	neuropathologica	PROPN
fnp-3866	173	3	,	,	PUNCT
fnp-3866	173	4	141(2	141(2	NUM
fnp-3866	173	5	)	)	PUNCT
fnp-3866	173	6	,	,	PUNCT
fnp-3866	173	7	159–172	159–172	NUM
fnp-3866	173	8	.	.	PUNCT
fnp-3866	174	1	https://doi.org/10.1007/s00401-020-02255-2	https://doi.org/10.1007/s00401-020-02255-2	NUM
fnp-3866	174	2	barnat	barnat	NOUN
fnp-3866	174	3	,	,	PUNCT
fnp-3866	174	4	m.	m.	NOUN
fnp-3866	174	5	,	,	PUNCT
fnp-3866	174	6	capizzi	capizzi	NOUN
fnp-3866	174	7	,	,	PUNCT
fnp-3866	174	8	m.	m.	NOUN
fnp-3866	174	9	,	,	PUNCT
fnp-3866	174	10	aparicio	aparicio	PROPN
fnp-3866	174	11	,	,	PUNCT
fnp-3866	174	12	e.	e.	PROPN
fnp-3866	174	13	,	,	PUNCT
fnp-3866	174	14	boluda	boluda	PROPN
fnp-3866	174	15	,	,	PUNCT
fnp-3866	174	16	s.	s.	PROPN
fnp-3866	174	17	,	,	PUNCT
fnp-3866	174	18	wennagel	wennagel	NOUN
fnp-3866	174	19	,	,	PUNCT
fnp-3866	174	20	d.	d.	PROPN
fnp-3866	174	21	,	,	PUNCT
fnp-3866	174	22	kacher	kacher	PROPN
fnp-3866	174	23	,	,	PUNCT
fnp-3866	174	24	r.	r.	PROPN
fnp-3866	174	25	,	,	PUNCT
fnp-3866	174	26	kassem	kassem	PROPN
fnp-3866	174	27	,	,	PUNCT
fnp-3866	174	28	r.	r.	PROPN
fnp-3866	174	29	,	,	PUNCT
fnp-3866	174	30	lenoir	lenoir	PROPN
fnp-3866	174	31	,	,	PUNCT
fnp-3866	174	32	s.	s.	PROPN
fnp-3866	174	33	,	,	PUNCT
fnp-3866	174	34	agasse	agasse	PROPN
fnp-3866	174	35	,	,	PUNCT
fnp-3866	174	36	f.	f.	PROPN
fnp-3866	174	37	,	,	PUNCT
fnp-3866	174	38	braz	braz	PROPN
fnp-3866	174	39	,	,	PUNCT
fnp-3866	174	40	b.y	b.y	PROPN
fnp-3866	174	41	.	.	PROPN
fnp-3866	174	42	,	,	PUNCT
fnp-3866	174	43	liu	liu	PROPN
fnp-3866	174	44	,	,	PUNCT
fnp-3866	174	45	j.-p	j.-p	PROPN
fnp-3866	174	46	.	.	PROPN
fnp-3866	174	47	,	,	PUNCT
fnp-3866	174	48	ighil	ighil	PROPN
fnp-3866	174	49	,	,	PUNCT
fnp-3866	174	50	j.	j.	PROPN
fnp-3866	174	51	,	,	PUNCT
fnp-3866	174	52	tessier	tessier	NOUN
fnp-3866	174	53	,	,	PUNCT
fnp-3866	174	54	a.	a.	NOUN
fnp-3866	174	55	,	,	PUNCT
fnp-3866	174	56	zeitlin	zeitlin	PROPN
fnp-3866	174	57	,	,	PUNCT
fnp-3866	174	58	s.o	s.o	PROPN
fnp-3866	174	59	.	.	PROPN
fnp-3866	174	60	,	,	PUNCT
fnp-3866	174	61	duyckaerts	duyckaert	NOUN
fnp-3866	174	62	,	,	PUNCT
fnp-3866	174	63	c.	c.	NOUN
fnp-3866	174	64	,	,	PUNCT
fnp-3866	174	65	dommergues	dommergue	NOUN
fnp-3866	174	66	,	,	PUNCT
fnp-3866	174	67	m.	m.	NOUN
fnp-3866	174	68	,	,	PUNCT
fnp-3866	174	69	durr	durr	NOUN
fnp-3866	174	70	,	,	PUNCT
fnp-3866	174	71	a.	a.	NOUN
fnp-3866	174	72	,	,	PUNCT
fnp-3866	174	73	humbert	humbert	PROPN
fnp-3866	174	74	,	,	PUNCT
fnp-3866	174	75	s.	s.	PROPN
fnp-3866	174	76	,	,	PUNCT
fnp-3866	174	77	(	(	PUNCT
fnp-3866	174	78	2020	2020	NUM
fnp-3866	174	79	)	)	PUNCT
fnp-3866	174	80	.	.	PUNCT
fnp-3866	175	1	huntington	huntington	PROPN
fnp-3866	175	2	's	's	PART
fnp-3866	175	3	disease	disease	NOUN
fnp-3866	175	4	alters	alter	VERB
fnp-3866	175	5	human	human	ADJ
fnp-3866	175	6	neurodevelopment	neurodevelopment	NOUN
fnp-3866	175	7	.	.	PUNCT
fnp-3866	176	1	science	science	NOUN
fnp-3866	176	2	,	,	PUNCT
fnp-3866	176	3	369(6505	369(6505	NUM
fnp-3866	176	4	)	)	PUNCT
fnp-3866	176	5	,	,	PUNCT
fnp-3866	176	6	787	787	NUM
fnp-3866	176	7	-	-	SYM
fnp-3866	176	8	793	793	NUM
fnp-3866	176	9	.	.	PUNCT
fnp-3866	177	1	https://doi.org/10.1126/science.aax3338	https://doi.org/10.1126/science.aax3338	PROPN
fnp-3866	177	2	bieniek	bieniek	PROPN
fnp-3866	177	3	,	,	PUNCT
fnp-3866	177	4	k.	k.	PROPN
fnp-3866	177	5	f.	f.	PROPN
fnp-3866	177	6	,	,	PUNCT
fnp-3866	177	7	cairns	cairns	PROPN
fnp-3866	177	8	,	,	PUNCT
fnp-3866	177	9	n.	n.	PROPN
fnp-3866	177	10	j.	j.	PROPN
fnp-3866	177	11	,	,	PUNCT
fnp-3866	177	12	crary	crary	PROPN
fnp-3866	177	13	,	,	PUNCT
fnp-3866	177	14	j.	j.	PROPN
fnp-3866	177	15	f.	f.	PROPN
fnp-3866	177	16	,	,	PUNCT
fnp-3866	177	17	dickson	dickson	PROPN
fnp-3866	177	18	,	,	PUNCT
fnp-3866	177	19	d.	d.	PROPN
fnp-3866	177	20	w.	w.	PROPN
fnp-3866	177	21	,	,	PUNCT
fnp-3866	177	22	folkerth	folkerth	PROPN
fnp-3866	177	23	,	,	PUNCT
fnp-3866	177	24	r.	r.	PROPN
fnp-3866	177	25	d.	d.	PROPN
fnp-3866	177	26	,	,	PUNCT
fnp-3866	177	27	keene	keene	PROPN
fnp-3866	177	28	,	,	PUNCT
fnp-3866	177	29	c.	c.	PROPN
fnp-3866	177	30	d.	d.	PROPN
fnp-3866	177	31	,	,	PUNCT
fnp-3866	177	32	litvan	litvan	PROPN
fnp-3866	177	33	,	,	PUNCT
fnp-3866	177	34	i.	i.	PROPN
fnp-3866	177	35	,	,	PUNCT
fnp-3866	177	36	perl	perl	PROPN
fnp-3866	177	37	,	,	PUNCT
fnp-3866	177	38	d.	d.	PROPN
fnp-3866	177	39	p.	p.	PROPN
fnp-3866	177	40	,	,	PUNCT
fnp-3866	177	41	stein	stein	PROPN
fnp-3866	177	42	,	,	PUNCT
fnp-3866	177	43	t.	t.	PROPN
fnp-3866	177	44	d.	d.	PROPN
fnp-3866	177	45	,	,	PUNCT
fnp-3866	177	46	vonsattel	vonsattel	NOUN
fnp-3866	177	47	,	,	PUNCT
fnp-3866	177	48	j.-p	j.-p	PROPN
fnp-3866	177	49	.	.	PROPN
fnp-3866	177	50	,	,	PUNCT
fnp-3866	177	51	stewart	stewart	PROPN
fnp-3866	177	52	,	,	PUNCT
fnp-3866	177	53	w.	w.	PROPN
fnp-3866	177	54	,	,	PUNCT
fnp-3866	177	55	dams	dams	NOUN
fnp-3866	177	56	-	-	PUNCT
fnp-3866	177	57	o’connor	o’connor	ADV
fnp-3866	177	58	,	,	PUNCT
fnp-3866	177	59	k.	k.	PROPN
fnp-3866	177	60	,	,	PUNCT
fnp-3866	177	61	gordon	gordon	PROPN
fnp-3866	177	62	,	,	PUNCT
fnp-3866	177	63	w.	w.	PROPN
fnp-3866	177	64	a.	a.	PROPN
fnp-3866	177	65	,	,	PUNCT
fnp-3866	177	66	tripodis	tripodi	NOUN
fnp-3866	177	67	,	,	PUNCT
fnp-3866	177	68	y.	y.	PROPN
fnp-3866	177	69	,	,	PUNCT
fnp-3866	177	70	alvarez	alvarez	PROPN
fnp-3866	177	71	,	,	PUNCT
fnp-3866	177	72	v.	v.	PROPN
fnp-3866	177	73	e.	e.	PROPN
fnp-3866	177	74	,	,	PUNCT
fnp-3866	177	75	mez	mez	PROPN
fnp-3866	177	76	,	,	PUNCT
fnp-3866	177	77	j.	j.	PROPN
fnp-3866	177	78	,	,	PUNCT
fnp-3866	177	79	alosco	alosco	PROPN
fnp-3866	177	80	,	,	PUNCT
fnp-3866	177	81	m.	m.	PROPN
fnp-3866	177	82	l.	l.	PROPN
fnp-3866	177	83	,	,	PUNCT
fnp-3866	177	84	&	&	CCONJ
fnp-3866	177	85	mckee	mckee	PROPN
fnp-3866	177	86	,	,	PUNCT
fnp-3866	177	87	a.	a.	PROPN
fnp-3866	177	88	c.	c.	PROPN
fnp-3866	177	89	(	(	PUNCT
fnp-3866	177	90	2021	2021	NUM
fnp-3866	177	91	)	)	PUNCT
fnp-3866	177	92	.	.	PUNCT
fnp-3866	178	1	the	the	DET
fnp-3866	178	2	second	second	ADJ
fnp-3866	178	3	ninds	nind	NOUN
fnp-3866	178	4	/	/	SYM
fnp-3866	178	5	nibib	nibib	NOUN
fnp-3866	178	6	consensus	consensus	NOUN
fnp-3866	178	7	meeting	meeting	NOUN
fnp-3866	178	8	to	to	PART
fnp-3866	178	9	define	define	VERB
fnp-3866	178	10	neuropathological	neuropathological	ADJ
fnp-3866	178	11	criteria	criterion	NOUN
fnp-3866	178	12	for	for	ADP
fnp-3866	178	13	the	the	DET
fnp-3866	178	14	diagnosis	diagnosis	NOUN
fnp-3866	178	15	of	of	ADP
fnp-3866	178	16	chronic	chronic	ADJ
fnp-3866	178	17	traumatic	traumatic	ADJ
fnp-3866	178	18	encephalopathy	encephalopathy	NOUN
fnp-3866	178	19	.	.	PUNCT
fnp-3866	179	1	journal	journal	NOUN
fnp-3866	179	2	of	of	ADP
fnp-3866	179	3	neuropathology	neuropathology	NOUN
fnp-3866	179	4	and	and	CCONJ
fnp-3866	179	5	experimental	experimental	ADJ
fnp-3866	179	6	neurology	neurology	NOUN
fnp-3866	179	7	,	,	PUNCT
fnp-3866	179	8	80(3	80(3	NUM
fnp-3866	179	9	)	)	PUNCT
fnp-3866	179	10	,	,	PUNCT
fnp-3866	179	11	210–219	210–219	NUM
fnp-3866	179	12	.	.	PUNCT
fnp-3866	180	1	https://doi.org/10.1093/jnen/nlab001	https://doi.org/10.1093/jnen/nlab001	PROPN
fnp-3866	180	2	blalock	blalock	NOUN
fnp-3866	180	3	,	,	PUNCT
fnp-3866	180	4	e.	e.	PROPN
fnp-3866	180	5	m.	m.	PROPN
fnp-3866	180	6	,	,	PUNCT
fnp-3866	180	7	buechel	buechel	PROPN
fnp-3866	180	8	,	,	PUNCT
fnp-3866	180	9	h.	h.	PROPN
fnp-3866	180	10	m.	m.	PROPN
fnp-3866	180	11	,	,	PUNCT
fnp-3866	180	12	popovic	popovic	PROPN
fnp-3866	180	13	,	,	PUNCT
fnp-3866	180	14	j.	j.	PROPN
fnp-3866	180	15	,	,	PUNCT
fnp-3866	180	16	geddes	geddes	PROPN
fnp-3866	180	17	,	,	PUNCT
fnp-3866	180	18	j.	j.	PROPN
fnp-3866	180	19	w.	w.	PROPN
fnp-3866	180	20	,	,	PUNCT
fnp-3866	180	21	&	&	CCONJ
fnp-3866	180	22	landfield	landfield	PROPN
fnp-3866	180	23	,	,	PUNCT
fnp-3866	180	24	p.	p.	PROPN
fnp-3866	180	25	w.	w.	PROPN
fnp-3866	180	26	(	(	PUNCT
fnp-3866	180	27	2011	2011	NUM
fnp-3866	180	28	)	)	PUNCT
fnp-3866	180	29	.	.	PUNCT
fnp-3866	181	1	microarray	microarray	VERB
fnp-3866	181	2	analyses	analysis	NOUN
fnp-3866	181	3	of	of	ADP
fnp-3866	181	4	laser	laser	NOUN
fnp-3866	181	5	-	-	PUNCT
fnp-3866	181	6	captured	capture	VERB
fnp-3866	181	7	hippocampus	hippocampus	NOUN
fnp-3866	181	8	reveal	reveal	VERB
fnp-3866	181	9	distinct	distinct	ADJ
fnp-3866	181	10	gray	gray	ADJ
fnp-3866	181	11	and	and	CCONJ
fnp-3866	181	12	white	white	ADJ
fnp-3866	181	13	matter	matter	NOUN
fnp-3866	181	14	signatures	signature	NOUN
fnp-3866	181	15	associated	associate	VERB
fnp-3866	181	16	with	with	ADP
fnp-3866	181	17	incipient	incipient	ADJ
fnp-3866	181	18	alzheimer	alzheimer	PROPN
fnp-3866	181	19	’s	’s	PART
fnp-3866	181	20	disease	disease	NOUN
fnp-3866	181	21	.	.	PUNCT
fnp-3866	182	1	journal	journal	PROPN
fnp-3866	182	2	of	of	ADP
fnp-3866	182	3	chemical	chemical	PROPN
fnp-3866	182	4	neuroanatomy	neuroanatomy	NOUN
fnp-3866	182	5	,	,	PUNCT
fnp-3866	182	6	42(2	42(2	PROPN
fnp-3866	182	7	)	)	PUNCT
fnp-3866	182	8	,	,	PUNCT
fnp-3866	182	9	118–126	118–126	NUM
fnp-3866	182	10	.	.	PUNCT
fnp-3866	183	1	https://doi.org/10.1016/j.jchemneu.2011.06.007	https://doi.org/10.1016/j.jchemneu.2011.06.007	ADJ
fnp-3866	183	2	braak	braak	NOUN
fnp-3866	183	3	,	,	PUNCT
fnp-3866	183	4	h.	h.	PROPN
fnp-3866	183	5	,	,	PUNCT
fnp-3866	183	6	del	del	PROPN
fnp-3866	183	7	tredici	tredici	PROPN
fnp-3866	183	8	,	,	PUNCT
fnp-3866	183	9	k.	k.	PROPN
fnp-3866	183	10	,	,	PUNCT
fnp-3866	183	11	rüb	rüb	PROPN
fnp-3866	183	12	,	,	PUNCT
fnp-3866	183	13	u.	u.	PROPN
fnp-3866	183	14	,	,	PUNCT
fnp-3866	183	15	de	de	X
fnp-3866	183	16	vos	vos	PROPN
fnp-3866	183	17	,	,	PUNCT
fnp-3866	183	18	r.	r.	PROPN
fnp-3866	183	19	a.	a.	PROPN
fnp-3866	183	20	i.	i.	PROPN
fnp-3866	183	21	,	,	PUNCT
fnp-3866	183	22	jansen	jansen	PROPN
fnp-3866	183	23	steur	steur	PROPN
fnp-3866	183	24	,	,	PUNCT
fnp-3866	183	25	e.	e.	PROPN
fnp-3866	183	26	n.	n.	PROPN
fnp-3866	183	27	h.	h.	PROPN
fnp-3866	183	28	,	,	PUNCT
fnp-3866	183	29	&	&	CCONJ
fnp-3866	183	30	braak	braak	PROPN
fnp-3866	183	31	,	,	PUNCT
fnp-3866	183	32	e.	e.	PROPN
fnp-3866	183	33	(	(	PUNCT
fnp-3866	183	34	2003	2003	NUM
fnp-3866	183	35	)	)	PUNCT
fnp-3866	183	36	.	.	PUNCT
fnp-3866	184	1	staging	staging	NOUN
fnp-3866	184	2	of	of	ADP
fnp-3866	184	3	brain	brain	NOUN
fnp-3866	184	4	pathology	pathology	NOUN
fnp-3866	184	5	related	relate	VERB
fnp-3866	184	6	to	to	ADP
fnp-3866	184	7	sporadic	sporadic	ADJ
fnp-3866	184	8	parkinson	parkinson	NOUN
fnp-3866	184	9	’s	’s	PART
fnp-3866	184	10	disease	disease	NOUN
fnp-3866	184	11	.	.	PUNCT
fnp-3866	185	1	neurobiology	neurobiology	NOUN
fnp-3866	185	2	of	of	ADP
fnp-3866	185	3	aging	aging	NOUN
fnp-3866	185	4	,	,	PUNCT
fnp-3866	185	5	24(2	24(2	NUM
fnp-3866	185	6	)	)	PUNCT
fnp-3866	185	7	,	,	PUNCT
fnp-3866	185	8	197–211	197–211	NUM
fnp-3866	185	9	.	.	PUNCT
fnp-3866	186	1	https://doi.org/10.1016/s0197-4580(02)00065-9	https://doi.org/10.1016/s0197-4580(02)00065-9	PROPN
fnp-3866	186	2	cama	cama	NOUN
fnp-3866	186	3	,	,	PUNCT
fnp-3866	186	4	v.	v.	PROPN
fnp-3866	186	5	f.	f.	PROPN
fnp-3866	186	6	,	,	PUNCT
fnp-3866	186	7	marín	marín	PROPN
fnp-3866	186	8	-	-	PUNCT
fnp-3866	186	9	prida	prida	PROPN
fnp-3866	186	10	,	,	PUNCT
fnp-3866	186	11	j.	j.	PROPN
fnp-3866	186	12	,	,	PUNCT
fnp-3866	186	13	acosta	acosta	PROPN
fnp-3866	186	14	-	-	PUNCT
fnp-3866	186	15	rivero	rivero	PROPN
fnp-3866	186	16	,	,	PUNCT
fnp-3866	186	17	n.	n.	PROPN
fnp-3866	186	18	,	,	PUNCT
fnp-3866	186	19	acosta	acosta	PROPN
fnp-3866	186	20	,	,	PUNCT
fnp-3866	186	21	e.	e.	PROPN
fnp-3866	186	22	f.	f.	PROPN
fnp-3866	186	23	,	,	PUNCT
fnp-3866	186	24	díaz	díaz	PROPN
fnp-3866	186	25	,	,	PUNCT
fnp-3866	186	26	l.	l.	PROPN
fnp-3866	186	27	o.	o.	PROPN
fnp-3866	186	28	,	,	PUNCT
fnp-3866	186	29	casadesús	casadesús	PROPN
fnp-3866	186	30	,	,	PUNCT
fnp-3866	186	31	a.	a.	NOUN
fnp-3866	186	32	v.	v.	PROPN
fnp-3866	186	33	,	,	PUNCT
fnp-3866	186	34	fernández	fernández	PROPN
fnp-3866	186	35	-	-	PUNCT
fnp-3866	186	36	marrero	marrero	PROPN
fnp-3866	186	37	,	,	PUNCT
fnp-3866	186	38	b.	b.	PROPN
fnp-3866	186	39	,	,	PUNCT
fnp-3866	186	40	gilva	gilva	NOUN
fnp-3866	186	41	-	-	PUNCT
fnp-3866	186	42	rodríguez	rodríguez	NOUN
fnp-3866	186	43	,	,	PUNCT
fnp-3866	186	44	n.	n.	NOUN
fnp-3866	186	45	,	,	PUNCT
fnp-3866	186	46	cremata	cremata	NOUN
fnp-3866	186	47	-	-	PUNCT
fnp-3866	186	48	garcía	garcía	ADJ
fnp-3866	186	49	,	,	PUNCT
fnp-3866	186	50	d.	d.	PROPN
fnp-3866	186	51	,	,	PUNCT
fnp-3866	186	52	cervantes	cervante	NOUN
fnp-3866	186	53	-	-	PUNCT
fnp-3866	186	54	llanos	llanos	PROPN
fnp-3866	186	55	,	,	PUNCT
fnp-3866	186	56	m.	m.	NOUN
fnp-3866	186	57	,	,	PUNCT
fnp-3866	186	58	piniella	piniella	NOUN
fnp-3866	186	59	-	-	PUNCT
fnp-3866	186	60	matamoros	matamoros	PROPN
fnp-3866	186	61	,	,	PUNCT
fnp-3866	186	62	b.	b.	PROPN
fnp-3866	186	63	,	,	PUNCT
fnp-3866	186	64	sánchez	sánchez	PROPN
fnp-3866	186	65	,	,	PUNCT
fnp-3866	186	66	d.	d.	PROPN
fnp-3866	186	67	,	,	PUNCT
fnp-3866	186	68	del	del	PROPN
fnp-3866	186	69	rosario	rosario	PROPN
fnp-3866	186	70	-	-	PUNCT
fnp-3866	186	71	cruz	cruz	PROPN
fnp-3866	186	72	,	,	PUNCT
fnp-3866	186	73	l.	l.	PROPN
fnp-3866	186	74	,	,	PUNCT
fnp-3866	186	75	borrajero	borrajero	PROPN
fnp-3866	186	76	,	,	PUNCT
fnp-3866	186	77	i.	i.	PROPN
fnp-3866	186	78	,	,	PUNCT
fnp-3866	186	79	díaz	díaz	NOUN
fnp-3866	186	80	,	,	PUNCT
fnp-3866	186	81	a.	a.	NOUN
fnp-3866	186	82	,	,	PUNCT
fnp-3866	186	83	gonzález	gonzález	PROPN
fnp-3866	186	84	,	,	PUNCT
fnp-3866	186	85	y.	y.	PROPN
fnp-3866	186	86	,	,	PUNCT
fnp-3866	186	87	pentón	pentón	NOUN
fnp-3866	186	88	-	-	PUNCT
fnp-3866	186	89	arias	aria	NOUN
fnp-3866	186	90	,	,	PUNCT
fnp-3866	186	91	e.	e.	PROPN
fnp-3866	186	92	,	,	PUNCT
fnp-3866	186	93	montero	montero	PROPN
fnp-3866	186	94	-	-	PUNCT
fnp-3866	186	95	gonzález	gonzález	PROPN
fnp-3866	186	96	,	,	PUNCT
fnp-3866	186	97	t.	t.	PROPN
fnp-3866	186	98	,	,	PUNCT
fnp-3866	186	99	guillen	guillen	PROPN
fnp-3866	186	100	-	-	PUNCT
fnp-3866	186	101	nieto	nieto	PROPN
fnp-3866	186	102	,	,	PUNCT
fnp-3866	186	103	g.	g.	PROPN
fnp-3866	186	104	,	,	PUNCT
fnp-3866	186	105	&	&	CCONJ
fnp-3866	186	106	pentón	pentón	PROPN
fnp-3866	186	107	-	-	PUNCT
fnp-3866	186	108	rol	rol	NOUN
fnp-3866	186	109	,	,	PUNCT
fnp-3866	186	110	g.	g.	PROPN
fnp-3866	186	111	(	(	PUNCT
fnp-3866	186	112	2021	2021	NUM
fnp-3866	186	113	)	)	PUNCT
fnp-3866	186	114	.	.	PUNCT
fnp-3866	187	1	the	the	DET
fnp-3866	187	2	microglial	microglial	ADJ
fnp-3866	187	3	nlrp3	nlrp3	NOUN
fnp-3866	187	4	inflammasome	inflammasome	NOUN
fnp-3866	187	5	is	be	AUX
fnp-3866	187	6	involved	involve	VERB
fnp-3866	187	7	in	in	ADP
fnp-3866	187	8	human	human	ADJ
fnp-3866	187	9	sars	sar	NOUN
fnp-3866	187	10	-	-	PUNCT
fnp-3866	187	11	cov-2	cov-2	NOUN
fnp-3866	187	12	cerebral	cerebral	ADJ
fnp-3866	187	13	pathogenicity	pathogenicity	NOUN
fnp-3866	187	14	:	:	PUNCT
fnp-3866	187	15	a	a	DET
fnp-3866	187	16	report	report	NOUN
fnp-3866	187	17	of	of	ADP
fnp-3866	187	18	three	three	NUM
fnp-3866	187	19	post	post	ADJ
fnp-3866	187	20	-	-	ADJ
fnp-3866	187	21	mortem	mortem	ADJ
fnp-3866	187	22	cases	case	NOUN
fnp-3866	187	23	.	.	PUNCT
fnp-3866	188	1	journal	journal	NOUN
fnp-3866	188	2	of	of	ADP
fnp-3866	188	3	neuroimmunology	neuroimmunology	PROPN
fnp-3866	188	4	,	,	PUNCT
fnp-3866	188	5	361	361	NUM
fnp-3866	188	6	,	,	PUNCT
fnp-3866	188	7	577728	577728	NUM
fnp-3866	188	8	.	.	PUNCT
fnp-3866	189	1	https://doi.org/10.1016/j.jneuroim.2021.577728	https://doi.org/10.1016/j.jneuroim.2021.577728	NOUN
fnp-3866	189	2	crary	crary	PROPN
fnp-3866	189	3	,	,	PUNCT
fnp-3866	189	4	j.	j.	PROPN
fnp-3866	189	5	f.	f.	PROPN
fnp-3866	189	6	,	,	PUNCT
fnp-3866	189	7	trojanowski	trojanowski	PROPN
fnp-3866	189	8	,	,	PUNCT
fnp-3866	189	9	j.	j.	PROPN
fnp-3866	189	10	q.	q.	PROPN
fnp-3866	189	11	,	,	PUNCT
fnp-3866	189	12	schneider	schneider	PROPN
fnp-3866	189	13	,	,	PUNCT
fnp-3866	189	14	j.	j.	PROPN
fnp-3866	189	15	a.	a.	PROPN
fnp-3866	189	16	,	,	PUNCT
fnp-3866	189	17	abisambra	abisambra	PROPN
fnp-3866	189	18	,	,	PUNCT
fnp-3866	189	19	j.	j.	PROPN
fnp-3866	189	20	f.	f.	PROPN
fnp-3866	189	21	,	,	PUNCT
fnp-3866	189	22	abner	abner	PROPN
fnp-3866	189	23	,	,	PUNCT
fnp-3866	189	24	e.	e.	PROPN
fnp-3866	189	25	l.	l.	PROPN
fnp-3866	189	26	,	,	PUNCT
fnp-3866	189	27	alafuzoff	alafuzoff	PROPN
fnp-3866	189	28	,	,	PUNCT
fnp-3866	189	29	i.	i.	PROPN
fnp-3866	189	30	,	,	PUNCT
fnp-3866	189	31	arnold	arnold	PROPN
fnp-3866	189	32	,	,	PUNCT
fnp-3866	189	33	s.	s.	PROPN
fnp-3866	189	34	e.	e.	PROPN
fnp-3866	189	35	,	,	PUNCT
fnp-3866	189	36	attems	attem	VERB
fnp-3866	189	37	,	,	PUNCT
fnp-3866	189	38	j.	j.	PROPN
fnp-3866	189	39	,	,	PUNCT
fnp-3866	189	40	beach	beach	PROPN
fnp-3866	189	41	,	,	PUNCT
fnp-3866	189	42	t.	t.	PROPN
fnp-3866	189	43	g.	g.	PROPN
fnp-3866	189	44	,	,	PUNCT
fnp-3866	189	45	bigio	bigio	NOUN
fnp-3866	189	46	,	,	PUNCT
fnp-3866	189	47	e.	e.	PROPN
fnp-3866	189	48	h.	h.	PROPN
fnp-3866	189	49	,	,	PUNCT
fnp-3866	189	50	cairns	cairns	PROPN
fnp-3866	189	51	,	,	PUNCT
fnp-3866	189	52	n.	n.	PROPN
fnp-3866	189	53	j.	j.	PROPN
fnp-3866	189	54	,	,	PUNCT
fnp-3866	189	55	dickson	dickson	PROPN
fnp-3866	189	56	,	,	PUNCT
fnp-3866	189	57	d.	d.	PROPN
fnp-3866	189	58	w.	w.	PROPN
fnp-3866	189	59	,	,	PUNCT
fnp-3866	189	60	gearing	gearing	NOUN
fnp-3866	189	61	,	,	PUNCT
fnp-3866	189	62	m.	m.	NOUN
fnp-3866	189	63	,	,	PUNCT
fnp-3866	189	64	grinberg	grinberg	PROPN
fnp-3866	189	65	,	,	PUNCT
fnp-3866	189	66	l.	l.	PROPN
fnp-3866	189	67	t.	t.	PROPN
fnp-3866	189	68	,	,	PUNCT
fnp-3866	189	69	hof	hof	PROPN
fnp-3866	189	70	,	,	PUNCT
fnp-3866	189	71	p.	p.	PROPN
fnp-3866	189	72	r.	r.	PROPN
fnp-3866	189	73	,	,	PUNCT
fnp-3866	189	74	hyman	hyman	PROPN
fnp-3866	189	75	,	,	PUNCT
fnp-3866	189	76	b.	b.	PROPN
fnp-3866	189	77	t.	t.	PROPN
fnp-3866	189	78	,	,	PUNCT
fnp-3866	189	79	jellinger	jellinger	PROPN
fnp-3866	189	80	,	,	PUNCT
fnp-3866	189	81	k.	k.	PROPN
fnp-3866	189	82	,	,	PUNCT
fnp-3866	189	83	jicha	jicha	PROPN
fnp-3866	189	84	,	,	PUNCT
fnp-3866	189	85	g.	g.	PROPN
fnp-3866	189	86	a.	a.	PROPN
fnp-3866	189	87	,	,	PUNCT
fnp-3866	189	88	kovacs	kovacs	PROPN
fnp-3866	189	89	,	,	PUNCT
fnp-3866	189	90	g.	g.	PROPN
fnp-3866	189	91	g.	g.	PROPN
fnp-3866	189	92	,	,	PUNCT
fnp-3866	189	93	…	…	PUNCT
fnp-3866	189	94	nelson	nelson	PROPN
fnp-3866	189	95	,	,	PUNCT
fnp-3866	189	96	p.	p.	NOUN
fnp-3866	189	97	t.	t.	PROPN
fnp-3866	189	98	(	(	PUNCT
fnp-3866	189	99	2014	2014	NUM
fnp-3866	189	100	)	)	PUNCT
fnp-3866	189	101	.	.	PUNCT
fnp-3866	190	1	primary	primary	ADJ
fnp-3866	190	2	age	age	NOUN
fnp-3866	190	3	-	-	PUNCT
fnp-3866	190	4	related	relate	VERB
fnp-3866	190	5	tauopathy	tauopathy	NOUN
fnp-3866	190	6	(	(	PUNCT
fnp-3866	190	7	part	part	NOUN
fnp-3866	190	8	):	):	PUNCT
fnp-3866	190	9	a	a	DET
fnp-3866	190	10	common	common	ADJ
fnp-3866	190	11	pathology	pathology	NOUN
fnp-3866	190	12	associated	associate	VERB
fnp-3866	190	13	with	with	ADP
fnp-3866	190	14	human	human	ADJ
fnp-3866	190	15	aging	aging	NOUN
fnp-3866	190	16	.	.	PUNCT
fnp-3866	191	1	acta	acta	PROPN
fnp-3866	191	2	neuropathologica	neuropathologica	PROPN
fnp-3866	191	3	,	,	PUNCT
fnp-3866	191	4	128(6	128(6	NUM
fnp-3866	191	5	)	)	PUNCT
fnp-3866	191	6	,	,	PUNCT
fnp-3866	191	7	755–766	755–766	NUM
fnp-3866	191	8	.	.	PUNCT
fnp-3866	192	1	https://doi.org/10.1007/s00401-014-1349-0	https://doi.org/10.1007/s00401-014-1349-0	NUM
fnp-3866	192	2	crivelli	crivelli	PROPN
fnp-3866	192	3	,	,	PUNCT
fnp-3866	192	4	l.	l.	PROPN
fnp-3866	192	5	,	,	PUNCT
fnp-3866	192	6	palmer	palmer	PROPN
fnp-3866	192	7	,	,	PUNCT
fnp-3866	192	8	k.	k.	PROPN
fnp-3866	192	9	,	,	PUNCT
fnp-3866	192	10	calandri	calandri	PROPN
fnp-3866	192	11	,	,	PUNCT
fnp-3866	192	12	i.	i.	PROPN
fnp-3866	192	13	,	,	PUNCT
fnp-3866	192	14	guekht	guekht	PROPN
fnp-3866	192	15	,	,	PUNCT
fnp-3866	192	16	a.	a.	PROPN
fnp-3866	192	17	,	,	PUNCT
fnp-3866	192	18	beghi	beghi	PROPN
fnp-3866	192	19	,	,	PUNCT
fnp-3866	192	20	e.	e.	PROPN
fnp-3866	192	21	,	,	PUNCT
fnp-3866	192	22	carroll	carroll	PROPN
fnp-3866	192	23	,	,	PUNCT
fnp-3866	192	24	w.	w.	PROPN
fnp-3866	192	25	,	,	PUNCT
fnp-3866	192	26	frontera	frontera	PROPN
fnp-3866	192	27	,	,	PUNCT
fnp-3866	192	28	j.	j.	PROPN
fnp-3866	192	29	,	,	PUNCT
fnp-3866	192	30	garcía	garcía	NOUN
fnp-3866	192	31	-	-	PUNCT
fnp-3866	192	32	azorín	azorín	PROPN
fnp-3866	192	33	,	,	PUNCT
fnp-3866	192	34	d.	d.	PROPN
fnp-3866	192	35	,	,	PUNCT
fnp-3866	192	36	westenberg	westenberg	PROPN
fnp-3866	192	37	,	,	PUNCT
fnp-3866	192	38	e.	e.	PROPN
fnp-3866	192	39	,	,	PUNCT
fnp-3866	192	40	winkler	winkler	PROPN
fnp-3866	192	41	,	,	PUNCT
fnp-3866	192	42	a.	a.	PROPN
fnp-3866	192	43	s.	s.	PROPN
fnp-3866	192	44	,	,	PUNCT
fnp-3866	192	45	mangialasche	mangialasche	PROPN
fnp-3866	192	46	,	,	PUNCT
fnp-3866	192	47	f.	f.	PROPN
fnp-3866	192	48	,	,	PUNCT
fnp-3866	192	49	allegri	allegri	PROPN
fnp-3866	192	50	,	,	PUNCT
fnp-3866	192	51	r.	r.	PROPN
fnp-3866	192	52	f.	f.	PROPN
fnp-3866	192	53	,	,	PUNCT
fnp-3866	192	54	&	&	CCONJ
fnp-3866	192	55	kivipelto	kivipelto	PROPN
fnp-3866	192	56	,	,	PUNCT
fnp-3866	192	57	m.	m.	NOUN
fnp-3866	192	58	(	(	PUNCT
fnp-3866	192	59	2022	2022	NUM
fnp-3866	192	60	)	)	PUNCT
fnp-3866	192	61	.	.	PUNCT
fnp-3866	193	1	changes	change	NOUN
fnp-3866	193	2	in	in	ADP
fnp-3866	193	3	cognitive	cognitive	ADJ
fnp-3866	193	4	functioning	functioning	NOUN
fnp-3866	193	5	after	after	ADP
fnp-3866	193	6	covid-19	covid-19	PROPN
fnp-3866	193	7	:	:	PUNCT
fnp-3866	193	8	a	a	DET
fnp-3866	193	9	systematic	systematic	ADJ
fnp-3866	193	10	review	review	NOUN
fnp-3866	193	11	and	and	CCONJ
fnp-3866	193	12	meta	meta	ADJ
fnp-3866	193	13	-	-	PUNCT
fnp-3866	193	14	analysis	analysis	NOUN
fnp-3866	193	15	.	.	PUNCT
fnp-3866	194	1	alzheimer	alzheimer	PROPN
fnp-3866	194	2	’s	’s	PART
fnp-3866	194	3	&	&	CCONJ
fnp-3866	194	4	dementia	dementia	PROPN
fnp-3866	194	5	:	:	PUNCT
fnp-3866	194	6	the	the	DET
fnp-3866	194	7	journal	journal	NOUN
fnp-3866	194	8	of	of	ADP
fnp-3866	194	9	the	the	DET
fnp-3866	194	10	alzheimer	alzheimer	PROPN
fnp-3866	194	11	’s	’s	PROPN
fnp-3866	194	12	association	association	NOUN
fnp-3866	194	13	.	.	PUNCT
fnp-3866	195	1	https://doi.org/10.1002/alz.12644	https://doi.org/10.1002/alz.12644	PROPN
fnp-3866	195	2	farrell	farrell	PROPN
fnp-3866	195	3	,	,	PUNCT
fnp-3866	195	4	k.	k.	PROPN
fnp-3866	195	5	,	,	PUNCT
fnp-3866	195	6	kim	kim	PROPN
fnp-3866	195	7	,	,	PUNCT
fnp-3866	195	8	s.	s.	PROPN
fnp-3866	195	9	,	,	PUNCT
fnp-3866	195	10	han	han	PROPN
fnp-3866	195	11	,	,	PUNCT
fnp-3866	195	12	n.	n.	PROPN
fnp-3866	195	13	,	,	PUNCT
fnp-3866	195	14	iida	iida	PROPN
fnp-3866	195	15	,	,	PUNCT
fnp-3866	195	16	m.	m.	NOUN
fnp-3866	195	17	a.	a.	PROPN
fnp-3866	195	18	,	,	PUNCT
fnp-3866	195	19	gonzalez	gonzalez	PROPN
fnp-3866	195	20	,	,	PUNCT
fnp-3866	195	21	e.	e.	PROPN
fnp-3866	195	22	m.	m.	PROPN
fnp-3866	195	23	,	,	PUNCT
fnp-3866	195	24	otero	otero	PROPN
fnp-3866	195	25	-	-	PUNCT
fnp-3866	195	26	garcia	garcia	PROPN
fnp-3866	195	27	,	,	PUNCT
fnp-3866	195	28	m.	m.	NOUN
fnp-3866	195	29	,	,	PUNCT
fnp-3866	195	30	walker	walker	PROPN
fnp-3866	195	31	,	,	PUNCT
fnp-3866	195	32	j.	j.	PROPN
fnp-3866	195	33	m.	m.	PROPN
fnp-3866	195	34	,	,	PUNCT
fnp-3866	195	35	richardson	richardson	PROPN
fnp-3866	195	36	,	,	PUNCT
fnp-3866	195	37	t.	t.	PROPN
fnp-3866	195	38	e.	e.	PROPN
fnp-3866	195	39	,	,	PUNCT
fnp-3866	195	40	renton	renton	PROPN
fnp-3866	195	41	,	,	PUNCT
fnp-3866	195	42	a.	a.	PROPN
fnp-3866	195	43	e.	e.	PROPN
fnp-3866	195	44	,	,	PUNCT
fnp-3866	195	45	andrews	andrews	PROPN
fnp-3866	195	46	,	,	PUNCT
fnp-3866	195	47	s.	s.	PROPN
fnp-3866	195	48	j.	j.	PROPN
fnp-3866	195	49	,	,	PUNCT
fnp-3866	195	50	fulton	fulton	PROPN
fnp-3866	195	51	-	-	PUNCT
fnp-3866	195	52	howard	howard	PROPN
fnp-3866	195	53	,	,	PUNCT
fnp-3866	195	54	b.	b.	PROPN
fnp-3866	195	55	,	,	PUNCT
fnp-3866	195	56	humphrey	humphrey	PROPN
fnp-3866	195	57	,	,	PUNCT
fnp-3866	195	58	j.	j.	PROPN
fnp-3866	195	59	,	,	PUNCT
fnp-3866	195	60	vialle	vialle	PROPN
fnp-3866	195	61	,	,	PUNCT
fnp-3866	195	62	r.	r.	PROPN
fnp-3866	195	63	a.	a.	PROPN
fnp-3866	195	64	,	,	PUNCT
fnp-3866	195	65	bowles	bowles	PROPN
fnp-3866	195	66	,	,	PUNCT
fnp-3866	195	67	k.	k.	PROPN
fnp-3866	195	68	r.	r.	PROPN
fnp-3866	195	69	,	,	PUNCT
fnp-3866	195	70	de	de	PROPN
fnp-3866	195	71	paiva	paiva	PROPN
fnp-3866	195	72	lopes	lopes	PROPN
fnp-3866	195	73	,	,	PUNCT
fnp-3866	195	74	k.	k.	PROPN
fnp-3866	195	75	,	,	PUNCT
fnp-3866	195	76	whitney	whitney	PROPN
fnp-3866	195	77	,	,	PUNCT
fnp-3866	195	78	k.	k.	PROPN
fnp-3866	195	79	,	,	PUNCT
fnp-3866	195	80	dangoor	dangoor	PROPN
fnp-3866	195	81	,	,	PUNCT
fnp-3866	195	82	d.	d.	PROPN
fnp-3866	195	83	k.	k.	PROPN
fnp-3866	195	84	,	,	PUNCT
fnp-3866	195	85	walsh	walsh	PROPN
fnp-3866	195	86	,	,	PUNCT
fnp-3866	195	87	h.	h.	PROPN
fnp-3866	195	88	,	,	PUNCT
fnp-3866	195	89	marcora	marcora	PROPN
fnp-3866	195	90	,	,	PUNCT
fnp-3866	195	91	e.	e.	PROPN
fnp-3866	195	92	,	,	PUNCT
fnp-3866	195	93	…	…	PUNCT
fnp-3866	195	94	crary	crary	NOUN
fnp-3866	195	95	,	,	PUNCT
fnp-3866	195	96	j.	j.	PROPN
fnp-3866	195	97	f.	f.	PROPN
fnp-3866	195	98	(	(	PUNCT
fnp-3866	195	99	2022	2022	NUM
fnp-3866	195	100	)	)	PUNCT
fnp-3866	195	101	.	.	PUNCT
fnp-3866	196	1	genome	genome	NOUN
fnp-3866	196	2	-	-	PUNCT
fnp-3866	196	3	wide	wide	ADJ
fnp-3866	196	4	association	association	NOUN
fnp-3866	196	5	study	study	NOUN
fnp-3866	196	6	and	and	CCONJ
fnp-3866	196	7	functional	functional	ADJ
fnp-3866	196	8	validation	validation	NOUN
fnp-3866	196	9	implicates	implicate	VERB
fnp-3866	196	10	jade1	jade1	NOUN
fnp-3866	196	11	in	in	ADP
fnp-3866	196	12	tauopathy	tauopathy	NOUN
fnp-3866	196	13	.	.	PUNCT
fnp-3866	197	1	acta	acta	PROPN
fnp-3866	197	2	neuropathologica	neuropathologica	PROPN
fnp-3866	197	3	,	,	PUNCT
fnp-3866	197	4	143(1	143(1	NUM
fnp-3866	197	5	)	)	PUNCT
fnp-3866	197	6	,	,	PUNCT
fnp-3866	197	7	33–53	33–53	NUM
fnp-3866	197	8	.	.	PUNCT
fnp-3866	198	1	https://doi.org/10.1007/s00401-021-02379-z	https://doi.org/10.1007/s00401-021-02379-z	PROPN
fnp-3866	198	2	hickman	hickman	PROPN
fnp-3866	198	3	,	,	PUNCT
fnp-3866	198	4	r.	r.	PROPN
fnp-3866	198	5	a.	a.	PROPN
fnp-3866	198	6	,	,	PUNCT
fnp-3866	198	7	faust	faust	PROPN
fnp-3866	198	8	,	,	PUNCT
fnp-3866	198	9	p.	p.	PROPN
fnp-3866	198	10	l.	l.	PROPN
fnp-3866	198	11	,	,	PUNCT
fnp-3866	198	12	rosenblum	rosenblum	PROPN
fnp-3866	198	13	,	,	PUNCT
fnp-3866	198	14	m.	m.	PROPN
fnp-3866	198	15	k.	k.	PROPN
fnp-3866	198	16	,	,	PUNCT
fnp-3866	198	17	marder	marder	PROPN
fnp-3866	198	18	,	,	PUNCT
fnp-3866	198	19	k.	k.	PROPN
fnp-3866	198	20	,	,	PUNCT
fnp-3866	198	21	mehler	mehler	NOUN
fnp-3866	198	22	,	,	PUNCT
fnp-3866	198	23	m.	m.	NOUN
fnp-3866	198	24	f.	f.	PROPN
fnp-3866	198	25	,	,	PUNCT
fnp-3866	198	26	&	&	CCONJ
fnp-3866	198	27	vonsattel	vonsattel	PROPN
fnp-3866	198	28	,	,	PUNCT
fnp-3866	198	29	j.	j.	PROPN
fnp-3866	198	30	p.	p.	PROPN
fnp-3866	198	31	(	(	PUNCT
fnp-3866	198	32	2021	2021	NUM
fnp-3866	198	33	)	)	PUNCT
fnp-3866	198	34	.	.	PUNCT
fnp-3866	199	1	developmental	developmental	ADJ
fnp-3866	199	2	malformations	malformation	NOUN
fnp-3866	199	3	in	in	ADP
fnp-3866	199	4	huntington	huntington	PROPN
fnp-3866	199	5	disease	disease	NOUN
fnp-3866	199	6	:	:	PUNCT
fnp-3866	199	7	neuropathologic	neuropathologic	ADJ
fnp-3866	199	8	evidence	evidence	NOUN
fnp-3866	199	9	of	of	ADP
fnp-3866	199	10	focal	focal	ADJ
fnp-3866	199	11	neuronal	neuronal	ADJ
fnp-3866	199	12	migration	migration	NOUN
fnp-3866	199	13	defects	defect	NOUN
fnp-3866	199	14	in	in	ADP
fnp-3866	199	15	a	a	DET
fnp-3866	199	16	subset	subset	NOUN
fnp-3866	199	17	of	of	ADP
fnp-3866	199	18	adult	adult	NOUN
fnp-3866	199	19	brains	brain	NOUN
fnp-3866	199	20	.	.	PUNCT
fnp-3866	200	1	acta	acta	PROPN
fnp-3866	200	2	neuropathologica	neuropathologica	PROPN
fnp-3866	200	3	,	,	PUNCT
fnp-3866	200	4	141(3	141(3	NUM
fnp-3866	200	5	)	)	PUNCT
fnp-3866	200	6	,	,	PUNCT
fnp-3866	200	7	399–413	399–413	NUM
fnp-3866	200	8	.	.	PUNCT
fnp-3866	201	1	https://doi.org/10.1007/s00401-021-02269-4	https://doi.org/10.1007/s00401-021-02269-4	NUM
fnp-3866	201	2	janocko	janocko	NOUN
fnp-3866	201	3	,	,	PUNCT
fnp-3866	201	4	n.	n.	PROPN
fnp-3866	201	5	j.	j.	PROPN
fnp-3866	201	6	,	,	PUNCT
fnp-3866	201	7	brodersen	brodersen	PROPN
fnp-3866	201	8	,	,	PUNCT
fnp-3866	201	9	k.	k.	PROPN
fnp-3866	201	10	a.	a.	PROPN
fnp-3866	201	11	,	,	PUNCT
fnp-3866	201	12	soto	soto	NOUN
fnp-3866	201	13	-	-	PUNCT
fnp-3866	201	14	ortolaza	ortolaza	PROPN
fnp-3866	201	15	,	,	PUNCT
fnp-3866	201	16	a.	a.	NOUN
fnp-3866	201	17	i.	i.	PROPN
fnp-3866	201	18	,	,	PUNCT
fnp-3866	201	19	ross	ross	PROPN
fnp-3866	201	20	,	,	PUNCT
fnp-3866	201	21	o.	o.	PROPN
fnp-3866	201	22	a.	a.	PROPN
fnp-3866	201	23	,	,	PUNCT
fnp-3866	201	24	liesinger	liesinger	NOUN
fnp-3866	201	25	,	,	PUNCT
fnp-3866	201	26	a.	a.	NOUN
fnp-3866	201	27	m.	m.	NOUN
fnp-3866	201	28	,	,	PUNCT
fnp-3866	201	29	duara	duara	PROPN
fnp-3866	201	30	,	,	PUNCT
fnp-3866	201	31	r.	r.	PROPN
fnp-3866	201	32	,	,	PUNCT
fnp-3866	201	33	graff	graff	NOUN
fnp-3866	201	34	-	-	PUNCT
fnp-3866	201	35	radford	radford	PROPN
fnp-3866	201	36	,	,	PUNCT
fnp-3866	201	37	n.	n.	PROPN
fnp-3866	201	38	r.	r.	PROPN
fnp-3866	201	39	,	,	PUNCT
fnp-3866	201	40	dickson	dickson	PROPN
fnp-3866	201	41	,	,	PUNCT
fnp-3866	201	42	d.	d.	PROPN
fnp-3866	201	43	w.	w.	PROPN
fnp-3866	201	44	,	,	PUNCT
fnp-3866	201	45	&	&	CCONJ
fnp-3866	201	46	murray	murray	PROPN
fnp-3866	201	47	,	,	PUNCT
fnp-3866	201	48	m.	m.	PROPN
fnp-3866	201	49	e.	e.	PROPN
fnp-3866	201	50	(	(	PUNCT
fnp-3866	201	51	2012	2012	NUM
fnp-3866	201	52	)	)	PUNCT
fnp-3866	201	53	.	.	PUNCT
fnp-3866	202	1	neuropathologically	neuropathologically	ADV
fnp-3866	202	2	defined	define	VERB
fnp-3866	202	3	subtypes	subtype	NOUN
fnp-3866	202	4	of	of	ADP
fnp-3866	202	5	alzheimer	alzheimer	PROPN
fnp-3866	202	6	’s	’s	PART
fnp-3866	202	7	disease	disease	NOUN
fnp-3866	202	8	differ	differ	VERB
fnp-3866	202	9	significantly	significantly	ADV
fnp-3866	202	10	from	from	ADP
fnp-3866	202	11	neurofibrillary	neurofibrillary	ADJ
fnp-3866	202	12	tangle	tangle	NOUN
fnp-3866	202	13	-	-	PUNCT
fnp-3866	202	14	predominant	predominant	ADJ
fnp-3866	202	15	dementia	dementia	NOUN
fnp-3866	202	16	.	.	PUNCT
fnp-3866	203	1	acta	acta	PROPN
fnp-3866	203	2	neuropathologica	neuropathologica	PROPN
fnp-3866	203	3	,	,	PUNCT
fnp-3866	203	4	124(5	124(5	NUM
fnp-3866	203	5	)	)	PUNCT
fnp-3866	203	6	,	,	PUNCT
fnp-3866	203	7	681–692	681–692	NUM
fnp-3866	203	8	.	.	PUNCT
fnp-3866	204	1	https://doi.org/10.1007/s00401-012-1044-y	https://doi.org/10.1007/s00401-012-1044-y	PROPN
fnp-3866	204	2	krey	krey	PROPN
fnp-3866	204	3	,	,	PUNCT
fnp-3866	204	4	l.	l.	PROPN
fnp-3866	204	5	,	,	PUNCT
fnp-3866	204	6	huber	huber	PROPN
fnp-3866	204	7	,	,	PUNCT
fnp-3866	204	8	m.	m.	PROPN
fnp-3866	204	9	k.	k.	PROPN
fnp-3866	204	10	,	,	PUNCT
fnp-3866	204	11	höglinger	höglinger	NOUN
fnp-3866	204	12	,	,	PUNCT
fnp-3866	204	13	g.	g.	PROPN
fnp-3866	204	14	u.	u.	PROPN
fnp-3866	204	15	,	,	PUNCT
fnp-3866	204	16	&	&	CCONJ
fnp-3866	204	17	wegner	wegner	PROPN
fnp-3866	204	18	,	,	PUNCT
fnp-3866	204	19	f.	f.	PROPN
fnp-3866	204	20	(	(	PUNCT
fnp-3866	204	21	2021	2021	NUM
fnp-3866	204	22	)	)	PUNCT
fnp-3866	204	23	.	.	PUNCT
fnp-3866	205	1	can	can	AUX
fnp-3866	205	2	sars	sars	PROPN
fnp-3866	205	3	-	-	PUNCT
fnp-3866	205	4	cov-2	cov-2	PART
fnp-3866	205	5	infection	infection	NOUN
fnp-3866	205	6	lead	lead	NOUN
fnp-3866	205	7	to	to	ADP
fnp-3866	205	8	neurodegeneration	neurodegeneration	NOUN
fnp-3866	205	9	and	and	CCONJ
fnp-3866	205	10	parkinson	parkinson	NOUN
fnp-3866	205	11	’s	’s	PART
fnp-3866	205	12	disease	disease	NOUN
fnp-3866	205	13	?	?	PUNCT
fnp-3866	206	1	brain	brain	NOUN
fnp-3866	206	2	sciences	science	NOUN
fnp-3866	206	3	,	,	PUNCT
fnp-3866	206	4	11(12	11(12	NUM
fnp-3866	206	5	)	)	PUNCT
fnp-3866	206	6	,	,	PUNCT
fnp-3866	206	7	1654	1654	NUM
fnp-3866	206	8	.	.	PUNCT
fnp-3866	207	1	https://doi.org/10.3390/brainsci11121654	https://doi.org/10.3390/brainsci11121654	PROPN
fnp-3866	207	2	lennon	lennon	PROPN
fnp-3866	207	3	,	,	PUNCT
fnp-3866	207	4	j.	j.	PROPN
fnp-3866	207	5	c.	c.	PROPN
fnp-3866	207	6	(	(	PUNCT
fnp-3866	207	7	2020	2020	NUM
fnp-3866	207	8	)	)	PUNCT
fnp-3866	207	9	.	.	PUNCT
fnp-3866	208	1	neurologic	neurologic	ADJ
fnp-3866	208	2	and	and	CCONJ
fnp-3866	208	3	immunologic	immunologic	ADJ
fnp-3866	208	4	complications	complication	NOUN
fnp-3866	208	5	of	of	ADP
fnp-3866	208	6	covid-19	covid-19	PROPN
fnp-3866	208	7	:	:	PUNCT
fnp-3866	208	8	potential	potential	ADJ
fnp-3866	208	9	long	long	ADJ
fnp-3866	208	10	-	-	PUNCT
fnp-3866	208	11	term	term	NOUN
fnp-3866	208	12	risk	risk	NOUN
fnp-3866	208	13	factors	factor	NOUN
fnp-3866	208	14	for	for	ADP
fnp-3866	208	15	alzheimer	alzheimer	PROPN
fnp-3866	208	16	’s	’s	PART
fnp-3866	208	17	disease	disease	NOUN
fnp-3866	208	18	.	.	PUNCT
fnp-3866	209	1	journal	journal	PROPN
fnp-3866	209	2	of	of	ADP
fnp-3866	209	3	alzheimer	alzheimer	PROPN
fnp-3866	209	4	’s	’s	PART
fnp-3866	209	5	disease	disease	NOUN
fnp-3866	209	6	reports	report	VERB
fnp-3866	209	7	,	,	PUNCT
fnp-3866	209	8	4(1	4(1	NOUN
fnp-3866	209	9	)	)	PUNCT
fnp-3866	209	10	,	,	PUNCT
fnp-3866	209	11	217–221	217–221	NUM
fnp-3866	209	12	.	.	PUNCT
fnp-3866	210	1	https://doi.org/10.3233/adr-200190	https://doi.org/10.3233/adr-200190	NOUN
fnp-3866	210	2	leverenz	leverenz	NOUN
fnp-3866	210	3	,	,	PUNCT
fnp-3866	210	4	j.	j.	PROPN
fnp-3866	210	5	b.	b.	PROPN
fnp-3866	210	6	,	,	PUNCT
fnp-3866	210	7	hamilton	hamilton	PROPN
fnp-3866	210	8	,	,	PUNCT
fnp-3866	210	9	r.	r.	PROPN
fnp-3866	210	10	,	,	PUNCT
fnp-3866	210	11	tsuang	tsuang	PROPN
fnp-3866	210	12	,	,	PUNCT
fnp-3866	210	13	d.	d.	PROPN
fnp-3866	210	14	w.	w.	PROPN
fnp-3866	210	15	,	,	PUNCT
fnp-3866	210	16	schantz	schantz	PROPN
fnp-3866	210	17	,	,	PUNCT
fnp-3866	210	18	a.	a.	NOUN
fnp-3866	210	19	,	,	PUNCT
fnp-3866	210	20	vavrek	vavrek	NOUN
fnp-3866	210	21	,	,	PUNCT
fnp-3866	210	22	d.	d.	PROPN
fnp-3866	210	23	,	,	PUNCT
fnp-3866	210	24	larson	larson	PROPN
fnp-3866	210	25	,	,	PUNCT
fnp-3866	210	26	e.	e.	PROPN
fnp-3866	210	27	b.	b.	PROPN
fnp-3866	210	28	,	,	PUNCT
fnp-3866	210	29	kukull	kukull	PROPN
fnp-3866	210	30	,	,	PUNCT
fnp-3866	210	31	w.	w.	PROPN
fnp-3866	210	32	a.	a.	PROPN
fnp-3866	210	33	,	,	PUNCT
fnp-3866	210	34	lopez	lopez	NOUN
fnp-3866	210	35	,	,	PUNCT
fnp-3866	210	36	o.	o.	PROPN
fnp-3866	210	37	,	,	PUNCT
fnp-3866	210	38	galasko	galasko	PROPN
fnp-3866	210	39	,	,	PUNCT
fnp-3866	210	40	d.	d.	PROPN
fnp-3866	210	41	,	,	PUNCT
fnp-3866	210	42	masliah	masliah	PROPN
fnp-3866	210	43	,	,	PUNCT
fnp-3866	210	44	e.	e.	PROPN
fnp-3866	210	45	,	,	PUNCT
fnp-3866	210	46	kaye	kaye	PROPN
fnp-3866	210	47	,	,	PUNCT
fnp-3866	210	48	j.	j.	PROPN
fnp-3866	210	49	,	,	PUNCT
fnp-3866	210	50	woltjer	woltjer	PROPN
fnp-3866	210	51	,	,	PUNCT
fnp-3866	210	52	r.	r.	PROPN
fnp-3866	210	53	,	,	PUNCT
fnp-3866	210	54	clark	clark	PROPN
fnp-3866	210	55	,	,	PUNCT
fnp-3866	210	56	c.	c.	PROPN
fnp-3866	210	57	,	,	PUNCT
fnp-3866	210	58	trojanowski	trojanowski	PROPN
fnp-3866	210	59	,	,	PUNCT
fnp-3866	210	60	j.	j.	PROPN
fnp-3866	210	61	q.	q.	PROPN
fnp-3866	210	62	,	,	PUNCT
fnp-3866	210	63	&	&	CCONJ
fnp-3866	210	64	montine	montine	PROPN
fnp-3866	210	65	,	,	PUNCT
fnp-3866	210	66	t.	t.	PROPN
fnp-3866	210	67	j.	j.	PROPN
fnp-3866	210	68	(	(	PUNCT
fnp-3866	210	69	2008	2008	NUM
fnp-3866	210	70	)	)	PUNCT
fnp-3866	210	71	.	.	PUNCT
fnp-3866	211	1	empiric	empiric	ADJ
fnp-3866	211	2	refinement	refinement	NOUN
fnp-3866	211	3	of	of	ADP
fnp-3866	211	4	the	the	DET
fnp-3866	211	5	pathologic	pathologic	ADJ
fnp-3866	211	6	assessment	assessment	NOUN
fnp-3866	211	7	of	of	ADP
fnp-3866	211	8	lewy	lewy	PROPN
fnp-3866	211	9	-	-	PUNCT
fnp-3866	211	10	related	relate	VERB
fnp-3866	211	11	pathology	pathology	NOUN
fnp-3866	211	12	in	in	ADP
fnp-3866	211	13	the	the	DET
fnp-3866	211	14	dementia	dementia	NOUN
fnp-3866	211	15	patient	patient	NOUN
fnp-3866	211	16	.	.	PUNCT
fnp-3866	212	1	brain	brain	NOUN
fnp-3866	212	2	pathology	pathology	PROPN
fnp-3866	212	3	(	(	PUNCT
fnp-3866	212	4	zurich	zurich	PROPN
fnp-3866	212	5	,	,	PUNCT
fnp-3866	212	6	switzerland	switzerland	PROPN
fnp-3866	212	7	)	)	PUNCT
fnp-3866	212	8	,	,	PUNCT
fnp-3866	212	9	18(2	18(2	NUM
fnp-3866	212	10	)	)	PUNCT
fnp-3866	212	11	,	,	PUNCT
fnp-3866	212	12	220–224	220–224	NUM
fnp-3866	212	13	.	.	PUNCT
fnp-3866	213	1	https://doi.org/10.1111/j.1750-3639.2007.00117.x	https://doi.org/10.1111/j.1750-3639.2007.00117.x	PROPN
fnp-3866	213	2	mahoney	mahoney	PROPN
fnp-3866	213	3	,	,	PUNCT
fnp-3866	213	4	e.	e.	PROPN
fnp-3866	213	5	r.	r.	PROPN
fnp-3866	213	6	,	,	PUNCT
fnp-3866	213	7	dumitrescu	dumitrescu	PROPN
fnp-3866	213	8	,	,	PUNCT
fnp-3866	213	9	l.	l.	PROPN
fnp-3866	213	10	,	,	PUNCT
fnp-3866	213	11	moore	moore	PROPN
fnp-3866	213	12	,	,	PUNCT
fnp-3866	213	13	a.	a.	NOUN
fnp-3866	213	14	m.	m.	NOUN
fnp-3866	213	15	,	,	PUNCT
fnp-3866	213	16	cambronero	cambronero	PROPN
fnp-3866	213	17	,	,	PUNCT
fnp-3866	213	18	f.	f.	PROPN
fnp-3866	213	19	e.	e.	PROPN
fnp-3866	213	20	,	,	PUNCT
fnp-3866	213	21	de	de	X
fnp-3866	213	22	jager	jager	PROPN
fnp-3866	213	23	,	,	PUNCT
fnp-3866	213	24	p.	p.	PROPN
fnp-3866	213	25	l.	l.	PROPN
fnp-3866	213	26	,	,	PUNCT
fnp-3866	213	27	koran	koran	PROPN
fnp-3866	213	28	,	,	PUNCT
fnp-3866	213	29	m.	m.	PROPN
fnp-3866	213	30	e.	e.	PROPN
fnp-3866	213	31	i.	i.	PROPN
fnp-3866	213	32	,	,	PUNCT
fnp-3866	213	33	petyuk	petyuk	NOUN
fnp-3866	213	34	,	,	PUNCT
fnp-3866	213	35	v.	v.	PROPN
fnp-3866	213	36	a.	a.	PROPN
fnp-3866	213	37	,	,	PUNCT
fnp-3866	213	38	robinson	robinson	PROPN
fnp-3866	213	39	,	,	PUNCT
fnp-3866	213	40	r.	r.	PROPN
fnp-3866	213	41	a.	a.	PROPN
fnp-3866	213	42	s.	s.	PROPN
fnp-3866	213	43	,	,	PUNCT
fnp-3866	213	44	goyal	goyal	PROPN
fnp-3866	213	45	,	,	PUNCT
fnp-3866	213	46	s.	s.	PROPN
fnp-3866	213	47	,	,	PUNCT
fnp-3866	213	48	schneider	schneider	PROPN
fnp-3866	213	49	,	,	PUNCT
fnp-3866	213	50	j.	j.	PROPN
fnp-3866	213	51	a.	a.	PROPN
fnp-3866	213	52	,	,	PUNCT
fnp-3866	213	53	bennett	bennett	PROPN
fnp-3866	213	54	,	,	PUNCT
fnp-3866	213	55	d.	d.	PROPN
fnp-3866	213	56	a.	a.	PROPN
fnp-3866	213	57	,	,	PUNCT
fnp-3866	213	58	jefferson	jefferson	PROPN
fnp-3866	213	59	,	,	PUNCT
fnp-3866	213	60	a.	a.	PROPN
fnp-3866	213	61	l.	l.	PROPN
fnp-3866	213	62	,	,	PUNCT
fnp-3866	213	63	&	&	CCONJ
fnp-3866	213	64	hohman	hohman	NOUN
fnp-3866	213	65	,	,	PUNCT
fnp-3866	213	66	t.	t.	PROPN
fnp-3866	213	67	j.	j.	PROPN
fnp-3866	213	68	(	(	PUNCT
fnp-3866	213	69	2021	2021	NUM
fnp-3866	213	70	)	)	PUNCT
fnp-3866	213	71	.	.	PUNCT
fnp-3866	214	1	brain	brain	NOUN
fnp-3866	214	2	expression	expression	NOUN
fnp-3866	214	3	of	of	ADP
fnp-3866	214	4	the	the	DET
fnp-3866	214	5	vascular	vascular	ADJ
fnp-3866	214	6	endothelial	endothelial	ADJ
fnp-3866	214	7	growth	growth	NOUN
fnp-3866	214	8	factor	factor	NOUN
fnp-3866	214	9	gene	gene	NOUN
fnp-3866	214	10	family	family	NOUN
fnp-3866	214	11	in	in	ADP
fnp-3866	214	12	cognitive	cognitive	ADJ
fnp-3866	214	13	aging	aging	NOUN
fnp-3866	214	14	and	and	CCONJ
fnp-3866	214	15	alzheimer	alzheimer	PROPN
fnp-3866	214	16	’s	’s	PART
fnp-3866	214	17	disease	disease	NOUN
fnp-3866	214	18	.	.	PUNCT
fnp-3866	215	1	molecular	molecular	ADJ
fnp-3866	215	2	psychiatry	psychiatry	NOUN
fnp-3866	215	3	,	,	PUNCT
fnp-3866	215	4	26(3	26(3	NUM
fnp-3866	215	5	)	)	PUNCT
fnp-3866	215	6	,	,	PUNCT
fnp-3866	215	7	888–896	888–896	NUM
fnp-3866	215	8	.	.	PUNCT
fnp-3866	216	1	https://doi.org/10.1038/s41380-019-0458-5	https://doi.org/10.1038/s41380-019-0458-5	PROPN
fnp-3866	216	2	mao	mao	PROPN
fnp-3866	216	3	,	,	PUNCT
fnp-3866	216	4	f.	f.	PROPN
fnp-3866	216	5	,	,	PUNCT
fnp-3866	216	6	robinson	robinson	PROPN
fnp-3866	216	7	,	,	PUNCT
fnp-3866	216	8	j.	j.	PROPN
fnp-3866	216	9	l.	l.	PROPN
fnp-3866	216	10	,	,	PUNCT
fnp-3866	216	11	unger	unger	PROPN
fnp-3866	216	12	,	,	PUNCT
fnp-3866	216	13	t.	t.	PROPN
fnp-3866	216	14	,	,	PUNCT
fnp-3866	216	15	posavi	posavi	NOUN
fnp-3866	216	16	,	,	PUNCT
fnp-3866	216	17	m.	m.	NOUN
fnp-3866	216	18	,	,	PUNCT
fnp-3866	216	19	amado	amado	ADJ
fnp-3866	216	20	,	,	PUNCT
fnp-3866	216	21	d.	d.	PROPN
fnp-3866	216	22	a.	a.	PROPN
fnp-3866	216	23	,	,	PUNCT
fnp-3866	216	24	elman	elman	PROPN
fnp-3866	216	25	,	,	PUNCT
fnp-3866	216	26	l.	l.	PROPN
fnp-3866	216	27	,	,	PUNCT
fnp-3866	216	28	grossman	grossman	PROPN
fnp-3866	216	29	,	,	PUNCT
fnp-3866	216	30	m.	m.	NOUN
fnp-3866	216	31	,	,	PUNCT
fnp-3866	216	32	wolk	wolk	NOUN
fnp-3866	216	33	,	,	PUNCT
fnp-3866	216	34	d.	d.	PROPN
fnp-3866	216	35	a.	a.	PROPN
fnp-3866	216	36	,	,	PUNCT
fnp-3866	216	37	lee	lee	PROPN
fnp-3866	216	38	,	,	PUNCT
fnp-3866	216	39	e.	e.	PROPN
fnp-3866	216	40	b.	b.	PROPN
fnp-3866	216	41	,	,	PUNCT
fnp-3866	216	42	van	van	PROPN
fnp-3866	216	43	deerlin	deerlin	PROPN
fnp-3866	216	44	,	,	PUNCT
fnp-3866	216	45	v.	v.	ADP
fnp-3866	216	46	m.	m.	NOUN
fnp-3866	216	47	,	,	PUNCT
fnp-3866	216	48	porta	porta	PROPN
fnp-3866	216	49	,	,	PUNCT
fnp-3866	216	50	s.	s.	PROPN
fnp-3866	216	51	,	,	PUNCT
fnp-3866	216	52	lee	lee	PROPN
fnp-3866	216	53	,	,	PUNCT
fnp-3866	216	54	v.	v.	ADP
fnp-3866	216	55	m.	m.	NOUN
fnp-3866	216	56	y.	y.	PROPN
fnp-3866	216	57	,	,	PUNCT
fnp-3866	216	58	trojanowski	trojanowski	PROPN
fnp-3866	216	59	,	,	PUNCT
fnp-3866	216	60	j.	j.	PROPN
fnp-3866	216	61	q.	q.	PROPN
fnp-3866	216	62	,	,	PUNCT
fnp-3866	216	63	&	&	CCONJ
fnp-3866	216	64	chen	chen	PROPN
fnp-3866	216	65	-	-	PUNCT
fnp-3866	216	66	plotkin	plotkin	PROPN
fnp-3866	216	67	,	,	PUNCT
fnp-3866	216	68	a.	a.	PROPN
fnp-3866	216	69	s.	s.	PROPN
fnp-3866	216	70	(	(	PUNCT
fnp-3866	216	71	2021	2021	NUM
fnp-3866	216	72	)	)	PUNCT
fnp-3866	216	73	.	.	PUNCT
fnp-3866	217	1	tmem106b	tmem106b	PROPN
fnp-3866	217	2	modifies	modify	VERB
fnp-3866	217	3	tdp-43	tdp-43	PART
fnp-3866	217	4	pathology	pathology	NOUN
fnp-3866	217	5	in	in	ADP
fnp-3866	217	6	human	human	ADJ
fnp-3866	217	7	als	als	NOUN
fnp-3866	217	8	brain	brain	NOUN
fnp-3866	217	9	and	and	CCONJ
fnp-3866	217	10	cell	cell	NOUN
fnp-3866	217	11	-	-	PUNCT
fnp-3866	217	12	based	base	VERB
fnp-3866	217	13	models	model	NOUN
fnp-3866	217	14	of	of	ADP
fnp-3866	217	15	tdp-43	tdp-43	PROPN
fnp-3866	217	16	proteinopathy	proteinopathy	ADJ
fnp-3866	217	17	.	.	PUNCT
fnp-3866	218	1	acta	acta	PROPN
fnp-3866	218	2	neuropathologica	neuropathologica	PROPN
fnp-3866	218	3	,	,	PUNCT
fnp-3866	218	4	142(4	142(4	NUM
fnp-3866	218	5	)	)	PUNCT
fnp-3866	218	6	,	,	PUNCT
fnp-3866	218	7	629–642	629–642	NUM
fnp-3866	218	8	.	.	PUNCT
fnp-3866	219	1	https://doi.org/10.1007/s00401-021-02330-2	https://doi.org/10.1007/s00401-021-02330-2	PROPN
fnp-3866	219	2	mckee	mckee	PROPN
fnp-3866	219	3	,	,	PUNCT
fnp-3866	219	4	a.	a.	PROPN
fnp-3866	219	5	c.	c.	PROPN
fnp-3866	219	6	,	,	PUNCT
fnp-3866	219	7	cairns	cairns	PROPN
fnp-3866	219	8	,	,	PUNCT
fnp-3866	219	9	n.	n.	PROPN
fnp-3866	219	10	j.	j.	PROPN
fnp-3866	219	11	,	,	PUNCT
fnp-3866	219	12	dickson	dickson	PROPN
fnp-3866	219	13	,	,	PUNCT
fnp-3866	219	14	d.	d.	PROPN
fnp-3866	219	15	w.	w.	PROPN
fnp-3866	219	16	,	,	PUNCT
fnp-3866	219	17	folkerth	folkerth	PROPN
fnp-3866	219	18	,	,	PUNCT
fnp-3866	219	19	r.	r.	PROPN
fnp-3866	219	20	d.	d.	PROPN
fnp-3866	219	21	,	,	PUNCT
fnp-3866	219	22	keene	keene	PROPN
fnp-3866	219	23	,	,	PUNCT
fnp-3866	219	24	c.	c.	PROPN
fnp-3866	219	25	d.	d.	PROPN
fnp-3866	219	26	,	,	PUNCT
fnp-3866	219	27	litvan	litvan	PROPN
fnp-3866	219	28	,	,	PUNCT
fnp-3866	219	29	i.	i.	PROPN
fnp-3866	219	30	,	,	PUNCT
fnp-3866	219	31	perl	perl	PROPN
fnp-3866	219	32	,	,	PUNCT
fnp-3866	219	33	d.	d.	PROPN
fnp-3866	219	34	p.	p.	PROPN
fnp-3866	219	35	,	,	PUNCT
fnp-3866	219	36	stein	stein	PROPN
fnp-3866	219	37	,	,	PUNCT
fnp-3866	219	38	t.	t.	PROPN
fnp-3866	219	39	d.	d.	PROPN
fnp-3866	219	40	,	,	PUNCT
fnp-3866	219	41	vonsattel	vonsattel	NOUN
fnp-3866	219	42	,	,	PUNCT
fnp-3866	219	43	j.-p	j.-p	PROPN
fnp-3866	219	44	.	.	PROPN
fnp-3866	219	45	,	,	PUNCT
fnp-3866	219	46	stewart	stewart	PROPN
fnp-3866	219	47	,	,	PUNCT
fnp-3866	219	48	w.	w.	PROPN
fnp-3866	219	49	,	,	PUNCT
fnp-3866	219	50	tripodis	tripodi	NOUN
fnp-3866	219	51	,	,	PUNCT
fnp-3866	219	52	y.	y.	PROPN
fnp-3866	219	53	,	,	PUNCT
fnp-3866	219	54	crary	crary	NOUN
fnp-3866	219	55	,	,	PUNCT
fnp-3866	219	56	j.	j.	PROPN
fnp-3866	219	57	f.	f.	PROPN
fnp-3866	219	58	,	,	PUNCT
fnp-3866	219	59	bieniek	bieniek	PROPN
fnp-3866	219	60	,	,	PUNCT
fnp-3866	219	61	k.	k.	PROPN
fnp-3866	219	62	f.	f.	PROPN
fnp-3866	219	63	,	,	PUNCT
fnp-3866	219	64	dams	dams	NOUN
fnp-3866	219	65	-	-	PUNCT
fnp-3866	219	66	o’connor	o’connor	ADV
fnp-3866	219	67	,	,	PUNCT
fnp-3866	219	68	k.	k.	PROPN
fnp-3866	219	69	,	,	PUNCT
fnp-3866	219	70	alvarez	alvarez	PROPN
fnp-3866	219	71	,	,	PUNCT
fnp-3866	219	72	v.	v.	PROPN
fnp-3866	219	73	e.	e.	PROPN
fnp-3866	219	74	,	,	PUNCT
fnp-3866	219	75	gordon	gordon	PROPN
fnp-3866	219	76	,	,	PUNCT
fnp-3866	219	77	w.	w.	PROPN
fnp-3866	219	78	a.	a.	PROPN
fnp-3866	219	79	,	,	PUNCT
fnp-3866	219	80	&	&	CCONJ
fnp-3866	219	81	tbi	tbi	PROPN
fnp-3866	219	82	/	/	SYM
fnp-3866	219	83	cte	cte	PROPN
fnp-3866	219	84	group	group	NOUN
fnp-3866	219	85	.	.	PUNCT
fnp-3866	220	1	(	(	PUNCT
fnp-3866	220	2	2016	2016	NUM
fnp-3866	220	3	)	)	PUNCT
fnp-3866	220	4	.	.	PUNCT
fnp-3866	221	1	the	the	DET
fnp-3866	221	2	first	first	ADJ
fnp-3866	221	3	ninds	nind	NOUN
fnp-3866	221	4	/	/	SYM
fnp-3866	221	5	nibib	nibib	NOUN
fnp-3866	221	6	consensus	consensus	NOUN
fnp-3866	221	7	meeting	meeting	NOUN
fnp-3866	221	8	to	to	PART
fnp-3866	221	9	define	define	VERB
fnp-3866	221	10	neuropathological	neuropathological	ADJ
fnp-3866	221	11	criteria	criterion	NOUN
fnp-3866	221	12	for	for	ADP
fnp-3866	221	13	the	the	DET
fnp-3866	221	14	diagnosis	diagnosis	NOUN
fnp-3866	221	15	of	of	ADP
fnp-3866	221	16	chronic	chronic	ADJ
fnp-3866	221	17	traumatic	traumatic	ADJ
fnp-3866	221	18	encephalopathy	encephalopathy	NOUN
fnp-3866	221	19	.	.	PUNCT
fnp-3866	222	1	acta	acta	PROPN
fnp-3866	222	2	neuropathologica	neuropathologica	PROPN
fnp-3866	222	3	,	,	PUNCT
fnp-3866	222	4	131(1	131(1	NUM
fnp-3866	222	5	)	)	PUNCT
fnp-3866	222	6	,	,	PUNCT
fnp-3866	222	7	75–86	75–86	NUM
fnp-3866	222	8	.	.	PUNCT
fnp-3866	223	1	https://doi.org/10.1007/s00401-015-1515-z	https://doi.org/10.1007/s00401-015-1515-z	INTJ
fnp-3866	223	2	mckee	mckee	PROPN
fnp-3866	223	3	,	,	PUNCT
fnp-3866	223	4	a.	a.	PROPN
fnp-3866	223	5	c.	c.	PROPN
fnp-3866	223	6	,	,	PUNCT
fnp-3866	223	7	stern	stern	ADJ
fnp-3866	223	8	,	,	PUNCT
fnp-3866	223	9	r.	r.	PROPN
fnp-3866	223	10	a.	a.	PROPN
fnp-3866	223	11	,	,	PUNCT
fnp-3866	223	12	nowinski	nowinski	ADJ
fnp-3866	223	13	,	,	PUNCT
fnp-3866	223	14	c.	c.	PROPN
fnp-3866	223	15	j.	j.	PROPN
fnp-3866	223	16	,	,	PUNCT
fnp-3866	223	17	stein	stein	PROPN
fnp-3866	223	18	,	,	PUNCT
fnp-3866	223	19	t.	t.	PROPN
fnp-3866	223	20	d.	d.	PROPN
fnp-3866	223	21	,	,	PUNCT
fnp-3866	223	22	alvarez	alvarez	PROPN
fnp-3866	223	23	,	,	PUNCT
fnp-3866	223	24	v.	v.	PROPN
fnp-3866	223	25	e.	e.	PROPN
fnp-3866	223	26	,	,	PUNCT
fnp-3866	223	27	daneshvar	daneshvar	PROPN
fnp-3866	223	28	,	,	PUNCT
fnp-3866	223	29	d.	d.	PROPN
fnp-3866	223	30	h.	h.	PROPN
fnp-3866	223	31	,	,	PUNCT
fnp-3866	223	32	lee	lee	PROPN
fnp-3866	223	33	,	,	PUNCT
fnp-3866	223	34	h.-s	h.-s	PROPN
fnp-3866	223	35	.	.	PUNCT
fnp-3866	223	36	,	,	PUNCT
fnp-3866	223	37	wojtowicz	wojtowicz	PROPN
fnp-3866	223	38	,	,	PUNCT
fnp-3866	223	39	s.	s.	PROPN
fnp-3866	223	40	m.	m.	PROPN
fnp-3866	223	41	,	,	PUNCT
fnp-3866	223	42	hall	hall	PROPN
fnp-3866	223	43	,	,	PUNCT
fnp-3866	223	44	g.	g.	PROPN
fnp-3866	223	45	,	,	PUNCT
fnp-3866	223	46	baugh	baugh	PROPN
fnp-3866	223	47	,	,	PUNCT
fnp-3866	223	48	c.	c.	PROPN
fnp-3866	223	49	m.	m.	PROPN
fnp-3866	223	50	,	,	PUNCT
fnp-3866	223	51	riley	riley	PROPN
fnp-3866	223	52	,	,	PUNCT
fnp-3866	223	53	d.	d.	PROPN
fnp-3866	223	54	o.	o.	PROPN
fnp-3866	223	55	,	,	PUNCT
fnp-3866	223	56	kubilus	kubilus	PROPN
fnp-3866	223	57	,	,	PUNCT
fnp-3866	223	58	c.	c.	PROPN
fnp-3866	223	59	a.	a.	PROPN
fnp-3866	223	60	,	,	PUNCT
fnp-3866	223	61	cormier	cormier	NOUN
fnp-3866	223	62	,	,	PUNCT
fnp-3866	223	63	k.	k.	PROPN
fnp-3866	223	64	a.	a.	PROPN
fnp-3866	223	65	,	,	PUNCT
fnp-3866	223	66	jacobs	jacobs	PROPN
fnp-3866	223	67	,	,	PUNCT
fnp-3866	223	68	m.	m.	NOUN
fnp-3866	223	69	a.	a.	PROPN
fnp-3866	223	70	,	,	PUNCT
fnp-3866	223	71	martin	martin	PROPN
fnp-3866	223	72	,	,	PUNCT
fnp-3866	223	73	b.	b.	PROPN
fnp-3866	223	74	r.	r.	PROPN
fnp-3866	223	75	,	,	PUNCT
fnp-3866	223	76	abraham	abraham	PROPN
fnp-3866	223	77	,	,	PUNCT
fnp-3866	223	78	c.	c.	PROPN
fnp-3866	223	79	r.	r.	PROPN
fnp-3866	223	80	,	,	PUNCT
fnp-3866	223	81	ikezu	ikezu	PROPN
fnp-3866	223	82	,	,	PUNCT
fnp-3866	223	83	t.	t.	PROPN
fnp-3866	223	84	,	,	PUNCT
fnp-3866	223	85	reichard	reichard	PROPN
fnp-3866	223	86	,	,	PUNCT
fnp-3866	223	87	r.	r.	PROPN
fnp-3866	223	88	r.	r.	PROPN
fnp-3866	223	89	,	,	PUNCT
fnp-3866	223	90	wolozin	wolozin	PROPN
fnp-3866	223	91	,	,	PUNCT
fnp-3866	223	92	b.	b.	PROPN
fnp-3866	223	93	l.	l.	PROPN
fnp-3866	223	94	,	,	PUNCT
fnp-3866	223	95	…	…	PUNCT
fnp-3866	223	96	cantu	cantu	PROPN
fnp-3866	223	97	,	,	PUNCT
fnp-3866	223	98	r.	r.	PROPN
fnp-3866	223	99	c.	c.	PROPN
fnp-3866	223	100	(	(	PUNCT
fnp-3866	223	101	2013	2013	NUM
fnp-3866	223	102	)	)	PUNCT
fnp-3866	223	103	.	.	PUNCT
fnp-3866	224	1	the	the	DET
fnp-3866	224	2	spectrum	spectrum	NOUN
fnp-3866	224	3	of	of	ADP
fnp-3866	224	4	disease	disease	NOUN
fnp-3866	224	5	in	in	ADP
fnp-3866	224	6	chronic	chronic	ADJ
fnp-3866	224	7	traumatic	traumatic	ADJ
fnp-3866	224	8	encephalopathy	encephalopathy	NOUN
fnp-3866	224	9	.	.	PUNCT
fnp-3866	225	1	brain	brain	NOUN
fnp-3866	225	2	:	:	PUNCT
fnp-3866	225	3	a	a	DET
fnp-3866	225	4	journal	journal	NOUN
fnp-3866	225	5	of	of	ADP
fnp-3866	225	6	neurology	neurology	NOUN
fnp-3866	225	7	,	,	PUNCT
fnp-3866	225	8	136(pt	136(pt	NUM
fnp-3866	225	9	1	1	NUM
fnp-3866	225	10	)	)	PUNCT
fnp-3866	225	11	,	,	PUNCT
fnp-3866	225	12	43–64	43–64	PROPN
fnp-3866	225	13	.	.	PUNCT
fnp-3866	226	1	https://doi.org/10.1093/brain/aws307	https://doi.org/10.1093/brain/aws307	PROPN
fnp-3866	226	2	mckeith	mckeith	PROPN
fnp-3866	226	3	,	,	PUNCT
fnp-3866	226	4	i.	i.	PROPN
fnp-3866	226	5	g.	g.	PROPN
fnp-3866	226	6	,	,	PUNCT
fnp-3866	226	7	dickson	dickson	PROPN
fnp-3866	226	8	,	,	PUNCT
fnp-3866	226	9	d.	d.	PROPN
fnp-3866	226	10	w.	w.	PROPN
fnp-3866	226	11	,	,	PUNCT
fnp-3866	226	12	lowe	lowe	PROPN
fnp-3866	226	13	,	,	PUNCT
fnp-3866	226	14	j.	j.	PROPN
fnp-3866	226	15	,	,	PUNCT
fnp-3866	226	16	emre	emre	PROPN
fnp-3866	226	17	,	,	PUNCT
fnp-3866	226	18	m.	m.	NOUN
fnp-3866	226	19	,	,	PUNCT
fnp-3866	226	20	o’brien	o’brien	PROPN
fnp-3866	226	21	,	,	PUNCT
fnp-3866	226	22	j.	j.	PROPN
fnp-3866	226	23	t.	t.	PROPN
fnp-3866	226	24	,	,	PUNCT
fnp-3866	226	25	feldman	feldman	PROPN
fnp-3866	226	26	,	,	PUNCT
fnp-3866	226	27	h.	h.	PROPN
fnp-3866	226	28	,	,	PUNCT
fnp-3866	226	29	cummings	cummings	PROPN
fnp-3866	226	30	,	,	PUNCT
fnp-3866	226	31	j.	j.	PROPN
fnp-3866	226	32	,	,	PUNCT
fnp-3866	226	33	duda	duda	PROPN
fnp-3866	226	34	,	,	PUNCT
fnp-3866	226	35	j.	j.	PROPN
fnp-3866	226	36	e.	e.	PROPN
fnp-3866	226	37	,	,	PUNCT
fnp-3866	226	38	lippa	lippa	PROPN
fnp-3866	226	39	,	,	PUNCT
fnp-3866	226	40	c.	c.	PROPN
fnp-3866	226	41	,	,	PUNCT
fnp-3866	226	42	perry	perry	PROPN
fnp-3866	226	43	,	,	PUNCT
fnp-3866	226	44	e.	e.	PROPN
fnp-3866	226	45	k.	k.	PROPN
fnp-3866	226	46	,	,	PUNCT
fnp-3866	226	47	aarsland	aarsland	PROPN
fnp-3866	226	48	,	,	PUNCT
fnp-3866	226	49	d.	d.	PROPN
fnp-3866	226	50	,	,	PUNCT
fnp-3866	226	51	arai	arai	PROPN
fnp-3866	226	52	,	,	PUNCT
fnp-3866	226	53	h.	h.	PROPN
fnp-3866	226	54	,	,	PUNCT
fnp-3866	226	55	ballard	ballard	PROPN
fnp-3866	226	56	,	,	PUNCT
fnp-3866	226	57	c.	c.	PROPN
fnp-3866	226	58	g.	g.	PROPN
fnp-3866	226	59	,	,	PUNCT
fnp-3866	226	60	boeve	boeve	PROPN
fnp-3866	226	61	,	,	PUNCT
fnp-3866	226	62	b.	b.	PROPN
fnp-3866	226	63	,	,	PUNCT
fnp-3866	226	64	burn	burn	VERB
fnp-3866	226	65	,	,	PUNCT
fnp-3866	226	66	d.	d.	PROPN
fnp-3866	226	67	j.	j.	PROPN
fnp-3866	226	68	,	,	PUNCT
fnp-3866	226	69	costa	costa	PROPN
fnp-3866	226	70	,	,	PUNCT
fnp-3866	226	71	d.	d.	PROPN
fnp-3866	226	72	,	,	PUNCT
fnp-3866	226	73	del	del	PROPN
fnp-3866	226	74	ser	ser	PROPN
fnp-3866	226	75	,	,	PUNCT
fnp-3866	226	76	t.	t.	PROPN
fnp-3866	226	77	,	,	PUNCT
fnp-3866	226	78	dubois	dubois	PROPN
fnp-3866	226	79	,	,	PUNCT
fnp-3866	226	80	b.	b.	PROPN
fnp-3866	226	81	,	,	PUNCT
fnp-3866	226	82	galasko	galasko	PROPN
fnp-3866	226	83	,	,	PUNCT
fnp-3866	226	84	d.	d.	PROPN
fnp-3866	226	85	,	,	PUNCT
fnp-3866	226	86	…	…	PUNCT
fnp-3866	226	87	consortium	consortium	NOUN
fnp-3866	226	88	on	on	ADP
fnp-3866	226	89	dlb	dlb	PROPN
fnp-3866	226	90	.	.	PUNCT
fnp-3866	227	1	(	(	PUNCT
fnp-3866	227	2	2005	2005	NUM
fnp-3866	227	3	)	)	PUNCT
fnp-3866	227	4	.	.	PUNCT
fnp-3866	228	1	diagnosis	diagnosis	NOUN
fnp-3866	228	2	and	and	CCONJ
fnp-3866	228	3	management	management	NOUN
fnp-3866	228	4	of	of	ADP
fnp-3866	228	5	dementia	dementia	NOUN
fnp-3866	228	6	with	with	ADP
fnp-3866	228	7	lewy	lewy	PROPN
fnp-3866	228	8	bodies	body	NOUN
fnp-3866	228	9	:	:	PUNCT
fnp-3866	228	10	third	third	ADJ
fnp-3866	228	11	report	report	NOUN
fnp-3866	228	12	of	of	ADP
fnp-3866	228	13	the	the	DET
fnp-3866	228	14	dlb	dlb	PROPN
fnp-3866	228	15	consortium	consortium	PROPN
fnp-3866	228	16	.	.	PUNCT
fnp-3866	229	1	neurology	neurology	NOUN
fnp-3866	229	2	,	,	PUNCT
fnp-3866	229	3	65(12	65(12	NUM
fnp-3866	229	4	)	)	PUNCT
fnp-3866	229	5	,	,	PUNCT
fnp-3866	229	6	1863–1872	1863–1872	NUM
fnp-3866	229	7	.	.	PUNCT
fnp-3866	230	1	https://doi.org/10.1212/01.wnl.0000187889.17253.b1	https://doi.org/10.1212/01.wnl.0000187889.17253.b1	PROPN
fnp-3866	230	2	murray	murray	PROPN
fnp-3866	230	3	,	,	PUNCT
fnp-3866	230	4	m.	m.	PROPN
fnp-3866	230	5	e.	e.	PROPN
fnp-3866	230	6	,	,	PUNCT
fnp-3866	230	7	graff	graff	NOUN
fnp-3866	230	8	-	-	PUNCT
fnp-3866	230	9	radford	radford	PROPN
fnp-3866	230	10	,	,	PUNCT
fnp-3866	230	11	n.	n.	PROPN
fnp-3866	230	12	r.	r.	PROPN
fnp-3866	230	13	,	,	PUNCT
fnp-3866	230	14	ross	ross	PROPN
fnp-3866	230	15	,	,	PUNCT
fnp-3866	230	16	o.	o.	PROPN
fnp-3866	230	17	a.	a.	PROPN
fnp-3866	230	18	,	,	PUNCT
fnp-3866	230	19	petersen	petersen	PROPN
fnp-3866	230	20	,	,	PUNCT
fnp-3866	230	21	r.	r.	PROPN
fnp-3866	230	22	c.	c.	PROPN
fnp-3866	230	23	,	,	PUNCT
fnp-3866	230	24	duara	duara	PROPN
fnp-3866	230	25	,	,	PUNCT
fnp-3866	230	26	r.	r.	PROPN
fnp-3866	230	27	,	,	PUNCT
fnp-3866	230	28	&	&	CCONJ
fnp-3866	230	29	dickson	dickson	PROPN
fnp-3866	230	30	,	,	PUNCT
fnp-3866	230	31	d.	d.	PROPN
fnp-3866	230	32	w.	w.	PROPN
fnp-3866	230	33	(	(	PUNCT
fnp-3866	230	34	2011	2011	NUM
fnp-3866	230	35	)	)	PUNCT
fnp-3866	230	36	.	.	PUNCT
fnp-3866	231	1	neuropathologically	neuropathologically	ADV
fnp-3866	231	2	defined	define	VERB
fnp-3866	231	3	subtypes	subtype	NOUN
fnp-3866	231	4	of	of	ADP
fnp-3866	231	5	alzheimer	alzheimer	PROPN
fnp-3866	231	6	’s	’s	PART
fnp-3866	231	7	disease	disease	NOUN
fnp-3866	231	8	with	with	ADP
fnp-3866	231	9	distinct	distinct	ADJ
fnp-3866	231	10	clinical	clinical	ADJ
fnp-3866	231	11	characteristics	characteristic	NOUN
fnp-3866	231	12	:	:	PUNCT
fnp-3866	231	13	a	a	DET
fnp-3866	231	14	retrospective	retrospective	ADJ
fnp-3866	231	15	study	study	NOUN
fnp-3866	231	16	.	.	PUNCT
fnp-3866	232	1	the	the	DET
fnp-3866	232	2	lancet	lancet	PROPN
fnp-3866	232	3	.	.	PUNCT
fnp-3866	233	1	neurology	neurology	NOUN
fnp-3866	233	2	,	,	PUNCT
fnp-3866	233	3	10(9	10(9	NUM
fnp-3866	233	4	)	)	PUNCT
fnp-3866	233	5	,	,	PUNCT
fnp-3866	233	6	785–796	785–796	NUM
fnp-3866	233	7	.	.	PUNCT
fnp-3866	234	1	https://doi.org/10.1016/s1474-4422(11)70156-9	https://doi.org/10.1016/s1474-4422(11)70156-9	PROPN
fnp-3866	234	2	navarro	navarro	PROPN
fnp-3866	234	3	,	,	PUNCT
fnp-3866	234	4	e.	e.	PROPN
fnp-3866	234	5	,	,	PUNCT
fnp-3866	234	6	udine	udine	PROPN
fnp-3866	234	7	,	,	PUNCT
fnp-3866	234	8	e.	e.	PROPN
fnp-3866	234	9	,	,	PUNCT
fnp-3866	234	10	de	de	PROPN
fnp-3866	234	11	paiva	paiva	PROPN
fnp-3866	234	12	lopes	lopes	PROPN
fnp-3866	234	13	,	,	PUNCT
fnp-3866	234	14	k.	k.	PROPN
fnp-3866	234	15	,	,	PUNCT
fnp-3866	234	16	parks	park	NOUN
fnp-3866	234	17	,	,	PUNCT
fnp-3866	234	18	m.	m.	NOUN
fnp-3866	234	19	,	,	PUNCT
fnp-3866	234	20	riboldi	riboldi	PROPN
fnp-3866	234	21	,	,	PUNCT
fnp-3866	234	22	g.	g.	PROPN
fnp-3866	234	23	,	,	PUNCT
fnp-3866	234	24	schilder	schilder	PROPN
fnp-3866	234	25	,	,	PUNCT
fnp-3866	234	26	b.	b.	PROPN
fnp-3866	234	27	m.	m.	PROPN
fnp-3866	234	28	,	,	PUNCT
fnp-3866	234	29	humphrey	humphrey	PROPN
fnp-3866	234	30	,	,	PUNCT
fnp-3866	234	31	j.	j.	PROPN
fnp-3866	234	32	,	,	PUNCT
fnp-3866	234	33	snijders	snijder	NOUN
fnp-3866	234	34	,	,	PUNCT
fnp-3866	234	35	g.	g.	PROPN
fnp-3866	234	36	j.	j.	PROPN
fnp-3866	234	37	l.	l.	PROPN
fnp-3866	234	38	,	,	PUNCT
fnp-3866	234	39	vialle	vialle	PROPN
fnp-3866	234	40	,	,	PUNCT
fnp-3866	234	41	r.	r.	PROPN
fnp-3866	234	42	a.	a.	PROPN
fnp-3866	234	43	,	,	PUNCT
fnp-3866	234	44	zhuang	zhuang	PROPN
fnp-3866	234	45	,	,	PUNCT
fnp-3866	234	46	m.	m.	NOUN
fnp-3866	234	47	,	,	PUNCT
fnp-3866	234	48	sikder	sikder	NOUN
fnp-3866	234	49	,	,	PUNCT
fnp-3866	234	50	t.	t.	PROPN
fnp-3866	234	51	,	,	PUNCT
fnp-3866	234	52	argyrou	argyrou	NOUN
fnp-3866	234	53	,	,	PUNCT
fnp-3866	234	54	c.	c.	PROPN
fnp-3866	234	55	,	,	PUNCT
fnp-3866	234	56	allan	allan	PROPN
fnp-3866	234	57	,	,	PUNCT
fnp-3866	234	58	a.	a.	PROPN
fnp-3866	234	59	,	,	PUNCT
fnp-3866	234	60	chao	chao	PROPN
fnp-3866	234	61	,	,	PUNCT
fnp-3866	234	62	m.	m.	PROPN
fnp-3866	234	63	j.	j.	PROPN
fnp-3866	234	64	,	,	PUNCT
fnp-3866	234	65	farrell	farrell	PROPN
fnp-3866	234	66	,	,	PUNCT
fnp-3866	234	67	k.	k.	PROPN
fnp-3866	234	68	,	,	PUNCT
fnp-3866	234	69	henderson	henderson	PROPN
fnp-3866	234	70	,	,	PUNCT
fnp-3866	234	71	b.	b.	PROPN
fnp-3866	234	72	,	,	PUNCT
fnp-3866	234	73	simon	simon	PROPN
fnp-3866	234	74	,	,	PUNCT
fnp-3866	234	75	s.	s.	PROPN
fnp-3866	234	76	,	,	PUNCT
fnp-3866	234	77	raymond	raymond	PROPN
fnp-3866	234	78	,	,	PUNCT
fnp-3866	234	79	d.	d.	PROPN
fnp-3866	234	80	,	,	PUNCT
fnp-3866	234	81	elango	elango	PROPN
fnp-3866	234	82	,	,	PUNCT
fnp-3866	234	83	s.	s.	PROPN
fnp-3866	234	84	,	,	PUNCT
fnp-3866	234	85	…	…	PUNCT
fnp-3866	234	86	raj	raj	NOUN
fnp-3866	234	87	,	,	PUNCT
fnp-3866	234	88	t.	t.	PROPN
fnp-3866	234	89	(	(	PUNCT
fnp-3866	234	90	2021	2021	NUM
fnp-3866	234	91	)	)	PUNCT
fnp-3866	234	92	.	.	PUNCT
fnp-3866	235	1	dysregulation	dysregulation	NOUN
fnp-3866	235	2	of	of	ADP
fnp-3866	235	3	mitochondrial	mitochondrial	ADJ
fnp-3866	235	4	and	and	CCONJ
fnp-3866	235	5	proteolysosomal	proteolysosomal	ADJ
fnp-3866	235	6	genes	gene	NOUN
fnp-3866	235	7	in	in	ADP
fnp-3866	235	8	parkinson	parkinson	NOUN
fnp-3866	235	9	’s	’s	PART
fnp-3866	235	10	disease	disease	NOUN
fnp-3866	235	11	myeloid	myeloid	NOUN
fnp-3866	235	12	cells	cell	NOUN
fnp-3866	235	13	.	.	PUNCT
fnp-3866	236	1	nature	nature	NOUN
fnp-3866	236	2	aging	aging	NOUN
fnp-3866	236	3	,	,	PUNCT
fnp-3866	236	4	1(9	1(9	NUM
fnp-3866	236	5	)	)	PUNCT
fnp-3866	236	6	,	,	PUNCT
fnp-3866	236	7	850–863	850–863	NUM
fnp-3866	236	8	.	.	PUNCT
fnp-3866	237	1	https://doi.org/10.1038/s43587-021-00110-x	https://doi.org/10.1038/s43587-021-00110-x	PROPN
fnp-3866	237	2	neff	neff	PROPN
fnp-3866	237	3	,	,	PUNCT
fnp-3866	237	4	r.	r.	PROPN
fnp-3866	237	5	a.	a.	PROPN
fnp-3866	237	6	,	,	PUNCT
fnp-3866	237	7	wang	wang	PROPN
fnp-3866	237	8	,	,	PUNCT
fnp-3866	237	9	m.	m.	NOUN
fnp-3866	237	10	,	,	PUNCT
fnp-3866	237	11	vatansever	vatansever	PROPN
fnp-3866	237	12	,	,	PUNCT
fnp-3866	237	13	s.	s.	PROPN
fnp-3866	237	14	,	,	PUNCT
fnp-3866	237	15	guo	guo	PROPN
fnp-3866	237	16	,	,	PUNCT
fnp-3866	237	17	l.	l.	PROPN
fnp-3866	237	18	,	,	PUNCT
fnp-3866	237	19	ming	ming	PROPN
fnp-3866	237	20	,	,	PUNCT
fnp-3866	237	21	c.	c.	PROPN
fnp-3866	237	22	,	,	PUNCT
fnp-3866	237	23	wang	wang	PROPN
fnp-3866	237	24	,	,	PUNCT
fnp-3866	237	25	q.	q.	PROPN
fnp-3866	237	26	,	,	PUNCT
fnp-3866	237	27	wang	wang	PROPN
fnp-3866	237	28	,	,	PUNCT
fnp-3866	237	29	e.	e.	PROPN
fnp-3866	237	30	,	,	PUNCT
fnp-3866	237	31	horgusluoglu	horgusluoglu	PROPN
fnp-3866	237	32	-	-	PUNCT
fnp-3866	237	33	moloch	moloch	PROPN
fnp-3866	237	34	,	,	PUNCT
fnp-3866	237	35	e.	e.	PROPN
fnp-3866	237	36	,	,	PUNCT
fnp-3866	237	37	song	song	NOUN
fnp-3866	237	38	,	,	PUNCT
fnp-3866	237	39	w.-m	w.-m	PROPN
fnp-3866	237	40	.	.	PROPN
fnp-3866	237	41	,	,	PUNCT
fnp-3866	237	42	li	li	PROPN
fnp-3866	237	43	,	,	PUNCT
fnp-3866	237	44	a.	a.	PROPN
fnp-3866	237	45	,	,	PUNCT
fnp-3866	237	46	castranio	castranio	PROPN
fnp-3866	237	47	,	,	PUNCT
fnp-3866	237	48	e.	e.	PROPN
fnp-3866	237	49	l.	l.	PROPN
fnp-3866	237	50	,	,	PUNCT
fnp-3866	237	51	tcw	tcw	PROPN
fnp-3866	237	52	,	,	PUNCT
fnp-3866	237	53	j.	j.	PROPN
fnp-3866	237	54	,	,	PUNCT
fnp-3866	237	55	ho	ho	PROPN
fnp-3866	237	56	,	,	PUNCT
fnp-3866	237	57	l.	l.	PROPN
fnp-3866	237	58	,	,	PUNCT
fnp-3866	237	59	goate	goate	NOUN
fnp-3866	237	60	,	,	PUNCT
fnp-3866	237	61	a.	a.	NOUN
fnp-3866	237	62	,	,	PUNCT
fnp-3866	237	63	fossati	fossati	PROPN
fnp-3866	237	64	,	,	PUNCT
fnp-3866	237	65	v.	v.	ADV
fnp-3866	237	66	,	,	PUNCT
fnp-3866	237	67	noggle	noggle	INTJ
fnp-3866	237	68	,	,	PUNCT
fnp-3866	237	69	s.	s.	PROPN
fnp-3866	237	70	,	,	PUNCT
fnp-3866	237	71	gandy	gandy	PROPN
fnp-3866	237	72	,	,	PUNCT
fnp-3866	237	73	s.	s.	PROPN
fnp-3866	237	74	,	,	PUNCT
fnp-3866	237	75	ehrlich	ehrlich	PROPN
fnp-3866	237	76	,	,	PUNCT
fnp-3866	237	77	m.	m.	PROPN
fnp-3866	237	78	e.	e.	PROPN
fnp-3866	237	79	,	,	PUNCT
fnp-3866	237	80	katsel	katsel	PROPN
fnp-3866	237	81	,	,	PUNCT
fnp-3866	237	82	p.	p.	PROPN
fnp-3866	237	83	,	,	PUNCT
fnp-3866	237	84	…	…	PUNCT
fnp-3866	237	85	zhang	zhang	PROPN
fnp-3866	237	86	,	,	PUNCT
fnp-3866	237	87	b.	b.	PROPN
fnp-3866	237	88	(	(	PUNCT
fnp-3866	237	89	2021	2021	NUM
fnp-3866	237	90	)	)	PUNCT
fnp-3866	237	91	.	.	PUNCT
fnp-3866	238	1	molecular	molecular	ADJ
fnp-3866	238	2	subtyping	subtyping	NOUN
fnp-3866	238	3	of	of	ADP
fnp-3866	238	4	alzheimer	alzheimer	PROPN
fnp-3866	238	5	’s	’s	PART
fnp-3866	238	6	disease	disease	NOUN
fnp-3866	238	7	using	use	VERB
fnp-3866	238	8	rna	rna	NOUN
fnp-3866	238	9	sequencing	sequence	VERB
fnp-3866	238	10	data	datum	NOUN
fnp-3866	238	11	reveals	reveal	VERB
fnp-3866	238	12	novel	novel	ADJ
fnp-3866	238	13	mechanisms	mechanism	NOUN
fnp-3866	238	14	and	and	CCONJ
fnp-3866	238	15	targets	target	NOUN
fnp-3866	238	16	.	.	PUNCT
fnp-3866	239	1	science	science	NOUN
fnp-3866	239	2	advances	advance	NOUN
fnp-3866	239	3	,	,	PUNCT
fnp-3866	239	4	7(2	7(2	NUM
fnp-3866	239	5	)	)	PUNCT
fnp-3866	239	6	,	,	PUNCT
fnp-3866	239	7	eabb5398	eabb5398	PROPN
fnp-3866	239	8	.	.	PUNCT
fnp-3866	240	1	https://doi.org/10.1126/sciadv.abb5398	https://doi.org/10.1126/sciadv.abb5398	PROPN
fnp-3866	240	2	reiken	reiken	VERB
fnp-3866	240	3	,	,	PUNCT
fnp-3866	240	4	s.	s.	PROPN
fnp-3866	240	5	,	,	PUNCT
fnp-3866	240	6	sittenfeld	sittenfeld	PROPN
fnp-3866	240	7	,	,	PUNCT
fnp-3866	240	8	l.	l.	PROPN
fnp-3866	240	9	,	,	PUNCT
fnp-3866	240	10	dridi	dridi	PROPN
fnp-3866	240	11	,	,	PUNCT
fnp-3866	240	12	h.	h.	PROPN
fnp-3866	240	13	,	,	PUNCT
fnp-3866	240	14	liu	liu	PROPN
fnp-3866	240	15	,	,	PUNCT
fnp-3866	240	16	y.	y.	PROPN
fnp-3866	240	17	,	,	PUNCT
fnp-3866	240	18	liu	liu	PROPN
fnp-3866	240	19	,	,	PUNCT
fnp-3866	240	20	x.	x.	PROPN
fnp-3866	240	21	,	,	PUNCT
fnp-3866	240	22	&	&	CCONJ
fnp-3866	240	23	marks	marks	PROPN
fnp-3866	240	24	,	,	PUNCT
fnp-3866	240	25	a.	a.	PROPN
fnp-3866	240	26	r.	r.	PROPN
fnp-3866	240	27	(	(	PUNCT
fnp-3866	240	28	2022	2022	NUM
fnp-3866	240	29	)	)	PUNCT
fnp-3866	240	30	.	.	PUNCT
fnp-3866	241	1	alzheimer’s	alzheimer’s	ADJ
fnp-3866	241	2	-	-	PUNCT
fnp-3866	241	3	like	like	ADJ
fnp-3866	241	4	signaling	signal	VERB
fnp-3866	241	5	in	in	ADP
fnp-3866	241	6	brains	brain	NOUN
fnp-3866	241	7	of	of	ADP
fnp-3866	241	8	covid-19	covid-19	PROPN
fnp-3866	241	9	patients	patient	NOUN
fnp-3866	241	10	.	.	PUNCT
fnp-3866	242	1	alzheimer	alzheimer	PROPN
fnp-3866	242	2	’s	’s	PART
fnp-3866	242	3	&	&	CCONJ
fnp-3866	242	4	dementia	dementia	PROPN
fnp-3866	242	5	:	:	PUNCT
fnp-3866	242	6	the	the	DET
fnp-3866	242	7	journal	journal	NOUN
fnp-3866	242	8	of	of	ADP
fnp-3866	242	9	the	the	DET
fnp-3866	242	10	alzheimer	alzheimer	PROPN
fnp-3866	242	11	’s	’s	PROPN
fnp-3866	242	12	association	association	PROPN
fnp-3866	242	13	.	.	PUNCT
fnp-3866	243	1	https://doi.org/10.1002/alz.12558	https://doi.org/10.1002/alz.12558	PROPN
fnp-3866	243	2	ritchie	ritchie	PROPN
fnp-3866	243	3	,	,	PUNCT
fnp-3866	243	4	k.	k.	PROPN
fnp-3866	243	5	,	,	PUNCT
fnp-3866	243	6	chan	chan	PROPN
fnp-3866	243	7	,	,	PUNCT
fnp-3866	243	8	d.	d.	PROPN
fnp-3866	243	9	,	,	PUNCT
fnp-3866	243	10	&	&	CCONJ
fnp-3866	243	11	watermeyer	watermeyer	NOUN
fnp-3866	243	12	,	,	PUNCT
fnp-3866	243	13	t.	t.	PROPN
fnp-3866	243	14	(	(	PUNCT
fnp-3866	243	15	2020	2020	NUM
fnp-3866	243	16	)	)	PUNCT
fnp-3866	243	17	.	.	PUNCT
fnp-3866	244	1	the	the	DET
fnp-3866	244	2	cognitive	cognitive	ADJ
fnp-3866	244	3	consequences	consequence	NOUN
fnp-3866	244	4	of	of	ADP
fnp-3866	244	5	the	the	DET
fnp-3866	244	6	covid-19	covid-19	PROPN
fnp-3866	244	7	epidemic	epidemic	NOUN
fnp-3866	244	8	:	:	PUNCT
fnp-3866	244	9	collateral	collateral	ADJ
fnp-3866	244	10	damage	damage	NOUN
fnp-3866	244	11	?	?	PUNCT
fnp-3866	245	1	brain	brain	NOUN
fnp-3866	245	2	communications	communication	NOUN
fnp-3866	245	3	,	,	PUNCT
fnp-3866	245	4	2(2	2(2	NUM
fnp-3866	245	5	)	)	PUNCT
fnp-3866	245	6	,	,	PUNCT
fnp-3866	245	7	fcaa069	fcaa069	PROPN
fnp-3866	245	8	.	.	PUNCT
fnp-3866	246	1	https://doi.org/10.1093/braincomms/fcaa069	https://doi.org/10.1093/braincomms/fcaa069	PROPN
fnp-3866	246	2	shahidehpour	shahidehpour	PROPN
fnp-3866	246	3	,	,	PUNCT
fnp-3866	246	4	r.	r.	PROPN
fnp-3866	246	5	k.	k.	PROPN
fnp-3866	246	6	,	,	PUNCT
fnp-3866	246	7	higdon	higdon	PROPN
fnp-3866	246	8	,	,	PUNCT
fnp-3866	246	9	r.	r.	PROPN
fnp-3866	246	10	e.	e.	PROPN
fnp-3866	246	11	,	,	PUNCT
fnp-3866	246	12	crawford	crawford	PROPN
fnp-3866	246	13	,	,	PUNCT
fnp-3866	246	14	n.	n.	PROPN
fnp-3866	246	15	g.	g.	PROPN
fnp-3866	246	16	,	,	PUNCT
fnp-3866	246	17	neltner	neltner	NOUN
fnp-3866	246	18	,	,	PUNCT
fnp-3866	246	19	j.	j.	PROPN
fnp-3866	246	20	h.	h.	PROPN
fnp-3866	246	21	,	,	PUNCT
fnp-3866	246	22	ighodaro	ighodaro	NOUN
fnp-3866	246	23	,	,	PUNCT
fnp-3866	246	24	e.	e.	PROPN
fnp-3866	246	25	t.	t.	PROPN
fnp-3866	246	26	,	,	PUNCT
fnp-3866	246	27	patel	patel	PROPN
fnp-3866	246	28	,	,	PUNCT
fnp-3866	246	29	e.	e.	PROPN
fnp-3866	246	30	,	,	PUNCT
fnp-3866	246	31	price	price	NOUN
fnp-3866	246	32	,	,	PUNCT
fnp-3866	246	33	d.	d.	PROPN
fnp-3866	246	34	,	,	PUNCT
fnp-3866	246	35	nelson	nelson	PROPN
fnp-3866	246	36	,	,	PUNCT
fnp-3866	246	37	p.	p.	PROPN
fnp-3866	246	38	t.	t.	PROPN
fnp-3866	246	39	,	,	PUNCT
fnp-3866	246	40	&	&	CCONJ
fnp-3866	246	41	bachstetter	bachstetter	PROPN
fnp-3866	246	42	,	,	PUNCT
fnp-3866	246	43	a.	a.	PROPN
fnp-3866	246	44	d.	d.	PROPN
fnp-3866	246	45	(	(	PUNCT
fnp-3866	246	46	2021	2021	NUM
fnp-3866	246	47	)	)	PUNCT
fnp-3866	246	48	.	.	PUNCT
fnp-3866	247	1	dystrophic	dystrophic	ADJ
fnp-3866	247	2	microglia	microglia	NOUN
fnp-3866	247	3	are	be	AUX
fnp-3866	247	4	associated	associate	VERB
fnp-3866	247	5	with	with	ADP
fnp-3866	247	6	neurodegenerative	neurodegenerative	ADJ
fnp-3866	247	7	disease	disease	NOUN
fnp-3866	247	8	and	and	CCONJ
fnp-3866	247	9	not	not	PART
fnp-3866	247	10	healthy	healthy	ADJ
fnp-3866	247	11	aging	aging	NOUN
fnp-3866	247	12	in	in	ADP
fnp-3866	247	13	the	the	DET
fnp-3866	247	14	human	human	ADJ
fnp-3866	247	15	brain	brain	NOUN
fnp-3866	247	16	.	.	PUNCT
fnp-3866	248	1	neurobiology	neurobiology	NOUN
fnp-3866	248	2	of	of	ADP
fnp-3866	248	3	aging	aging	NOUN
fnp-3866	248	4	,	,	PUNCT
fnp-3866	248	5	99	99	NUM
fnp-3866	248	6	,	,	PUNCT
fnp-3866	248	7	19–27	19–27	NUM
fnp-3866	248	8	.	.	PUNCT
fnp-3866	249	1	https://doi.org/10.1016/j.neurobiolaging.2020.12.003	https://doi.org/10.1016/j.neurobiolaging.2020.12.003	PROPN
fnp-3866	249	2	shen	shen	PROPN
fnp-3866	249	3	,	,	PUNCT
fnp-3866	249	4	w.-b	w.-b	PROPN
fnp-3866	249	5	.	.	PROPN
fnp-3866	249	6	,	,	PUNCT
fnp-3866	249	7	logue	logue	PROPN
fnp-3866	249	8	,	,	PUNCT
fnp-3866	249	9	j.	j.	PROPN
fnp-3866	249	10	,	,	PUNCT
fnp-3866	249	11	yang	yang	PROPN
fnp-3866	249	12	,	,	PUNCT
fnp-3866	249	13	p.	p.	PROPN
fnp-3866	249	14	,	,	PUNCT
fnp-3866	249	15	baracco	baracco	NOUN
fnp-3866	249	16	,	,	PUNCT
fnp-3866	249	17	l.	l.	PROPN
fnp-3866	249	18	,	,	PUNCT
fnp-3866	249	19	elahi	elahi	PROPN
fnp-3866	249	20	,	,	PUNCT
fnp-3866	249	21	m.	m.	NOUN
fnp-3866	249	22	,	,	PUNCT
fnp-3866	249	23	reece	reece	PROPN
fnp-3866	249	24	,	,	PUNCT
fnp-3866	249	25	e.	e.	PROPN
fnp-3866	249	26	a.	a.	PROPN
fnp-3866	249	27	,	,	PUNCT
fnp-3866	249	28	wang	wang	PROPN
fnp-3866	249	29	,	,	PUNCT
fnp-3866	249	30	b.	b.	PROPN
fnp-3866	249	31	,	,	PUNCT
fnp-3866	249	32	li	li	PROPN
fnp-3866	249	33	,	,	PUNCT
fnp-3866	249	34	l.	l.	PROPN
fnp-3866	249	35	,	,	PUNCT
fnp-3866	249	36	blanchard	blanchard	NOUN
fnp-3866	249	37	,	,	PUNCT
fnp-3866	249	38	t.	t.	PROPN
fnp-3866	249	39	g.	g.	PROPN
fnp-3866	249	40	,	,	PUNCT
fnp-3866	249	41	han	han	PROPN
fnp-3866	249	42	,	,	PUNCT
fnp-3866	249	43	z.	z.	PROPN
fnp-3866	249	44	,	,	PUNCT
fnp-3866	249	45	frieman	frieman	PROPN
fnp-3866	249	46	,	,	PUNCT
fnp-3866	249	47	m.	m.	PROPN
fnp-3866	249	48	b.	b.	PROPN
fnp-3866	249	49	,	,	PUNCT
fnp-3866	249	50	rissman	rissman	NOUN
fnp-3866	249	51	,	,	PUNCT
fnp-3866	249	52	r.	r.	PROPN
fnp-3866	249	53	a.	a.	PROPN
fnp-3866	249	54	,	,	PUNCT
fnp-3866	249	55	&	&	CCONJ
fnp-3866	249	56	yang	yang	PROPN
fnp-3866	249	57	,	,	PUNCT
fnp-3866	249	58	p.	p.	NOUN
fnp-3866	249	59	(	(	PUNCT
fnp-3866	249	60	2022	2022	NUM
fnp-3866	249	61	)	)	PUNCT
fnp-3866	249	62	.	.	PUNCT
fnp-3866	250	1	sars	sar	NOUN
fnp-3866	250	2	-	-	PUNCT
fnp-3866	250	3	cov-2	cov-2	PART
fnp-3866	250	4	invades	invade	VERB
fnp-3866	250	5	cognitive	cognitive	ADJ
fnp-3866	250	6	centers	center	NOUN
fnp-3866	250	7	of	of	ADP
fnp-3866	250	8	the	the	DET
fnp-3866	250	9	brain	brain	NOUN
fnp-3866	250	10	and	and	CCONJ
fnp-3866	250	11	induces	induce	VERB
fnp-3866	250	12	alzheimer’s	alzheimer’s	ADJ
fnp-3866	250	13	-	-	PUNCT
fnp-3866	250	14	like	like	ADJ
fnp-3866	250	15	neuropathology	neuropathology	NOUN
fnp-3866	250	16	.	.	PUNCT
fnp-3866	251	1	biorxiv	biorxiv	NOUN
fnp-3866	251	2	:	:	PUNCT
fnp-3866	252	1	the	the	DET
fnp-3866	252	2	preprint	preprint	NOUN
fnp-3866	252	3	server	server	NOUN
fnp-3866	252	4	for	for	ADP
fnp-3866	252	5	biology	biology	NOUN
fnp-3866	252	6	,	,	PUNCT
fnp-3866	252	7	2022.01.31.478476	2022.01.31.478476	NOUN
fnp-3866	252	8	.	.	PUNCT
fnp-3866	253	1	https://doi.org/10.1101/2022.01.31.478476	https://doi.org/10.1101/2022.01.31.478476	PROPN
fnp-3866	253	2	taquet	taquet	NOUN
fnp-3866	253	3	,	,	PUNCT
fnp-3866	253	4	m.	m.	NOUN
fnp-3866	253	5	,	,	PUNCT
fnp-3866	253	6	geddes	geddes	PROPN
fnp-3866	253	7	,	,	PUNCT
fnp-3866	253	8	j.	j.	PROPN
fnp-3866	253	9	r.	r.	PROPN
fnp-3866	253	10	,	,	PUNCT
fnp-3866	253	11	husain	husain	PROPN
fnp-3866	253	12	,	,	PUNCT
fnp-3866	253	13	m.	m.	NOUN
fnp-3866	253	14	,	,	PUNCT
fnp-3866	253	15	luciano	luciano	PROPN
fnp-3866	253	16	,	,	PUNCT
fnp-3866	253	17	s.	s.	PROPN
fnp-3866	253	18	,	,	PUNCT
fnp-3866	253	19	&	&	CCONJ
fnp-3866	253	20	harrison	harrison	PROPN
fnp-3866	253	21	,	,	PUNCT
fnp-3866	253	22	p.	p.	PROPN
fnp-3866	253	23	j.	j.	PROPN
fnp-3866	253	24	(	(	PUNCT
fnp-3866	253	25	2021	2021	NUM
fnp-3866	253	26	)	)	PUNCT
fnp-3866	253	27	.	.	PUNCT
fnp-3866	254	1	6	6	NUM
fnp-3866	254	2	-	-	PUNCT
fnp-3866	254	3	month	month	NOUN
fnp-3866	254	4	neurological	neurological	ADJ
fnp-3866	254	5	and	and	CCONJ
fnp-3866	254	6	psychiatric	psychiatric	ADJ
fnp-3866	254	7	outcomes	outcome	NOUN
fnp-3866	254	8	in	in	ADP
fnp-3866	254	9	236	236	NUM
fnp-3866	254	10	 	 	SPACE
fnp-3866	254	11	379	379	NUM
fnp-3866	254	12	survivors	survivor	NOUN
fnp-3866	254	13	of	of	ADP
fnp-3866	254	14	covid-19	covid-19	PROPN
fnp-3866	254	15	:	:	PUNCT
fnp-3866	254	16	a	a	DET
fnp-3866	254	17	retrospective	retrospective	ADJ
fnp-3866	254	18	cohort	cohort	NOUN
fnp-3866	254	19	study	study	NOUN
fnp-3866	254	20	using	use	VERB
fnp-3866	254	21	electronic	electronic	ADJ
fnp-3866	254	22	health	health	NOUN
fnp-3866	254	23	records	record	NOUN
fnp-3866	254	24	.	.	PUNCT
fnp-3866	255	1	the	the	DET
fnp-3866	255	2	lancet	lancet	PROPN
fnp-3866	255	3	.	.	PUNCT
fnp-3866	256	1	psychiatry	psychiatry	NOUN
fnp-3866	256	2	,	,	PUNCT
fnp-3866	256	3	8(5	8(5	NUM
fnp-3866	256	4	)	)	PUNCT
fnp-3866	256	5	,	,	PUNCT
fnp-3866	256	6	416–427	416–427	NUM
fnp-3866	256	7	.	.	PUNCT
fnp-3866	257	1	https://doi.org/10.1016/s2215-0366(21)00084-5	https://doi.org/10.1016/s2215-0366(21)00084-5	NOUN
fnp-3866	257	2	villa	villa	PROPN
fnp-3866	257	3	,	,	PUNCT
fnp-3866	257	4	c.	c.	PROPN
fnp-3866	257	5	,	,	PUNCT
fnp-3866	257	6	rivellini	rivellini	PROPN
fnp-3866	257	7	,	,	PUNCT
fnp-3866	257	8	e.	e.	PROPN
fnp-3866	257	9	,	,	PUNCT
fnp-3866	257	10	lavitrano	lavitrano	PROPN
fnp-3866	257	11	,	,	PUNCT
fnp-3866	257	12	m.	m.	NOUN
fnp-3866	257	13	,	,	PUNCT
fnp-3866	257	14	&	&	CCONJ
fnp-3866	257	15	combi	combi	PROPN
fnp-3866	257	16	,	,	PUNCT
fnp-3866	257	17	r.	r.	PROPN
fnp-3866	257	18	(	(	PUNCT
fnp-3866	257	19	2022	2022	NUM
fnp-3866	257	20	)	)	PUNCT
fnp-3866	257	21	.	.	PUNCT
fnp-3866	258	1	can	can	AUX
fnp-3866	258	2	sars	sars	PROPN
fnp-3866	258	3	-	-	PUNCT
fnp-3866	258	4	cov-2	cov-2	PART
fnp-3866	258	5	infection	infection	NOUN
fnp-3866	258	6	exacerbate	exacerbate	VERB
fnp-3866	258	7	alzheimer	alzheimer	PROPN
fnp-3866	258	8	’s	’s	PART
fnp-3866	258	9	disease	disease	NOUN
fnp-3866	258	10	?	?	PUNCT
fnp-3866	259	1	an	an	DET
fnp-3866	259	2	overview	overview	NOUN
fnp-3866	259	3	of	of	ADP
fnp-3866	259	4	shared	share	VERB
fnp-3866	259	5	risk	risk	NOUN
fnp-3866	259	6	factors	factor	NOUN
fnp-3866	259	7	and	and	CCONJ
fnp-3866	259	8	pathogenetic	pathogenetic	ADJ
fnp-3866	259	9	mechanisms	mechanism	NOUN
fnp-3866	259	10	.	.	PUNCT
fnp-3866	260	1	journal	journal	NOUN
fnp-3866	260	2	of	of	ADP
fnp-3866	260	3	personalized	personalized	ADJ
fnp-3866	260	4	medicine	medicine	NOUN
fnp-3866	260	5	,	,	PUNCT
fnp-3866	260	6	12(1	12(1	NUM
fnp-3866	260	7	)	)	PUNCT
fnp-3866	260	8	,	,	PUNCT
fnp-3866	260	9	29	29	NUM
fnp-3866	260	10	.	.	PUNCT
fnp-3866	261	1	https://doi.org/10.3390/jpm12010029	https://doi.org/10.3390/jpm12010029	PROPN
fnp-3866	261	2	zhao	zhao	PROPN
fnp-3866	261	3	,	,	PUNCT
fnp-3866	261	4	y.	y.	PROPN
fnp-3866	261	5	,	,	PUNCT
fnp-3866	261	6	li	li	PROPN
fnp-3866	261	7	,	,	PUNCT
fnp-3866	261	8	w.	w.	PROPN
fnp-3866	261	9	,	,	PUNCT
fnp-3866	261	10	&	&	CCONJ
fnp-3866	261	11	lukiw	lukiw	PROPN
fnp-3866	261	12	,	,	PUNCT
fnp-3866	261	13	w.	w.	NOUN
fnp-3866	261	14	(	(	PUNCT
fnp-3866	261	15	2021	2021	NUM
fnp-3866	261	16	)	)	PUNCT
fnp-3866	261	17	.	.	PUNCT
fnp-3866	262	1	ubiquity	ubiquity	NOUN
fnp-3866	262	2	of	of	ADP
fnp-3866	262	3	the	the	DET
fnp-3866	262	4	sars	sar	NOUN
fnp-3866	262	5	-	-	PUNCT
fnp-3866	262	6	cov-2	cov-2	NOUN
fnp-3866	262	7	receptor	receptor	NOUN
fnp-3866	262	8	ace2	ace2	NOUN
fnp-3866	262	9	and	and	CCONJ
fnp-3866	262	10	upregulation	upregulation	NOUN
fnp-3866	262	11	in	in	ADP
fnp-3866	262	12	limbic	limbic	ADJ
fnp-3866	262	13	regions	region	NOUN
fnp-3866	262	14	of	of	ADP
fnp-3866	262	15	alzheimer	alzheimer	PROPN
fnp-3866	262	16	’s	’s	PART
fnp-3866	262	17	disease	disease	NOUN
fnp-3866	262	18	brain	brain	NOUN
fnp-3866	262	19	.	.	PUNCT
fnp-3866	263	1	folia	folia	PROPN
fnp-3866	263	2	neuropathologica	neuropathologica	PROPN
fnp-3866	263	3	,	,	PUNCT
fnp-3866	263	4	59(3	59(3	NUM
fnp-3866	263	5	)	)	PUNCT
fnp-3866	263	6	,	,	PUNCT
fnp-3866	263	7	232–238	232–238	NUM
fnp-3866	263	8	.	.	PUNCT
fnp-3866	264	1	https://doi.org/10.5114/fn.2021.109495	https://doi.org/10.5114/fn.2021.109495	ADJ
fnp-3866	264	2	copyright	copyright	NOUN
fnp-3866	264	3	:	:	PUNCT
fnp-3866	264	4	©	©	PROPN
fnp-3866	264	5	2022	2022	NUM
fnp-3866	264	6	the	the	DET
fnp-3866	264	7	author(s	author(s	NOUN
fnp-3866	264	8	)	)	PUNCT
fnp-3866	264	9	.	.	PUNCT
fnp-3866	265	1	this	this	PRON
fnp-3866	265	2	is	be	AUX
fnp-3866	265	3	an	an	DET
fnp-3866	265	4	open	open	ADJ
fnp-3866	265	5	access	access	NOUN
fnp-3866	265	6	article	article	NOUN
fnp-3866	265	7	distributed	distribute	VERB
fnp-3866	265	8	under	under	ADP
fnp-3866	265	9	the	the	DET
fnp-3866	265	10	terms	term	NOUN
fnp-3866	265	11	of	of	ADP
fnp-3866	265	12	the	the	DET
fnp-3866	265	13	creative	creative	ADJ
fnp-3866	265	14	commons	common	NOUN
fnp-3866	265	15	attribution	attribution	NOUN
fnp-3866	265	16	4.0	4.0	NUM
fnp-3866	265	17	international	international	ADJ
fnp-3866	265	18	license	license	NOUN
fnp-3866	265	19	(	(	PUNCT
fnp-3866	265	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-3866	265	21	)	)	PUNCT
fnp-3866	265	22	,	,	PUNCT
fnp-3866	265	23	which	which	PRON
fnp-3866	265	24	permits	permit	VERB
fnp-3866	265	25	unrestricted	unrestricted	ADJ
fnp-3866	265	26	use	use	NOUN
fnp-3866	265	27	,	,	PUNCT
fnp-3866	265	28	distribution	distribution	NOUN
fnp-3866	265	29	,	,	PUNCT
fnp-3866	265	30	and	and	CCONJ
fnp-3866	265	31	reproduction	reproduction	NOUN
fnp-3866	265	32	in	in	ADP
fnp-3866	265	33	any	any	DET
fnp-3866	265	34	medium	medium	NOUN
fnp-3866	265	35	,	,	PUNCT
fnp-3866	265	36	provided	provide	VERB
fnp-3866	265	37	the	the	DET
fnp-3866	265	38	original	original	ADJ
fnp-3866	265	39	author	author	NOUN
fnp-3866	265	40	and	and	CCONJ
fnp-3866	265	41	source	source	NOUN
fnp-3866	265	42	are	be	AUX
fnp-3866	265	43	credited	credit	VERB
fnp-3866	265	44	,	,	PUNCT
fnp-3866	265	45	a	a	DET
fnp-3866	265	46	link	link	NOUN
fnp-3866	265	47	to	to	ADP
fnp-3866	265	48	the	the	DET
fnp-3866	265	49	creative	creative	ADJ
fnp-3866	265	50	commons	common	NOUN
fnp-3866	265	51	license	license	NOUN
fnp-3866	265	52	is	be	AUX
fnp-3866	265	53	provided	provide	VERB
fnp-3866	265	54	,	,	PUNCT
fnp-3866	265	55	and	and	CCONJ
fnp-3866	265	56	any	any	DET
fnp-3866	265	57	changes	change	NOUN
fnp-3866	265	58	are	be	AUX
fnp-3866	265	59	indicated	indicate	VERB
fnp-3866	265	60	.	.	PUNCT
fnp-3866	266	1	the	the	DET
fnp-3866	266	2	creative	creative	ADJ
fnp-3866	266	3	commons	common	NOUN
fnp-3866	266	4	public	public	ADJ
fnp-3866	266	5	domain	domain	NOUN
fnp-3866	266	6	dedication	dedication	NOUN
fnp-3866	266	7	waiver	waiver	NOUN
fnp-3866	266	8	(	(	PUNCT
fnp-3866	266	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-3866	266	10	)	)	PUNCT
fnp-3866	266	11	applies	apply	VERB
fnp-3866	266	12	to	to	ADP
fnp-3866	266	13	the	the	DET
fnp-3866	266	14	data	datum	NOUN
fnp-3866	266	15	made	make	VERB
fnp-3866	266	16	available	available	ADJ
fnp-3866	266	17	in	in	ADP
fnp-3866	266	18	this	this	DET
fnp-3866	266	19	article	article	NOUN
fnp-3866	266	20	,	,	PUNCT
fnp-3866	266	21	unless	unless	SCONJ
fnp-3866	266	22	otherwise	otherwise	ADV
fnp-3866	266	23	stated	state	VERB
fnp-3866	266	24	.	.	PUNCT